| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAV8-Factor IX Hepatic Gene Transfer with Transient Immunosuppression Is Safe but Is Abrogated by Low Titers of Neutralizing Antibody in Rhesus Macaques.
|
Jiang, Haiyan
|
|
|
106 |
11 |
p. 5532
|
artikel
|
| 2 |
Aberrant Autocrine and Paracrine CD40L Signaling Promotes Primary Myeloma Cell Survival and Attenuates Bortezomib-Induced Apoptosis.
|
Chen-Kiang, Selina
|
|
|
106 |
11 |
p. 1564
|
artikel
|
| 3 |
Aberrant Cell Cycle and Expression Profiles of Cell Cycle Regulatory Genes in Myelodysplastic Syndrome.
|
Shao, Zonghong
|
|
|
106 |
11 |
p. 4897
|
artikel
|
| 4 |
Aberrant DNA Methylation of a Cell Cycle Regulatory Pathway Composed of p73, p15 and P57kip2 Is Associated with Poor Prognosis in Adult Patients with Philadelphia Chromosome Negative Acute Lymphocytic Leukemia (ALL).
|
Yang, Hui
|
|
|
106 |
11 |
p. 481
|
artikel
|
| 5 |
Aberrant DNA Methylation of the C/EBPalpha Promoter Region in Hematopoietic Malignancies.
|
Jost, Edgar
|
|
|
106 |
11 |
p. 4236
|
artikel
|
| 6 |
Aberrant Expression of Ikaros Induces T-Cell Leukemia/Lymphoma in Mice without Wild-Type Allelic Loss.
|
Kataoka, Itaru
|
|
|
106 |
11 |
p. 1224
|
artikel
|
| 7 |
Aberrant Expression of Trail in B Chronic Lymphocytic Leukemia (B-CLL) Cells.
|
Tiribelli, Mario
|
|
|
106 |
11 |
p. 4976
|
artikel
|
| 8 |
Aberrant Pre-mRNA Processing Due to Novel Splicing Mutations in the CBL Proto-Oncogene in Acute Myeloid Leukemia.
|
Arnoczky, Kristy J.
|
|
|
106 |
11 |
p. 4400
|
artikel
|
| 9 |
Aberrant Somatic Hypermutation in Extranodal Marginal Zone B-Cell Lymphoma of MALT Type.
|
Deutsch, Alexander
|
|
|
106 |
11 |
p. 417
|
artikel
|
| 10 |
A Better Strategy To Extend the Proliferative Lifespan of Human T-Cells In Vitro.
|
Roeth, Alexander
|
|
|
106 |
11 |
p. 2398
|
artikel
|
| 11 |
A Bioinformatic Approach to CLL IGHV Sequence Analysis Identifies Extensive Ig Sequence Archetypes among BothMutated and Unmutated Sequences.
|
Messmer, Bradley T.
|
|
|
106 |
11 |
p. 176
|
artikel
|
| 12 |
A Biologically Distinctive Subgroup of Acute Myelogenous Leukemia with Characteristic Nuclear Morphology and a High Frequency of FLT3 Mutation.
|
Chen, Weina
|
|
|
106 |
11 |
p. 4522
|
artikel
|
| 13 |
5′-ABL Gene Deletion on Derivative Chromosome 9 Detected by FISH: Prognostic Significance in CML Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
|
Chaudhri, Naeem A.
|
|
|
106 |
11 |
p. 2039
|
artikel
|
| 14 |
Abnormal Angiogenesis, Neurogenesis and Lymphangiogenesis in the Skin Underlies Delayed Wound Healing in the Sickle Mouse: Acceleration of Healing by Topical Opioids.
|
Gupta, Kalpna
|
|
|
106 |
11 |
p. 3177
|
artikel
|
| 15 |
Abnormal Bone Marrow-Derived Mesenchymal Stem Cell: Another Clone in Hematological Malignancy?.
|
Yeh, Su-Peng
|
|
|
106 |
11 |
p. 1397
|
artikel
|
| 16 |
Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom's Macroglobulinemia.
|
Xu, Lian
|
|
|
106 |
11 |
p. 1003
|
artikel
|
| 17 |
Abnormal PI 3-Kinase Activity Due to Increased Lyn with Decreased PTEN and Absent SHIP in Bone Marrow Cells from Patients with Myelodysplastic Syndromes.
|
Lee, Daniel W.
|
|
|
106 |
11 |
p. 3446
|
artikel
|
| 18 |
Abnormal Platelet Function Is Common in Pediatric Congenital Cardiac Surgery Patients.
|
Boshkov, Lynn K.
|
|
|
106 |
11 |
p. 2182
|
artikel
|
| 19 |
Abnormal Pulmonary Function in Adults and Children with Sickle Cell Disease.
|
Morris, Claudia R.
|
|
|
106 |
11 |
p. 2319
|
artikel
|
| 20 |
Abnormal Pulmonary Function in Adults with Sickle Cell Disease: Association of Decreased DLCO with Systemic Disease.
|
Klings, Elizabeth S.
|
|
|
106 |
11 |
p. 316
|
artikel
|
| 21 |
ABO Mismatched Platelet, Plasma and Cryoprecipitate Transfusions and Bleeding in Transfused Surgical Patients.
|
Blumberg, Neil
|
|
|
106 |
11 |
p. 4166
|
artikel
|
| 22 |
A Breakage-Fusion-Bridge Cycle Generated by Telomeric Loss May Underlie the dup(21q) of Acute Lymphoblastic Leukemia.
|
Robinson, Hazel M.
|
|
|
106 |
11 |
p. 2843
|
artikel
|
| 23 |
Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.
|
Nishio, Mitsufumi
|
|
|
106 |
11 |
p. 1412
|
artikel
|
| 24 |
Absence of nNOS Increases Longevity of Long Term Bone Marrow Cultures and Radiation Resistance.
|
Cao, Shaonan
|
|
|
106 |
11 |
p. 4197
|
artikel
|
| 25 |
Absence of P21 Gene Augments Proliferation of Mesenchymal Stem Cells.
|
Tsai, Anthony Y.
|
|
|
106 |
11 |
p. 3039
|
artikel
|
| 26 |
Absence of Spred1, a Negative Regulator of Ras/MAPK Pathway, as a Mechanism Responsible for the Constitutive Activation of RTK Mediated Signalling in Acute Leukemias.
|
Cilloni, Daniela
|
|
|
106 |
11 |
p. 2287
|
artikel
|
| 27 |
Absolute Lymphocyte Count and CD4 Count Predict a Superior Progression-Free Survival in Non-Hodgkin Lymphoma Patients Treated with Rituximab and Interleukin-12.
|
Joao, Cristina
|
|
|
106 |
11 |
p. 1495
|
artikel
|
| 28 |
Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin's Disease.
|
Siddiqui, Mustaqeem
|
|
|
106 |
11 |
p. 2667
|
artikel
|
| 29 |
Absolute Lymphocyte Count Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP or R-CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.
|
Porrata, Luis F.
|
|
|
106 |
11 |
p. 931
|
artikel
|
| 30 |
Absolute Number of Transplanted CD34+ Cells Expressing c-mpl (CD110) Correlates with Speed of Platelet Engraftment Following Autologous Stem Cell Transplantation.
|
Sartor, Mary
|
|
|
106 |
11 |
p. 1078
|
artikel
|
| 31 |
Absolute Quantitative Detection of Abl Tyrosine Kinase Domain Mutations Using a Novel Microfluidic Platform and Allele-Specific PCR.
|
Oehler, Vivian
|
|
|
106 |
11 |
p. 2859
|
artikel
|
| 32 |
Absolute Values of Serum Immunoglobulin Free Light Chains Predict for Survival in Patients with Primary Systemic Amyloidosis Undergoing Peripheral Blood Stem Cell Transplant.
|
Dispenzieri, Angela
|
|
|
106 |
11 |
p. 422
|
artikel
|
| 33 |
ABT-737, an Inhibitor of Bcl-2/Bcl-XL Proteins, Is Cytotoxic in Multiple Myeloma Cells.
|
Kline, Michael
|
|
|
106 |
11 |
p. 1589
|
artikel
|
| 34 |
ABVD with Pegfilgrastim (Neulasta) Support in Newly Diagnosed Hodgkin Lymphoma: Long-Term Safety and Efficacy Results of a Phase-II Study.
|
Younes, Anas
|
|
|
106 |
11 |
p. 4790
|
artikel
|
| 35 |
A Case Illustrating That Cancer Tips the Scale of Thrombosis.
|
Scott, Emma C.
|
|
|
106 |
11 |
p. 4128
|
artikel
|
| 36 |
A Case of Acquired Hemophilia Post Treatment with Recombinant Human Activated Protein C (rh APC).
|
Patsiornik, Yelena
|
|
|
106 |
11 |
p. 4021
|
artikel
|
| 37 |
A Case of Chronic Myelomonocytic Leukemia Progressing from Dysplastic to Proliferative Phenotype after Acquisition of a RAS Point Mutation.
|
Ricci, Clara
|
|
|
106 |
11 |
p. 4958
|
artikel
|
| 38 |
A Case of Fulminant Myelodysplastic Syndrome Versus Acute Erythroleukemia Variant.
|
Mazzella, Fermina M.
|
|
|
106 |
11 |
p. 4900
|
artikel
|
| 39 |
A Case of Multiple Myeloma(MM) with Myelofiblosis(MF) Undergone Autologous Peripherial Blood Stem Cell Transplantation.
|
Jiang, Zhisheng
|
|
|
106 |
11 |
p. 5496
|
artikel
|
| 40 |
A Case of Prekallikrein Deficiency in a Pediatric Patient.
|
Carpenter, Shannon L.
|
|
|
106 |
11 |
p. 4100
|
artikel
|
| 41 |
A Case Report of Prophylactic Hemin Treatments in the Management of Patients with Life-Threatening Attacks of Acute Intermittent Porphyria.
|
Mills, Richard E.
|
|
|
106 |
11 |
p. 3757
|
artikel
|
| 42 |
A Case Study of a Patient with Chemotherapy Resistant CLL Successfully Retreated with Alemtuzumab.
|
Egyed, Miklós
|
|
|
106 |
11 |
p. 5037
|
artikel
|
| 43 |
A Cautionary Tale.
|
Pearlman, Eugene S.
|
|
|
106 |
11 |
p. 4978
|
artikel
|
| 44 |
Accelerated Delivery of Rituximab Is Safe on an Out-Patient Basis.
|
Middleton, Helen J.
|
|
|
106 |
11 |
p. 4777
|
artikel
|
| 45 |
Accelerated R-COP:A Pilot Study for the Treatment of Follicular Lymphoma.
|
Bertino, Joseph R.
|
|
|
106 |
11 |
p. 4747
|
artikel
|
| 46 |
Accelerated Shortening of Long Telomeres and Accumulation of Short Telomeres in Dyskeratosis Congenita.
|
Bessler, Monica
|
|
|
106 |
11 |
p. 1053
|
artikel
|
| 47 |
Acceleration of Leukemogenesis in NUP98-HOXD13 Transgenic Mice by Infection with the MOL4070LTR Virus, and Identification of Collaborating Genes.
|
Slape, Christopher
|
|
|
106 |
11 |
p. 1597
|
artikel
|
| 48 |
Accumulation of NFkB1 (p105) and NFkB2 (p100) Is Essential for Apoptosis Induced by Proteasome Inhibition in a Lymphoma Model.
|
Bernal-Mizrachi, Leon
|
|
|
106 |
11 |
p. 2607
|
artikel
|
| 49 |
A Clinical Database Supports Better Patient Care, and Clinical Research in a Sickle Cell Center at a Large County Hospital.
|
Jonas, William S.
|
|
|
106 |
11 |
p. 5579
|
artikel
|
| 50 |
A Comparative Analysis of Chromosome 13 Gene Expression and Copy Number Changes in Multiple Myeloma Using Array-Based Methods.
|
Baker, Angela S.
|
|
|
106 |
11 |
p. 1557
|
artikel
|
| 51 |
A Comparative Analysis of Outcomes in Primary Myelodysplastic Syndrome (MDS) and Therapy-Related MDS Reveals Two Subgroups with Differing Risk Profiles: Implications for the Application of a Prognostic Classification.
|
Alvares, Caroline
|
|
|
106 |
11 |
p. 2532
|
artikel
|
| 52 |
A Comparative Pharmacodynamic Study of Anti-Xa Activity To Evaluate the Accumulation Effect of Tinzaparin and Enoxaparin Given at Prophylactic Dose over 8 Days in Medical Elderly Patients with Impaired Renal Function.
|
Mahé, Isabelle
|
|
|
106 |
11 |
p. 4152
|
artikel
|
| 53 |
A Comparison of Administration Time between Red Blood Cell Transfusion and Chemotherapy.
|
Chin-Yee, Ian H.
|
|
|
106 |
11 |
p. 4186
|
artikel
|
| 54 |
A Comparison of Five Different Culture Protocols Shows That Growth of Human CD34+ Peripheral Blood Stem Cells in SCF, IL-3, Flt-3 Ligand and EPO Results in Exponential Erythroid Expansion and a Globin Gene Expression Pattern Which Is Similar to That Seen in Human Bone Marrow.
|
Mabaera, Rodwell H.
|
|
|
106 |
11 |
p. 3649
|
artikel
|
| 55 |
A Comparison of Mesenchymal Cells from Different Tissues To Suppress T-Cell Activation.
|
Keyser, Kirsten A.
|
|
|
106 |
11 |
p. 4323
|
artikel
|
| 56 |
A Comparison of Outcome and Second Malignancies in Adolescents and Adult Patients with Hodgkin's Lymphoma (HL). Results from the German Hodgkin Study Group.
|
Bredenfeld, Henning
|
|
|
106 |
11 |
p. 2670
|
artikel
|
| 57 |
A ComParison of Retroviral Integration Sites in Donor T-Lymphocytes In Vivo and In Vitro.
|
Giordano, Frank A.
|
|
|
106 |
11 |
p. 1403
|
artikel
|
| 58 |
A Comparison of 3 Staging Systems for the Outcome Following Autologous Stem Cell Transplantation (ASCT) in Patients with Multiple Myeloma (MM).
|
Sohn, Hee-Jung
|
|
|
106 |
11 |
p. 5479
|
artikel
|
| 59 |
A Comparison of Zap-70 by Immunohistochemistry and Flow Cytometry Using Two Different Flow Analysis Methods.
|
Hertzberg, Lawrence
|
|
|
106 |
11 |
p. 4994
|
artikel
|
| 60 |
A Comprehensive Analysis of Cytogenetic Abnormalities in Myeloma: Results of the FISH Analysis of 1000 Patients Enrolled in the IFM99 Trials.
|
Loiseau, Herve Avet
|
|
|
106 |
11 |
p. 622
|
artikel
|
| 61 |
A Comprehensive Set of In Vitro Transcribed RNAs as Controls for Leukemia Molecular Diagnostics.
|
Hedges, John
|
|
|
106 |
11 |
p. 4528
|
artikel
|
| 62 |
A Continous Recurrent Course in a Case of Nodular-Sclerosis (NS) Classical Hodgkin's Lymphoma (cHL) Associated with Castleman's Disease (CD).
|
Rauco, Annamaria
|
|
|
106 |
11 |
p. 4824
|
artikel
|
| 63 |
Acquired Bortezomib (Velcade®)-Resistance Is Accompanied by Downmodulation of Proteasome Activity and Upregulation of Tripeptidyl Peptidase II (TPPII) and a Ubiquitin-Specific Protease.
|
Driessen, Christoph
|
|
|
106 |
11 |
p. 3375
|
artikel
|
| 64 |
Acquired Extramedullary Resistance to Dasatinib Due to Selection of Philadelphia-Positive Lymphoblast Clone Harboring a T315I BCR-ABL Gene Mutation: Reversal by Dose Escalation and Hydroxyurea.
|
Lundan, Tuija
|
|
|
106 |
11 |
p. 4579
|
artikel
|
| 65 |
Acquired Factor XI Deficiency Associated with Chronic Hepatitis C in Patients with Inherited Bleeding Disorders.
|
Rangarajan, Savita
|
|
|
106 |
11 |
p. 1778
|
artikel
|
| 66 |
Acquired Hemophilia A: A Single Institution's Experience.
|
Randhawa, Devinderpal
|
|
|
106 |
11 |
p. 4103
|
artikel
|
| 67 |
Acquired Hemophilia: Single Center Experience with a Standardized Approach.
|
Sucker, Christoph
|
|
|
106 |
11 |
p. 4059
|
artikel
|
| 68 |
Acquired Notch1 Mutations in Murine Precursor-T Leukemia/Lymphoma Models.
|
Lin, Yingwei
|
|
|
106 |
11 |
p. 2612
|
artikel
|
| 69 |
Acquired Pure Red Cell Aplasia Associated with Alemtuzumab, Mycophenolate, and Daclizumab Immunosuppression after Pancreas Transplant.
|
Elimelakh, Milena
|
|
|
106 |
11 |
p. 1058
|
artikel
|
| 70 |
Acquired Resistance to Activated Protein C (aAPCR) Is Associated with Increased Risk of Deep Vein Thrombosis in Multiple Myeloma.
|
Elice, Francesca
|
|
|
106 |
11 |
p. 3484
|
artikel
|
| 71 |
Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population.
|
Feng, Ying
|
|
|
106 |
11 |
p. 4124
|
artikel
|
| 72 |
Acquired Sideroblastic Anaemia Unresponsive to Pyridoxine Caused by a Somatic Mutation in ALA Synthase 2.
|
May, Alison
|
|
|
106 |
11 |
p. 3542
|
artikel
|
| 73 |
A Critical Role for the Bcl-2 Pathway in Notch-Mediated B Cell Apoptosis, Where Growth Arrest Is Independent of the E2A, IL-3 and p21Waf1/p27Kip1 Pathways.
|
Zweidler-McKay, Patrick A.
|
|
|
106 |
11 |
p. 237
|
artikel
|
| 74 |
A Critical Role of Blockade of Cell Differentiation in BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia (B-ALL): Basis for Superb Therapeutic Effect on B-ALL in Mice by Promotion of Pro-B Leukemic Cell Differentiation and Treatment with Imatinib.
|
Hu, Yiguo
|
|
|
106 |
11 |
p. 844
|
artikel
|
| 75 |
A Critical Role of Platelets and the Par4 Receptor in Developmental Growth Arrest of Thrombomodulin Null Embryos.
|
Sood, Rashmi
|
|
|
106 |
11 |
p. 529
|
artikel
|
| 76 |
A Critical Role of the Rho Family GTPase Cdc42 in Hematopoietic Stem Cell Mobilization, Homing, Engraftment and Differentiation.
|
Yang, Linda
|
|
|
106 |
11 |
p. 269
|
artikel
|
| 77 |
Activated JAK2 Signaling in Primary Human Hematopoietic Cells Drives Erythropoietin-Independent Erythropoiesis and Myelofibrosis.
|
Kennedy, James A.
|
|
|
106 |
11 |
p. 374
|
artikel
|
| 78 |
Activated Protein C Light Chain Mutations Distinguish Exosite Residue Requirements for Anticoagulant Versus Cytoprotective Activities.
|
Mosnier, Laurent O.
|
|
|
106 |
11 |
p. 29
|
artikel
|
| 79 |
Activated Protein C-Resistance Induced by a Low Molecular Weight Inhibitor.
|
Kalafatis, Michael
|
|
|
106 |
11 |
p. 2136
|
artikel
|
| 80 |
Activating FLT3 Mutations in CD4+/CD8− Pediatric T-Cell Acute Lymphoblastic Leukemias.
|
Van Vlierberghe, Pieter
|
|
|
106 |
11 |
p. 1465
|
artikel
|
| 81 |
Activating Notch1 Mutations Are an Early Event in T-Cell Malignancy of Ikaros Point Mutant Mice.
|
Mantha, Simon
|
|
|
106 |
11 |
p. 2616
|
artikel
|
| 82 |
Activating NOTCH1 Mutations Are Associated with Good Treatment Response in Childhood T-Cell Acute Lymphoblastic Leukemia.
|
Breit, Stephen
|
|
|
106 |
11 |
p. 1444
|
artikel
|
| 83 |
Activating Notch1 Mutations in Mouse Models of T-ALL.
|
O'Neil, Jennifer
|
|
|
106 |
11 |
p. 2609
|
artikel
|
| 84 |
Activating PTPN11 Mutants Promote Myelomonocytic Differentiation Due to Altered Hematopoietic Lineage-Specific Transcription Factor Expression.
|
Chan, Rebecca J.
|
|
|
106 |
11 |
p. 3519
|
artikel
|
| 85 |
Activation-Independent Platelet Adhesion and Aggregation under Elevated Shear Stress.
|
Ruggeri, Zaverio M.
|
|
|
106 |
11 |
p. 411
|
artikel
|
| 86 |
Activation of AKT and Enhanced Resistance to Apoptosis Induced by Surface IgM Ligation in ZAP-70-Positive Chronic Lymphocytic Leukemia B Cells.
|
Chen, Liguang
|
|
|
106 |
11 |
p. 2940
|
artikel
|
| 87 |
Activation of a Novel Proteasomal Independent Bcr/Abl Degradation Pathway by WP1130 Induces Apoptosis in CML Cells.
|
Bartholomeusz, Geoffrey A.
|
|
|
106 |
11 |
p. 2862
|
artikel
|
| 88 |
Activation of C/EBPα in Hematopoietic Stem Cells Leads to Growth Suppression and Impairment of Megakaryocyte Differentiation.
|
Fukuchi, Yumi
|
|
|
106 |
11 |
p. 2264
|
artikel
|
| 89 |
Activation of Clotting Factors in Thrombocytopenia Due to Platelets Destruction: A Possible Compensated Mechanism for Hemostasis.
|
Fontana, Vincenzo
|
|
|
106 |
11 |
p. 3999
|
artikel
|
| 90 |
Activation of Endothelial Cells, Coagulation and Fibrinolysis in Thai Children with Dengue Virus Infection.
|
Sosothikul, Darintr
|
|
|
106 |
11 |
p. 4039
|
artikel
|
| 91 |
Activation of HIV-1-Specific CD8+ and CD4+ Autologous Memory T-Cells by Dendritic Cells and B-Cells Electroporated with mRNA Encoding Consensus or Autologous HIV-1 Proteins.
|
Berneman, Zwi N.
|
|
|
106 |
11 |
p. 326
|
artikel
|
| 92 |
Activation of mTOR Signaling Pathway Contributes to Tumoral Cell Survival in ALK-Positive Anaplastic Large Cell Lymphoma.
|
Vega, Francisco
|
|
|
106 |
11 |
p. 2419
|
artikel
|
| 93 |
Activation of Phospholipase C γ 2 in Lymphoma Cells.
|
Huynh, Minh Q.
|
|
|
106 |
11 |
p. 1220
|
artikel
|
| 94 |
Activation of Platelet α Iibβ 3 by Exogenous Peptides Corresponding to the Transmembrane Domains of α Iib and β 3.
|
Yin, Hang
|
|
|
106 |
11 |
p. 384
|
artikel
|
| 95 |
Activation of the Classical Pathway of Complement by Resting and Shear Stress-Stimulated Human Endothelial Cells.
|
Yin, Wei
|
|
|
106 |
11 |
p. 2664
|
artikel
|
| 96 |
Activation of the P38 MAPK Pathway Mediates Resistance to Ara-C y Bcr/Abl Positive Cells.
|
Sanchez, Victor J.
|
|
|
106 |
11 |
p. 1528
|
artikel
|
| 97 |
Activation of the Unfolded Protein Response in Acute Leukemia and Myeloma.
|
Yujiri, Toshiaki
|
|
|
106 |
11 |
p. 4348
|
artikel
|
| 98 |
Active Combination Therapy of Bortezomib (Velcade) and Ibritumomab Tiuxetan (Zevalin) in an In Vivo Diffuse Large B-Cell Lymphoma Model.
|
Pervan, Milena
|
|
|
106 |
11 |
p. 2406
|
artikel
|
| 99 |
Active Management of Third Stage Labor Is Associated with a Lower Cord Blood Unit Volume.
|
Lapierre, Valerie
|
|
|
106 |
11 |
p. 5282
|
artikel
|
| 100 |
Activity of ABT-737, an Inhibitor of BCL-2 Family Proteins, in Imatinib- or Dasatinib-Resistant CML Cells: Involvement of BCL-2 Family Proteins for Drug Resistance.
|
Tauchi, Tetsuzo
|
|
|
106 |
11 |
p. 3364
|
artikel
|
| 101 |
Activity of Targeted Molecular Therapeutics Against Primary AML Cells: Putative Role of the Bone Marrow Microenvironment.
|
McQueen, Teresa
|
|
|
106 |
11 |
p. 2304
|
artikel
|
| 102 |
Activity of the Histone Deacetylase (HDAC) Inhibitor PXD101 in Preclinical Studies and in a Phase I Study in Patients with Advanced Haematological Tumors.
|
Gimsing, Peter
|
|
|
106 |
11 |
p. 3337
|
artikel
|
| 103 |
Activity of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in 22 Patients with Relapsed and Refractory Mantle Cell Lymphoma (MCL).
|
Younes, Anas
|
|
|
106 |
11 |
p. 2452
|
artikel
|
| 104 |
Activity Profiling of Proteasome Subunits and Deubiquitinating Enzymes in Human Hematopoetic Malignancies.
|
Driessen, Christoph
|
|
|
106 |
11 |
p. 617
|
artikel
|
| 105 |
Acute Activation of Endothelium Induces Circulation of Active Von Willebrand Factor in HELLP Sydrome.
|
Hulstein, Janine J.
|
|
|
106 |
11 |
p. 2658
|
artikel
|
| 106 |
Acute Differentiated Dendritic Cell Leukemia: A New Form of Pediatric Acute Myeloid Leukemia (AML) with MLL Translocations.
|
Nigro, Luca Lo
|
|
|
106 |
11 |
p. 3263
|
artikel
|
| 107 |
Acute Erythroid Leukemia (AEL): A Clinical, Morphological, Cytogenetic and Follow-Up Study of 69 Patients.
|
Luño, Elisa
|
|
|
106 |
11 |
p. 3271
|
artikel
|
| 108 |
Acute GVHD May Play a Role in Preventing Relapse Following Reduced Intensity Allografts for Acute Myeloid Leukemia.
|
Andritsos, Leslie
|
|
|
106 |
11 |
p. 1807
|
artikel
|
| 109 |
Acute Intermittent Porphyria during Pregnancy: A Case Outlining the Safety of Administering Hematin Infusions.
|
Jensen, Raymond J.
|
|
|
106 |
11 |
p. 3759
|
artikel
|
| 110 |
Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.
|
Leger, Chantal S.
|
|
|
106 |
11 |
p. 4605
|
artikel
|
| 111 |
Acute Lymphoblastic Leukaemia Cells Carrying the t(12;21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis.
|
Golay, Josee
|
|
|
106 |
11 |
p. 872
|
artikel
|
| 112 |
Acute Lymphoblastic Leukaemia Has a Poor Outcome in Children with Down Syndrome Due to Infective Death in Remission (Results of UK MRC ALL 97 Trial).
|
de la Fuente, Josu
|
|
|
106 |
11 |
p. 873
|
artikel
|
| 113 |
Acute Lymphoblastic Leukemia in Children with Associated Genetic Conditions Other Than Down Syndrome. The AIEOP Experience.
|
Ziino, Ottavio
|
|
|
106 |
11 |
p. 863
|
artikel
|
| 114 |
Acute Myeloid Leukemia (AML) in the Elderly. To Treat or Not To Treat: A Decision Analysis.
|
Kusminsky, Gustavo D.
|
|
|
106 |
11 |
p. 4606
|
artikel
|
| 115 |
Acute Myeloid Leukemia (AML-M2) with a Novel Translocation t(5;11)(q35;q13) and Normal Expression of Cyclin D1.
|
de Oliveira, Fabio M.
|
|
|
106 |
11 |
p. 4538
|
artikel
|
| 116 |
Acute Myeloid Leukemia Cells Require STAT5 for Survival.
|
Carroll, Martin
|
|
|
106 |
11 |
p. 1616
|
artikel
|
| 117 |
Acute Myeloid Leukemia in the Elderly, Intensive or Maintenance Therapy? Our Experience in Patients over 65 Years.
|
Mettivier, Vincenzo
|
|
|
106 |
11 |
p. 4640
|
artikel
|
| 118 |
Acute Panmyelosis with Myelofibrosis: An Evaluation of Distinctive Clinicopathological Features Including Bone Marrow Stroma.
|
Schmitt-Graeff, Annette
|
|
|
106 |
11 |
p. 4568
|
artikel
|
| 119 |
Acute Renal Failure Following Myeloablative Autologous and Allogeneic Haematopoietic Cell Transplantation.
|
Lopes, José A.
|
|
|
106 |
11 |
p. 5297
|
artikel
|
| 120 |
A Cyclophilin A-Independent Capsid Motif Renders HIV-1 Derived Vectors More Efficient at Transducing Human Cells.
|
Swan, Christina H.
|
|
|
106 |
11 |
p. 5531
|
artikel
|
| 121 |
ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.
|
Scharrer, Inge
|
|
|
106 |
11 |
p. 4027
|
artikel
|
| 122 |
ADAMTS13 Autoantibodies, Antigen and Proteolytic Activity in Patients with Thrombotic Thrombocytopenic Purpura.
|
Shelat, Suresh G.
|
|
|
106 |
11 |
p. 2642
|
artikel
|
| 123 |
ADAMTS-13 Binds Platelets in a Specific, Divalent Cation and Activation Dependent Manner.
|
Artoni, Andrea
|
|
|
106 |
11 |
p. 2657
|
artikel
|
| 124 |
ADAMTS13 Levels Support Hypothesis of Distinct Mechanistic Pathways for Early Versus Late-Onset of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP).
|
Kwaan, H.C.
|
|
|
106 |
11 |
p. 60
|
artikel
|
| 125 |
ADAMTS13 Proteolysis, Hepatic Stellate Cell Activation and Liver Fibrosis in a Rat Model.
|
Niiya, Masami
|
|
|
106 |
11 |
p. 689
|
artikel
|
| 126 |
Additional Cytogenetic Changes and Prior Genotoxic Exposure Predict Unfavorable Prognosis in Myelodysplastic Syndromes and Acute Myeloid Leukemia with der(1;7)(q10;p10).
|
Ohyashiki, Kazuma
|
|
|
106 |
11 |
p. 4894
|
artikel
|
| 127 |
Addition of Bortezomib (Velcade) to AML Induction Chemotherapy Is Well Tolerated and Results in a High Complete Remission Rate.
|
Attar, Eyal C.
|
|
|
106 |
11 |
p. 2782
|
artikel
|
| 128 |
Addition of GM-CSF to Imatinib Results in Major Cytogenetic Response in Patient with Chronic Myeloid Leukemia (CML).
|
Connor, Rebecca
|
|
|
106 |
11 |
p. 4884
|
artikel
|
| 129 |
Addition of Pegylated Megakaryocyte Growth Development Factor (pegMGDF) to G-CSF Improves the Mobilization of Primitive Hemopoietic Cells.
|
Larsen, Stephen R.
|
|
|
106 |
11 |
p. 1967
|
artikel
|
| 130 |
Additive Interaction between Oxaliplatin and DMAG in Pediatric Acute Lymphoblastic Leukemia (ALL) Cells. Evidence for Interference with Multiple Signaling Pathways.
|
Jayanthan, Aarthy
|
|
|
106 |
11 |
p. 4590
|
artikel
|
| 131 |
Adducin Forms a Bridge between the Spectrin-Actin Junctional Complex and Band 3.
|
Anong, William A.
|
|
|
106 |
11 |
p. 808
|
artikel
|
| 132 |
A Decision Analysis To Determine the Appropriate Treatment for Low-Risk Myelodysplastic Syndromes.
|
Sekeres, Mikkael A.
|
|
|
106 |
11 |
p. 2533
|
artikel
|
| 133 |
A Deletion 7q in a M0 Adult Acute Myeloid Leukemia (AML) with a Complete Cytogenetic Response to Idarubicin.
|
Domke, Lewis
|
|
|
106 |
11 |
p. 4601
|
artikel
|
| 134 |
Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific CD4+ T-Cells: Fundamentals for Targeting Adenovirus by Adoptive Immunotherapy.
|
Arbach, Olga
|
|
|
106 |
11 |
p. 3034
|
artikel
|
| 135 |
Adenovirus Induced Thrombocytopenia: The Role of P-Selectin and von Willebrand Factor in Virus- Mediated Platelet Clearance.
|
Othman, Maha
|
|
|
106 |
11 |
p. 222
|
artikel
|
| 136 |
Adenovirus-Interferon-g (TG1042) Demonstates Clinical Activity in Relapsing Primary Cutaneous Lymphoma (PCL): A Phase I/II Multicentric Trial.
|
Urosevic, Mirjana
|
|
|
106 |
11 |
p. 1497
|
artikel
|
| 137 |
Adenovirus Isolation Post Blood and Marrow Transplant (BMT) in Australia and New Zealand- Results of a 4 Year Clinical Multi -Institutional Prospective Cohort Study.
|
Bateman, Caroline M.
|
|
|
106 |
11 |
p. 79
|
artikel
|
| 138 |
Adhesive Characteristics of Hemoglobin SC Red Blood Cells.
|
Chien, Ai C.
|
|
|
106 |
11 |
p. 3780
|
artikel
|
| 139 |
A Differentiation Block in Erythroid Cells Lacking Erythroid Krupple-Like Factor (EKLF).
|
Gallagher, Patrick G.
|
|
|
106 |
11 |
p. 526
|
artikel
|
| 140 |
A Distinct Entity of Ocular Adnexal MALT Lymphoma with Trisomy 18.
|
Tanimoto, Kazuki
|
|
|
106 |
11 |
p. 983
|
artikel
|
| 141 |
A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.
|
Nilsson, Lars
|
|
|
106 |
11 |
p. 4382
|
artikel
|
| 142 |
Adjuvant Dexamethasone (D) ± Thalidomide (T) Improves Hematologic and Organ Responses after Risk-Adapted High-Dose Melphalan with Autologous Stem Cell Transplant (SCT) for Patients with Systemic AL Amyloidosis (AL).
|
Cohen, Adam D.
|
|
|
106 |
11 |
p. 1163
|
artikel
|
| 143 |
Administration of FFP Repletes and Sustains the Megakaryocyte/Platelet-Derived Factor V Pool To Confer Hemostatic Competence in a Factor V-Deficient Individual.
|
Bouchard, Beth A.
|
|
|
106 |
11 |
p. 1779
|
artikel
|
| 144 |
Administration of Low-Dose Cyclophosphamide Reduces Progression of Atherosclerosis in Mice by Controlling the Cellular Microenvironment.
|
Sato, Yayoi
|
|
|
106 |
11 |
p. 4452
|
artikel
|
| 145 |
Administration of Vaccines to Infants and Children with Hemophilia. A Survey of the Region III Comprehensive Hemophilia Treatment Centers.
|
Ritchey, Arthur K.
|
|
|
106 |
11 |
p. 4079
|
artikel
|
| 146 |
A DNA-Based RQ-PCR Screening Assay for the Identification of Cases with RUNX1 Copy Number Changes in Childhood B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL).
|
Haas, Oskar A.
|
|
|
106 |
11 |
p. 90
|
artikel
|
| 147 |
Adoptive Immunotherapy of p53-Mutated B-CLL with a Trifunctional Antibody (Anti-CD3 x Anti-CD20) and Allogeneic Donor Lymphocyte Transfusion.
|
Buhmann, Raymund
|
|
|
106 |
11 |
p. 4823
|
artikel
|
| 148 |
Adoptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells (ACTC) Enhances Numeric and Functional Lymphocyte Recovery after Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma.
|
Andreadis, Charalambos
|
|
|
106 |
11 |
p. 1505
|
artikel
|
| 149 |
Adoptive Immunotherapy with Donor Allodepleted T Cells.
|
Dal Cortivo, L.
|
|
|
106 |
11 |
p. 479
|
artikel
|
| 150 |
Adoptive Immunotherapy with Donor Lymphocyte Infusion after Allogeneic Nonmyeloablative Stem Cell Transplantation.
|
Qiao, Zhenhua
|
|
|
106 |
11 |
p. 5196
|
artikel
|
| 151 |
Adoptive Immunotherapy with Donor Lymphocyte Infusions after T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia.
|
Barge, Renee M.Y.
|
|
|
106 |
11 |
p. 2014
|
artikel
|
| 152 |
Adoptive Infusion of Allogeneic KIR Ligand Mismatched NK Cells Reduce GVHD in an MHC Matched Allogeneic Stem Cell Transplantation Model.
|
Lundqvist, Andreas
|
|
|
106 |
11 |
p. 1310
|
artikel
|
| 153 |
Adoptive T Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients with Cancer: A Phase I Clinical Study.
|
Mackensen, Andreas
|
|
|
106 |
11 |
p. 2393
|
artikel
|
| 154 |
Adoptive Transfer of Adenovirus Specific T-Cells in Children with Systemic Adenovirus Infection after Allogeneic Stem Cell Transplantation.
|
Feuchtinger, Tobias F.
|
|
|
106 |
11 |
p. 80
|
artikel
|
| 155 |
Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
|
Zakrzewski, Johannes L.
|
|
|
106 |
11 |
p. 63
|
artikel
|
| 156 |
Adoptive Transfer of Nf1+/− Bone Marrow Is Sufficient for Neurofibroma Progression in Krox20;Nf1flox/flox
Mice.
|
Yang, Fengchun
|
|
|
106 |
11 |
p. 3064
|
artikel
|
| 157 |
A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia.
|
Kimura, Shinya
|
|
|
106 |
11 |
p. 1522
|
artikel
|
| 158 |
Adult Acute Lymphoblastic Leukemia and Cytogenetic Abnormalities in Different Racial and Ethnic Subgroups.
|
Tamkus, Deimante
|
|
|
106 |
11 |
p. 4547
|
artikel
|
| 159 |
Adult Human Blood Leukocytes as an Efficient Source for Tissue-Committed Neural Progenitors.
|
Porat, Yael
|
|
|
106 |
11 |
p. 1686
|
artikel
|
| 160 |
Adult Human Blood Leukocytes as a Source of Tissue-Committed Progenitors for Cellular Therapy of Cardiovascular Disease.
|
Porat, Yael
|
|
|
106 |
11 |
p. 32
|
artikel
|
| 161 |
Adult Human Hematopoietic Cells Differentiate into Mature T Cells Via a CD3-4+8- Intermediate within the Mouse Thymic Microenvironment; a New Model System for the Study of Human Thymocyte Development.
|
Kraft, Daniel L.
|
|
|
106 |
11 |
p. 522
|
artikel
|
| 162 |
Adult Onset of Hemophagocytic Syndrome: Report of 13 Cases from a Single Institution.
|
Rossi, Valentina
|
|
|
106 |
11 |
p. 3880
|
artikel
|
| 163 |
Advanced Glycation End Products (AGEs)-Mediated Cell Growth of Human Acute Myelogenous Leukemia Via Mitogen-Activated Protein (MAP) Kinase Pathways.
|
Kim, Ju Young
|
|
|
106 |
11 |
p. 2762
|
artikel
|
| 164 |
Adverse Events (AEs): Are They Factored into Costs of Hemophilia Care?.
|
Aledort, Louis M.
|
|
|
106 |
11 |
p. 5550
|
artikel
|
| 165 |
Adverse Events in Sickle Cell Patients with Nocturnal Hypoxia.
|
Campbell, Andrew D.
|
|
|
106 |
11 |
p. 3793
|
artikel
|
| 166 |
A Early Report of Bone Marrow Transplantation from HLA Mismatched Mother for β-Thalassemia Major.
|
Li, Chunfu
|
|
|
106 |
11 |
p. 5443
|
artikel
|
| 167 |
Afibrinogenaemia Resulting from a Novel Putative Splicing Mutation, and Evidence for Tissue Specific Expression of FGAα RNA.
|
Cutler, Jacky
|
|
|
106 |
11 |
p. 2137
|
artikel
|
| 168 |
AF1q Is a Novel Poor Prognostic Marker for Adult Acute Myelogenous Leukemia (AML) Patients with Normal Cytogenetics.
|
Strunk, Crawford J.
|
|
|
106 |
11 |
p. 3294
|
artikel
|
| 169 |
African American Patients with Multiple Myeloma Have Prolonged Responses after Autologous Stem Cell Transplantation.
|
Saraf, Santosh
|
|
|
106 |
11 |
p. 3131
|
artikel
|
| 170 |
A Fully-Automated Screening Method for Anti-HLA Antibodies: Implications for Screening Plasma Donations To Prevent Transfusion-Related Acute Lung Injury (TRALI).
|
Culler, Elizabeth
|
|
|
106 |
11 |
p. 959
|
artikel
|
| 171 |
A Gain of Function Mutation in JAK2 Is Frequently Found in Patients with AML-M2 and Normal Karyotype.
|
Marcotegui, Nerea
|
|
|
106 |
11 |
p. 2366
|
artikel
|
| 172 |
A G>A Transition in the Non-Coding Exon 1 of the Factor XI Gene as the Cause of Factor XI Deficiency in Three Afro-Caribbean Patients.
|
Mitchell, Michael J.
|
|
|
106 |
11 |
p. 1788
|
artikel
|
| 173 |
Age-Decline in the Activity of the Plasma Membrane Ca2+ Pump (PMCA) of Normal Human Red Blood Cells (RBCs).
|
Bookchin, Robert M.
|
|
|
106 |
11 |
p. 1670
|
artikel
|
| 174 |
A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL).
|
Willman, Cheryl L.
|
|
|
106 |
11 |
p. 762
|
artikel
|
| 175 |
A Gene Expression Connectivity Map Identifies Rapamycin as a Glucocorticoid Resistance Reversal Agent in Lymphoblastic Leukemia.
|
Armstrong, Scott A.
|
|
|
106 |
11 |
p. 108
|
artikel
|
| 176 |
A Gene Polymorphism within the Kinase Domain of BCR-ABL and Its Effects on Sensitivity to Tyrosine Kinase Inhibitors.
|
Crossman, Lucy C.
|
|
|
106 |
11 |
p. 1530
|
artikel
|
| 177 |
A Gene-Targeted Mouse Model for Bone Marrow Failure Syndrome.
|
Kasai, Masataka
|
|
|
106 |
11 |
p. 4235
|
artikel
|
| 178 |
A Genetic Basis for Adult Onset TTP?.
|
Camilleri, Raymond S.
|
|
|
106 |
11 |
p. 1228
|
artikel
|
| 179 |
A Genetic Mutation on Murine Chromosome 7 Causes Thrombocytosis Associated with Thrombopoietin Excess - A Model of Jak2V617F Negative Idiopathic Thrombocytosis.
|
Stevenson, William S.
|
|
|
106 |
11 |
p. 3525
|
artikel
|
| 180 |
A Genome-Modified Mouse Line with an Insertion Mutation at the AML1/Runx1 Gene Locus Detected from a Patient with Myelodysplastic Syndrome.
|
Fukushime-Nakase, Yoko
|
|
|
106 |
11 |
p. 1599
|
artikel
|
| 181 |
A Genome-Wide Retroviral Insertional Mutagenesis Screen for Genes Cooperating with Truncated, Oncogenic GATA1s.
|
Li, Zhe
|
|
|
106 |
11 |
p. 2990
|
artikel
|
| 182 |
Age Related Expression Patterns of Mouse Liver Nuclear Proteins.
|
Kurachi, Sumiko
|
|
|
106 |
11 |
p. 1948
|
artikel
|
| 183 |
Age-Related Induction of CD4+ T-Cell Unresponsiveness Is Reversible and Dependant of the Host's Environment.
|
Horna, Pedro
|
|
|
106 |
11 |
p. 3925
|
artikel
|
| 184 |
Age-Related Reference Values of Molecular Markers in Endothelial Cell Activation, Coagulation and Fibrinolysis in Thai Children Versus Adults.
|
Sosothikul, Darintr
|
|
|
106 |
11 |
p. 4040
|
artikel
|
| 185 |
Age-Related Transcription Levels of KU70 and BIK in CD34+ Hematopoietic Stem and Progenitor Cells.
|
Prall, Wolf C.
|
|
|
106 |
11 |
p. 4205
|
artikel
|
| 186 |
Age Significantly Influences Presentation and Patterns of Care in Patients with Newly Diagnosed Diffuse Large Cell Lymphoma (DLCL): Collective Data from 5 Centers Participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project.
|
Rodriguez, Maria Alma
|
|
|
106 |
11 |
p. 1335
|
artikel
|
| 187 |
Aggregates of Reticulocytes, Monocytes and Platelets Exist in Whole Blood of Sickle Cell Patients: Roles for Plasma Fibronectin, α4 Integrins and PSGL-1.
|
Brittain, Julia E.
|
|
|
106 |
11 |
p. 2330
|
artikel
|
| 188 |
Aggressive Cutaneous Squamous Cell Carcinoma (SCC) in Chronic Lymphocytic Leukaemia (CLL).
|
Lane, Steven W.
|
|
|
106 |
11 |
p. 4993
|
artikel
|
| 189 |
Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring.
|
Choueiri, Toni K.
|
|
|
106 |
11 |
p. 5155
|
artikel
|
| 190 |
A Global Role for EKLF in Definitive and Primitive Erythropoiesis.
|
Perkins, Andrew C.
|
|
|
106 |
11 |
p. 1745
|
artikel
|
| 191 |
A Green Tea Polyphenol, Epigallocatechin-3-Gallate, Induces Selective Apoptosis in Multiple Myeloma Cells: Mechanism of Action and Therapeutic Potential.
|
Shammas, Masood A.
|
|
|
106 |
11 |
p. 1590
|
artikel
|
| 192 |
A Hemophilia Patient with C1 Domain Arg2150His Mutation Developed a High Titer Inhibitor Not Inhibiting Autologous Factor VIII after Switching to Third Generation Recombinant Product.
|
Gerhardt, Andrea
|
|
|
106 |
11 |
p. 4060
|
artikel
|
| 193 |
A Highly Effective Model of Risk Assessment in Diffuse Large B Cell Lymphoma (DLBCL) Using Classification and Regression Tree (CART) Analysis.
|
Barrans, Sharon L.
|
|
|
106 |
11 |
p. 1918
|
artikel
|
| 194 |
A High Throughput Seeking Myeloma Therapeutics Identifies Glucocorticoids as Inhibitors of c-Maf-Dependent Transactivation of Cyclin D2.
|
Mao, Xinliang
|
|
|
106 |
11 |
p. 3384
|
artikel
|
| 195 |
AHSP Is a Quantitative Trait Gene That Modifies the Phenotype of β Thalassemia.
|
Lai, Mei I.
|
|
|
106 |
11 |
p. 3638
|
artikel
|
| 196 |
A Human Antibody, Cloned from a Patient with Heparin-Induced Thrombocytopenia, That Binds Heparin/Platelet Factor 4 Complexes.
|
Dessain, Scott K.
|
|
|
106 |
11 |
p. 58
|
artikel
|
| 197 |
A Human Anti-CD1a Monoclonal Antibody for Targeted Immunotherapy in Langerhans Cell Histiocytosis and Hematologic Malignancies.
|
Bechan, Gitanjali
|
|
|
106 |
11 |
p. 4815
|
artikel
|
| 198 |
A Humanized Anti-CD70 Monoclonal Antibody Targets CD70-Expressing Multiple Myeloma.
|
McEarchern, Julie A.
|
|
|
106 |
11 |
p. 1591
|
artikel
|
| 199 |
A Humanized Anti-CD30 Monoclonal Antibody, XmAb™2513, with Enhanced In Vitro Potency Against CD30-Positive Lymphomas Mediated by High Affinity Fc-Receptor Binding.
|
Hammond, Philip W.
|
|
|
106 |
11 |
p. 1470
|
artikel
|
| 200 |
A Humanized HLA-DR Antibody (HU1D10, Apolizumab) in Combination with G-CSF (Filgrastim) for the Treatment of Non-Hodgkin's Lymphoma: A Pilot Study.
|
Rech, Juergen
|
|
|
106 |
11 |
p. 4775
|
artikel
|
| 201 |
A Human SIL-SCL Fusion Gene Displays a Development Block at the CD4− CD8− to CD4+CD8+ Transition in Transgenic Mice.
|
Cheng, Yue
|
|
|
106 |
11 |
p. 2833
|
artikel
|
| 202 |
A Hypomorphic Cbfb Allele Reveals a Critical Dosage-Sensitive Function of Core Binding Factors at the Earliest Stages of T Cell Development.
|
Maillard, Ivan
|
|
|
106 |
11 |
p. 124
|
artikel
|
| 203 |
Akt Activation Regulates Macrophage Survival and Differentiation: Role of M-CSF and Endogenous ROS.
|
Wang, Yijie
|
|
|
106 |
11 |
p. 2208
|
artikel
|
| 204 |
AKT Mediates Platelet Activation by Stimulating Nitric Oxide Synthesis and cGMP Elevation.
|
Stojanovic, Aleksandra
|
|
|
106 |
11 |
p. 1652
|
artikel
|
| 205 |
Akt2 Supports aIIbb3-Dependent Reorganization of the Actin Cytoskeleton in Platelets.
|
August, Shelley
|
|
|
106 |
11 |
p. 3565
|
artikel
|
| 206 |
Aldehyde Dehydrogenase (ALDH) Activity in Fresh (Pre-Freezing) and Post-Thawing Leukapheresis and Cord Blood Collections.
|
Perotti, Cesare
|
|
|
106 |
11 |
p. 5276
|
artikel
|
| 207 |
Aldehyde Dehydrogenase Expression in Primitive Human Hematopoietic Progenitor Cells with Side Population Characteristic and in Samples from Patients with Acute Myeloid Leukemia.
|
Meissauer, Ute
|
|
|
106 |
11 |
p. 4570
|
artikel
|
| 208 |
Aldehyde Dehydrogenase-Positive Hematopoetic Progenitor Cells in Peripheral Blood and Progenitor Cell Apheresis Products: Characterization and Correlation with Kinetics of Engraftment.
|
Hildebrandt, Martin
|
|
|
106 |
11 |
p. 1076
|
artikel
|
| 209 |
A LDI-PCR Based Method Allows the Identification of Any MLL Rearrangement.
|
Meyer, Claus
|
|
|
106 |
11 |
p. 2848
|
artikel
|
| 210 |
Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation.
|
Kline, Justin P.
|
|
|
106 |
11 |
p. 1818
|
artikel
|
| 211 |
Alemtuzumab Is Effective in Patients with Advanced, Pretreated B-Cell Chronic Lymphocytic Leukemia: A Nationwide Study of Routine Use in Austria.
|
Fiegl, Michael
|
|
|
106 |
11 |
p. 2971
|
artikel
|
| 212 |
ALFA-9000 Trial - An Analysis of Cytogenetic Subsets: Significant Long-Term Benefit of Early Induction Reinforcement Is Observed in CBF-AML Only.
|
Gardin, Claude
|
|
|
106 |
11 |
p. 1842
|
artikel
|
| 213 |
Alkylphosphocholine Perifosine Inhibits Myeloma Cell Growth While Inducing Myeloid Hyperplasia in a Murine Myeloma Model.
|
Catley, Laurence
|
|
|
106 |
11 |
p. 1579
|
artikel
|
| 214 |
All IPI Factors Are Equal, but LDH Is More Equal Than Others.
|
van Imhoff, Gustaaf W.
|
|
|
106 |
11 |
p. 1913
|
artikel
|
| 215 |
Alloantibody Formation in Sickle Cell Disease Patients Receiving Multiple Transfusions.
|
Sakhalkar, Vishwas S.
|
|
|
106 |
11 |
p. 3795
|
artikel
|
| 216 |
Allogeneic (Allo-) or Autologous (Auto-) Peripheral Blood Stem Cell Transplantation (SCT) Randomized Versus a Second Intensive Consolidation after a Common Induction and Consolidation Course in Patients with Bad Prognosis Myelodysplastic Syndromes and Acute Myelogenous Leukemia Following MDS of More Than 6 Months Duration: The Final Analysis of a Joint Study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups.
|
De Witte, T.M.
|
|
|
106 |
11 |
p. 794
|
artikel
|
| 217 |
Allogeneic and Matched Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies Using a Modified Reduced Intensity Conditioning Regimen.
|
Raflores, Marion
|
|
|
106 |
11 |
p. 5324
|
artikel
|
| 218 |
Allogeneic Blood Stem Cell Transplantation in Patients with Hematologic Diseases after Conditioning with Treosulfan and Fludarabine.
|
Casper, Jochen
|
|
|
106 |
11 |
p. 2744
|
artikel
|
| 219 |
Allogeneic Bone Marrow Transplantation in a Child with Hemophilia A and Severe Aplastic Anemia.
|
Ostronoff, Mauricio
|
|
|
106 |
11 |
p. 5421
|
artikel
|
| 220 |
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.
|
Maruyama, Dai
|
|
|
106 |
11 |
p. 1142
|
artikel
|
| 221 |
Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Relapsed or Refractory Follicular Lymphoma.
|
Maris, Michael B.
|
|
|
106 |
11 |
p. 1130
|
artikel
|
| 222 |
Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Leukemia in First Relapse or Second Remission.
|
Lee, Je-Hwan
|
|
|
106 |
11 |
p. 5415
|
artikel
|
| 223 |
Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.
|
Baron, Frederic
|
|
|
106 |
11 |
p. 1143
|
artikel
|
| 224 |
Allogeneic Hematopoietic Stem Cell Transplantation after Combination Therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia.
|
Usui, Noriko
|
|
|
106 |
11 |
p. 5304
|
artikel
|
| 225 |
Allogeneic Hematopoietic Stem Cell Transplantation for Pesaro IIIβ-Thalassemia Major Using Fludarabine-Based Myeloablative or Non-Myeloablative Conditioning Regimen.
|
Zhu, Kanger
|
|
|
106 |
11 |
p. 3822
|
artikel
|
| 226 |
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).
|
Kumar, Priya
|
|
|
106 |
11 |
p. 2064
|
artikel
|
| 227 |
Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity.
|
Shimoni, Avichai
|
|
|
106 |
11 |
p. 47
|
artikel
|
| 228 |
Allogeneic Mesenchymal Stem Cells Can Mitigate Early, Ongoing, and Severe Graft Versus Host Disease but Require Delayed Administration for Optimal Effect.
|
Polchert, D.
|
|
|
106 |
11 |
p. 594
|
artikel
|
| 229 |
Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults.
|
Yanada, Masamitsu
|
|
|
106 |
11 |
p. 1134
|
artikel
|
| 230 |
Allogeneic Myelo-Ablative Stem Cell Transplant (SCT) as Salvage Therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome.
|
Cordonnier, Catherine
|
|
|
106 |
11 |
p. 3666
|
artikel
|
| 231 |
Allogeneic or Autologous Stem Cell Transplantation (SCT) for the Treatment of Pediatric Patients with Non-Hodgkins Lymphoma (NHL).
|
Ricafort, Rosanna
|
|
|
106 |
11 |
p. 2093
|
artikel
|
| 232 |
Allogeneic Peripheral Blood Stem Cell Transplants (PBSCT) May Have a Benefit in Acute Lymphoblastic Leukemia (ALL) Outcome.
|
Vigorito, Afonso C.
|
|
|
106 |
11 |
p. 1136
|
artikel
|
| 233 |
Allogeneic-SCT in Patients with Hematological Malignancies Aged 60 Years or Older: Importance of HLA-Matching.
|
Schleuning, Michael
|
|
|
106 |
11 |
p. 5360
|
artikel
|
| 234 |
Allogeneic Stem Cell Transplantation (AlloSCT) for Relapsed Hodgkin's Lymphoma (HL) Following Autologous Stem Cell Transplantation (AuSCT): Improved Progression-Free Survival (PFS) in Patients with Graft vs Host-Disease (GvHD) Suggests a Graft vs Lymphoma (GVL) Effect.
|
Altman, Jessica K.
|
|
|
106 |
11 |
p. 5455
|
artikel
|
| 235 |
Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
|
Blaise, Didier
|
|
|
106 |
11 |
p. 1140
|
artikel
|
| 236 |
Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Secondary Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS).
|
El-Cheikh, Jean
|
|
|
106 |
11 |
p. 5416
|
artikel
|
| 237 |
Allogeneic Stem Cell Transplantation (ASCT) and Donor Lymphocyte Infusions (DLI) in the Management of Chronic Myelomonocytic Leukemia (CMML).
|
Elliott, Michelle A.
|
|
|
106 |
11 |
p. 5422
|
artikel
|
| 238 |
Allogeneic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: No Increase in Relapse with Alemtuzumab-Depleted Grafts.
|
Thomson, Kirsty J.
|
|
|
106 |
11 |
p. 2053
|
artikel
|
| 239 |
Allogeneic Stem Cell Transplantation for Lymphoid Malignancies.
|
Novitzky, Nicolas
|
|
|
106 |
11 |
p. 5418
|
artikel
|
| 240 |
Allogeneic Stem Cell Transplantation from Unrelated Donors within the Seventh Decade of Life.
|
Dahlke, Joachim
|
|
|
106 |
11 |
p. 2062
|
artikel
|
| 241 |
Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).
|
Toor, Amir A.
|
|
|
106 |
11 |
p. 1767
|
artikel
|
| 242 |
Allogeneic Stem Cell Transplantation (SCT) with Reduced-Intensity Conditioning (RIC) in Children with Malignancies: A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
|
Sirvent, Anne
|
|
|
106 |
11 |
p. 3670
|
artikel
|
| 243 |
Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).
|
Tauro, S.
|
|
|
106 |
11 |
p. 1141
|
artikel
|
| 244 |
Allogeneic Stem Cell Transplantation with Peripheral Blood Stem Cells Mobilized by Pegylated-G-CSF.
|
Hill, Geoff
|
|
|
106 |
11 |
p. 1970
|
artikel
|
| 245 |
Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).
|
Kebriaei, Partow
|
|
|
106 |
11 |
p. 1135
|
artikel
|
| 246 |
Allogeneic Transplantation from an HLA-Matched Family Donor in First Complete Remission of Acute Myeloid Leukemia Had an Adverse Impact on Quality of Life in Patients Followed for at Least Five Years after Treatment: A Survey of the German AML Intergroup on 525 Patients.
|
Messerer, Dorle
|
|
|
106 |
11 |
p. 747
|
artikel
|
| 247 |
Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM).
|
Sahebi, Firoozeh
|
|
|
106 |
11 |
p. 5427
|
artikel
|
| 248 |
Allograft Cell Content and GVHD Differ in Murine Recipients of AMD3100 Versus G-CSF Mobilized Peripheral Blood Stem Cells.
|
Lundqvist, A.
|
|
|
106 |
11 |
p. 3108
|
artikel
|
| 249 |
Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).
|
Dean, Robert M.
|
|
|
106 |
11 |
p. 3662
|
artikel
|
| 250 |
Alloimmunisation of Patients Undergoing Bone Marrow Transplantation in the Setting of Leucodepleted Apheresis-Collected Single Donor Platelets.
|
Crawford, Julie H.
|
|
|
106 |
11 |
p. 962
|
artikel
|
| 251 |
Allotransplantation with Reduced Intensity Conditioning Regimens Modified To Lessen Transplant-Related Mortality Is a Useful Treatment for High-Risk Myeloid Diseases.
|
Bigelow, Carolyn L.
|
|
|
106 |
11 |
p. 5328
|
artikel
|
| 252 |
All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.
|
Schlenk, Richard F.
|
|
|
106 |
11 |
p. 1849
|
artikel
|
| 253 |
All Trans Retinoic Acid (atRA) Differentiation Markers in Normal and Retinoid-Resistant Acute Promyelocytic Leukemia Cells Revealed Induction of atRA Metabolism as Relevant Prognostic of APL Sensitivity to Therapy.
|
Quere, Ronan
|
|
|
106 |
11 |
p. 3256
|
artikel
|
| 254 |
A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.
|
Ahmann, Gregory J.
|
|
|
106 |
11 |
p. 3413
|
artikel
|
| 255 |
A Longitudinal Analysis of the T-Cell Receptor Vβ Repertoire in Aplastic Anemia Patients at Initial Presentation, Remission, and Relapse.
|
Cheng, Yunfeng
|
|
|
106 |
11 |
p. 2402
|
artikel
|
| 256 |
A “Loss-of-Tolerance” Phenotype of the Liver Macrophage System to LPS Induces Overwhelming Systemic Inflammation and Early Death in a Knockout-Transgenic Mouse Model of Sickle Cell Disease.
|
Meiler, Steffen E.
|
|
|
106 |
11 |
p. 2337
|
artikel
|
| 257 |
Alpha Hemoglobin Stabilizing Protein (AHSP) Is a Susceptibility Gene to Drug /Infection-Induced Hemolytic Anemia.
|
Kanno, Hitoshi
|
|
|
106 |
11 |
p. 1678
|
artikel
|
| 258 |
Alteration of the Factor X Zymogen to Protease Transition Provides Evidence for Allosteric Linkage between the S1 and FVa Binding Sites.
|
Toso, Raffaella
|
|
|
106 |
11 |
p. 30
|
artikel
|
| 259 |
Alterations in the Umbilical Cord Blood NK Cells Related to the Mode and the Time of Delivery.
|
Królak-Olejnik, Barbara
|
|
|
106 |
11 |
p. 3926
|
artikel
|
| 260 |
Altered Cellular Protein Levels of Tumor Suppressor Genes and Heat Shock Elements (TRAP1) Indicate Sensitivity to the Proteasome Inhibitor Bortezomib (Velcade®) in Mantle Cell Lymphoma.
|
Weinkauf, Marc
|
|
|
106 |
11 |
p. 2424
|
artikel
|
| 261 |
Altered Expression of Transcription and Chromatin Remodeling Factors in Deletional HPFH.
|
Costa, Fernando F.
|
|
|
106 |
11 |
p. 2705
|
artikel
|
| 262 |
Altered Expressions of CD30, c-Jun N-Terminal Kinase, NF-κB and JunB Are Involved in Disease Progression in CD30-Positive Anaplastic Large Cell Lymphoma.
|
Nakamaki, Tsuyoshi
|
|
|
106 |
11 |
p. 2827
|
artikel
|
| 263 |
Altered Hepcidin Regulation in Hereditary Hemochromatosis and Dysmetabolic Hyperferritinemia.
|
Nemeth, Elizabeta
|
|
|
106 |
11 |
p. 3590
|
artikel
|
| 264 |
Altered Oncogenic Fitness of Imatinib- and Dasatinib-Resistant BCR-ABL Mutants Is Due to Differential Intrinsic Kinase Activity and Signaling Pathway Selection Defined by Phosphoproteome Profiling.
|
Skaggs, Brian J.
|
|
|
106 |
11 |
p. 692
|
artikel
|
| 265 |
Alternate Week Administration of the Farnesyltransferase Inhibitor Tipifarnib (ZARNESTRA®, R115777) in Patients with Myelodysplastic Syndrome: Results of a Phase 1 Study.
|
Kurzrock, Razelle
|
|
|
106 |
11 |
p. 2521
|
artikel
|
| 266 |
Alternative Donor Stem Cell Transplantation after Reduced Intensity Conditioning Regimen for Patients with Bone Marrow Failure.
|
Kabbara, Nabil
|
|
|
106 |
11 |
p. 2894
|
artikel
|
| 267 |
A Lymphoid Progenitor Propagates AML in a Mouse Model of CALM/AF10 Positive Leukemia.
|
Deshpande, Aniruddha
|
|
|
106 |
11 |
p. 101
|
artikel
|
| 268 |
A Maintenance Therapy with Differentiating Agents and Low-Dose Chemotherapy Increases Remission Duration and Survival in High Risk AML and MDS Patients.
|
Ferrero, Dario
|
|
|
106 |
11 |
p. 4614
|
artikel
|
| 269 |
Am80, a RARα Specific Synthetic Retinoid Induced a Strong Growth Inhibition in Hematologic Malignant Cells Including Myeloid and Lymphoid Cell Lines.
|
Jimi, Shiro
|
|
|
106 |
11 |
p. 4438
|
artikel
|
| 270 |
Ambulatory Blood Pressure Monitoring (ABPM) in Children with Thalassemia Major (TM).
|
Kuskonmaz, Baris
|
|
|
106 |
11 |
p. 3839
|
artikel
|
| 271 |
Ambulatory Blood Pressure Monitoring in Multiple Myeloma Patients Treated with VAD Protocol.
|
Pyszel, Angelika
|
|
|
106 |
11 |
p. 5124
|
artikel
|
| 272 |
AMD3100 and G-CSF Mobilize Angiogenic Cells into the Blood of Healthy Donors.
|
Shepherd, Rebecca M.
|
|
|
106 |
11 |
p. 3022
|
artikel
|
| 273 |
AMD3100 + G-CSF Improves Hematopoietic Progenitor Cell (HPC) Collection in Patients with Hodgkin's Disease (HD).
|
Cashen, Amanda
|
|
|
106 |
11 |
p. 1979
|
artikel
|
| 274 |
AMD3100 Mobilized Apheresis Products Are Rich in T-Cells That Do Not Undergo a Th-2 Type Cytokine Polarization: Implications for Allografting.
|
Takahashi, Yoshiyuki
|
|
|
106 |
11 |
p. 296
|
artikel
|
| 275 |
AMD3100 Mobilizes Acute Promyelocytic Leukemia Cells from the Bone Marrow into the Peripheral Blood and Sensitizes Leukemia Cells to Chemotherapy.
|
Nervi, Bruno
|
|
|
106 |
11 |
p. 246
|
artikel
|
| 276 |
AMD3100 Plus G-CSF Use in Proven Poor Mobilizers in a Compassionate Use Protocol (CUP).
|
McGuirk, Joseph
|
|
|
106 |
11 |
p. 154
|
artikel
|
| 277 |
A Meta-Analysis on the Use of Intravenous Gamma Globulin and Corticosteroids in Children with Acute Immune Thrombocytopenic Purpura.
|
Chua, Mary N.
|
|
|
106 |
11 |
p. 4000
|
artikel
|
| 278 |
A Method for Rapid Purification of Murine Siderocytes.
|
Martin, Florent M.
|
|
|
106 |
11 |
p. 3703
|
artikel
|
| 279 |
A microRNA Cluster as a Target of Genomic Amplification in B-Cell Lymphomas.
|
Tagawa, Hiroyuki
|
|
|
106 |
11 |
p. 3011
|
artikel
|
| 280 |
A Mid-Treatment FDG-Positron Emission Tomography (PET) Scan Is Highly Predictive of Subsequent Treatment Failure in Patients with Diffuse Large B-Cell Lymphoma (DLBCL).
|
Ng, Ashley P.
|
|
|
106 |
11 |
p. 1931
|
artikel
|
| 281 |
Amino Acid Regions 572–579 and 657–666 of the Spacer Domain of ADAMTS13 Provide a Common Antigenic Core Required for Binding of Antibodies in Patients with Acquired TTP.
|
Luken, Brenda M.
|
|
|
106 |
11 |
p. 59
|
artikel
|
| 282 |
Aminopeptidase Inhibitor Bestatin Potentiates the Induced-Differentiation Activity of All-trans-Retinoic Acid in NB4 Cells Possibly through Down-Regulating c-myc Expression.
|
Lin, Mao-fang
|
|
|
106 |
11 |
p. 4443
|
artikel
|
| 283 |
Amiodarone- Induced Bone Marrow Granulomas.
|
Mohamed, Tarek
|
|
|
106 |
11 |
p. 4317
|
artikel
|
| 284 |
AML1-ETO9a, an Alternatively Spliced Form of AML1-ETO, Collaborates with AML1-ETO To Promote Leukemogenesis.
|
Yan, Ming
|
|
|
106 |
11 |
p. 661
|
artikel
|
| 285 |
AML-M4: Role of Eosinophilia and Cytogenetics on Treatment Response and Survival. The GIMEMA Experience.
|
Pulsoni, Alessandro
|
|
|
106 |
11 |
p. 4501
|
artikel
|
| 286 |
AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).
|
Kantarjian, Hagop M.
|
|
|
106 |
11 |
p. 37
|
artikel
|
| 287 |
AMN107 Appears Equipotent and May Synergise with Imatinib at the CML Stem Cell Level through Interaction with ABCG2.
|
Jorgensen, H.
|
|
|
106 |
11 |
p. 1080
|
artikel
|
| 288 |
A Model of Severe Congenital Neutropenia Reveals Signaling Pathways Mediating Mutant Elastase-Triggered Agranulocytosis.
|
Aprikyan, Andrew A.
|
|
|
106 |
11 |
p. 3070
|
artikel
|
| 289 |
A Model System for Proliferation and Characterisation of Stem Cells in Childhood T-ALL.
|
Cox, Charlotte V.
|
|
|
106 |
11 |
p. 1370
|
artikel
|
| 290 |
A Mouse Model of Alkylator-Induced Myelodysplastic Syndrome.
|
Edwin, Deepa
|
|
|
106 |
11 |
p. 368
|
artikel
|
| 291 |
AMP Deaminase Activation Contributes to Accelerated Adenine Nucleotide Pool Depletion during Periods of Energy Imbalance in Sickle Cell Erythrocytes.
|
Sabina, Richard L.
|
|
|
106 |
11 |
p. 1671
|
artikel
|
| 292 |
Amphotericin B and Itraconazole as Empirical Antifungal Therapy in Children with Acute Leukemia with Neutropenic Fever.
|
Kim, Sun-Young
|
|
|
106 |
11 |
p. 4577
|
artikel
|
| 293 |
A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.
|
Haferlach, Torsten
|
|
|
106 |
11 |
p. 757
|
artikel
|
| 294 |
A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated Bulky Stage II or Stage III or IV, Low-Grade B-Cell NHL.
|
Mena, Raul R.
|
|
|
106 |
11 |
p. 4750
|
artikel
|
| 295 |
A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade CLL.
|
Mena, Raul R.
|
|
|
106 |
11 |
p. 5045
|
artikel
|
| 296 |
A Multicenter Phase I/II Trial Evaluating the Safety and Efficacy of Lenalidomide [Revlimidä (R), CC-5013] in Combination with Doxorubicin and Dexamethasone (RAD) in Patients with Relapsed or Refractory Multiple Myeloma.
|
Gerecke, C.
|
|
|
106 |
11 |
p. 5136
|
artikel
|
| 297 |
A Multicenter Phase II Study of Combination Treatment with Melphalan, Arsenic Trioxide and Vitamin C (MAC) for Patients with Relapsed or Refractory Multiple Myeloma.
|
Berenson, James
|
|
|
106 |
11 |
p. 2564
|
artikel
|
| 298 |
A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.
|
Richardson, Paul
|
|
|
106 |
11 |
p. 2548
|
artikel
|
| 299 |
A Multicenter Prospective Randomized Study Testing Non-Inferiority of Thalidomide 100 mg/day as Compared with 400 mg/day in Patients with Refractory/Relapsed Multiple Myeloma: First Results of the Final Analysis of the IFM 01-02 Study.
|
Yakoub-Agha, Ibrahim
|
|
|
106 |
11 |
p. 364
|
artikel
|
| 300 |
A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.
|
Webert, Kathryn E.
|
|
|
106 |
11 |
p. 4183
|
artikel
|
| 301 |
A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).
|
van der Jagt, Richard H.C.
|
|
|
106 |
11 |
p. 4619
|
artikel
|
| 302 |
A Multicenter, Single-Arm, Open-Label Study To Evaluate the Efficacy and Safety of Single-Agent Lenalidomide in Patients with Relapsed and Refractory Multiple Myeloma; Prelininary Results.
|
Richardson, Paul
|
|
|
106 |
11 |
p. 1565
|
artikel
|
| 303 |
A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.
|
Jonas, William S.
|
|
|
106 |
11 |
p. 1339
|
artikel
|
| 304 |
A Multi-Institution Retrospective Case Report Analysis of Emergence of Breakthrough Zygomycoses in Patients on Prior Voriconazole Therapy.
|
Trifilio, Steven M.
|
|
|
106 |
11 |
p. 3227
|
artikel
|
| 305 |
A Multivariate Analysis of Human Promoter Sequences.
|
Dicato, Mario-Antoine
|
|
|
106 |
11 |
p. 4249
|
artikel
|
| 306 |
A Murine Marrow-Derived Multipotent Stem Cell Line Could Reconstitute Hematopoiesis after Transplantation into Lethallly Irradiated Syngeneic Mice.
|
Qiu, Huiying
|
|
|
106 |
11 |
p. 4226
|
artikel
|
| 307 |
A Murine Model of Bone Marrow Failure Mediated by Disparity in Minor Histocompatibility Antigens.
|
Chen, Jichun
|
|
|
106 |
11 |
p. 132
|
artikel
|
| 308 |
A Music Imagery Intervention for Adults with Acute Leukemia in Protective Environments.
|
Burns, Debra S.
|
|
|
106 |
11 |
p. 3130
|
artikel
|
| 309 |
A Mutation in Sec15l1 Disrupts the Transferrin Cycle and Causes Anemia in Hemoglobin Deficit (hbd) Mice.
|
Lim, Jackie E.
|
|
|
106 |
11 |
p. 513
|
artikel
|
| 310 |
An Accelerated Incidence of T-Cell Malignancies in a Mouse Model of XSCID Gene Therapy Is Associated with an Expanded Progenitor Cell Pool in the Bone Marrow.
|
Shou, Yan
|
|
|
106 |
11 |
p. 197
|
artikel
|
| 311 |
An Acidic Peptide Inhibits the Interleukin-6-Induced Activities of the Src Family Kinases Hck, Lyn and Fyn in Myeloma Cells.
|
Hausherr, Amparo
|
|
|
106 |
11 |
p. 2480
|
artikel
|
| 312 |
An Activating Mutation (Ser525Pro) within the Transactivation Domain of REL in Two Patients with Human B-Cell Lymphomas Enhances REL's In Vitro Transforming Activity.
|
Trautmann, Heiko
|
|
|
106 |
11 |
p. 2617
|
artikel
|
| 313 |
Anaemia Management in Patients on Peritoneal Dialysis in Portugal: A Nationwide Multicenter Survey.
|
Branco, Patrícia Q.
|
|
|
106 |
11 |
p. 3753
|
artikel
|
| 314 |
Anagrelide Treatment and Cardiovascular Evaluation in 130 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia (RIT).
|
Gugliotta, Luigi
|
|
|
106 |
11 |
p. 4956
|
artikel
|
| 315 |
An Alternative Transcript of the PANE1 Gene Encodes a Minor Histocompatibility Antigen That Is Selectively Expressed in Resting CD19+ Cells and B-CLL.
|
Brickner, Anthony G.
|
|
|
106 |
11 |
p. 2957
|
artikel
|
| 316 |
Analyses of Pokemon Protein Expression in Lymphoma Reveals Elevated Expression in Nodular Lymphocyte Predominant Hodgkin Lymphoma Compared to Classical Hodgkin Lymphoma.
|
Teruya-Feldstein, Julie
|
|
|
106 |
11 |
p. 965
|
artikel
|
| 317 |
Analysis of ADAMTS13 Activity in Plasma Products Using a Modified FRETS-VWF73 Assay.
|
Scott, Erik A.
|
|
|
106 |
11 |
p. 554
|
artikel
|
| 318 |
Analysis of B-CLL with Discordant ZAP-70 Expression and IgVH Mutational Status.
|
Letestu, Remi
|
|
|
106 |
11 |
p. 1194
|
artikel
|
| 319 |
Analysis of Both Clonal Functional and Non-Functional Immunoglobulin Heavy Chain (IgH) Rearrangements in Waldenström's Macroglobulinemia.
|
Martin-Jimenez, Patricia
|
|
|
106 |
11 |
p. 4334
|
artikel
|
| 320 |
Analysis of Clinical Characteristics and Prognostic Variables of Hodgkin's Lymphoma: A Single Center Experience.
|
ALshemmari, Salem H.
|
|
|
106 |
11 |
p. 4647
|
artikel
|
| 321 |
Analysis of Clonotypic Switch Junctions Reveals Multiple Myeloma Originates from a Single Class Switch Event with Ongoing Mutation in the Isotype Switched Progeny.
|
Taylor, Brian J.
|
|
|
106 |
11 |
p. 360
|
artikel
|
| 322 |
Analysis of Cytokine Profiling in Hepatitis-Associated Aplastic Anemia.
|
Lu, Jun
|
|
|
106 |
11 |
p. 1036
|
artikel
|
| 323 |
Analysis of EBV-Specific T Cell Responses in Transplant Recipients with PTLD.
|
Sebelin, Kathrin
|
|
|
106 |
11 |
p. 1915
|
artikel
|
| 324 |
Analysis of Epstein-Barr Virus Infections in Lymphoma Cell Lines.
|
Uphoff, Cord C.
|
|
|
106 |
11 |
p. 3906
|
artikel
|
| 325 |
Analysis of Expanded Human Cytokine Induced Killer Cells for Cellular Therapy.
|
Baker, Jeanette
|
|
|
106 |
11 |
p. 1063
|
artikel
|
| 326 |
Analysis of Factors Influencing Natural Killer (NK) Cell Activity during the Early Phase after Allogeneic Stem Cell Transplantation (SCT).
|
Fischer, Lars
|
|
|
106 |
11 |
p. 2192
|
artikel
|
| 327 |
Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.
|
Pozzi, Samantha
|
|
|
106 |
11 |
p. 5057
|
artikel
|
| 328 |
Analysis of Genetic Lesions in Atypical B-CLL by Pangenomic CGH-Arrays.
|
Roumier, Christophe
|
|
|
106 |
11 |
p. 4985
|
artikel
|
| 329 |
Analysis of IGFBP7 Expression Level and Its Correlation with Associated Genes in AML Patients.
|
Hu, Shao-yan
|
|
|
106 |
11 |
p. 4350
|
artikel
|
| 330 |
Analysis of IgVH, BCL-6, PIM, RHO/TTF and PAX5 Mutational Status in Splenic and Nodal Marginal Zone B Cell Lymphoma Suggests a Particular B Cell Origin.
|
Traverse-Glehen, Alexandra
|
|
|
106 |
11 |
p. 162
|
artikel
|
| 331 |
Analysis of JAK2 Mutation in Essential Thrombocythemia (ET) Patients with Monoclonal and Polyclonal X-Chromosome Inactivation Patterns (XCIPs).
|
Kiladjian, Jean-Jacques
|
|
|
106 |
11 |
p. 2603
|
artikel
|
| 332 |
Analysis of JAK2V617F Mutation, PRV-1 Overexpression and Endogenous Erythroid Colony (EEC) Formation Show Different Coexpression Patterns among Ph-Negative Chronic Myeloproliferative Disorders.
|
Bellosillo, Beatriz
|
|
|
106 |
11 |
p. 2592
|
artikel
|
| 333 |
Analysis of KIR Framework Loci in Patients with NK-Type Lymphoproliferative Disease of Granular Lymphocytes (LDGL).
|
Zambello, Renato
|
|
|
106 |
11 |
p. 2813
|
artikel
|
| 334 |
Analysis of Nuclear Factor Kappa B in Mantle Cell Lymphoma.
|
Schrader, Carsten
|
|
|
106 |
11 |
p. 4712
|
artikel
|
| 335 |
Analysis of PRAME Protein Expression in Normal Lymphoid Tissues and during B Ontogenesis.
|
de Figueiredo-Pontes, Lorena L.
|
|
|
106 |
11 |
p. 3924
|
artikel
|
| 336 |
Analysis of Prognosis in Follicular Lymphoma According to the FLIPI.
|
Hashimoto, Chizuko
|
|
|
106 |
11 |
p. 4682
|
artikel
|
| 337 |
Analysis of Structural Changes of the Factor VIII Gene: Intron 1 and 22, in Costarrican Families with Severe Haemophilia A.
|
Salazar-Sanchez, Lizbeth
|
|
|
106 |
11 |
p. 4096
|
artikel
|
| 338 |
Analysis of Survival, AML Transformation, and Transfusion Independence in Patients with High-Risk Myelodysplastic Syndromes (MDS) Receiving Azacitidine Determined Using a Prognostic Model.
|
Silverman, Lewis R.
|
|
|
106 |
11 |
p. 2523
|
artikel
|
| 339 |
Analysis of the Constitutively Active Wild-Type FLT3 Kinase Mediating Signaling.
|
Ozeki, Kazutaka
|
|
|
106 |
11 |
p. 4370
|
artikel
|
| 340 |
Analysis of the Effect of Soluble Transferrin Receptor 1 (sTfR1) on Iron Metabolism in Mice.
|
Flanagan, Jonathan M.
|
|
|
106 |
11 |
p. 3584
|
artikel
|
| 341 |
Analysis of the Human T Cell Receptor (TCR) Repertoire from Birth to Old Age Suggests That TCRVβfrequencies Are Established Independent of HLA.
|
Melenhorst, J. Joseph
|
|
|
106 |
11 |
p. 3313
|
artikel
|
| 342 |
Analysis of the T-Cell Receptor Repertoire in the Study of Immunological Abnormalities in Myelodysplastic Syndromes (MDS).
|
Du, Xin
|
|
|
106 |
11 |
p. 4921
|
artikel
|
| 343 |
Analysis of the X-Linked F-Cell Production Locus.
|
Keefer, Jeffrey R.
|
|
|
106 |
11 |
p. 3178
|
artikel
|
| 344 |
Analysis of Thrombi Retrieved from Cerebral Arteries of Patients with Acute Ischemic Stroke.
|
Marder, Victor J.
|
|
|
106 |
11 |
p. 263
|
artikel
|
| 345 |
Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.
|
Iwao, Noriaki
|
|
|
106 |
11 |
p. 5367
|
artikel
|
| 346 |
Analysis of 608 Umbilical Cord Blood (UCB) Transplants: HLA-Match Is a Critical Determinant of Transplant-Related Mortality (TRM) in the Post-Engraftment Period Even in the Absence of Acute Graft-vs-Host Disease (aGVHD).
|
Barker, Juliet N.
|
|
|
106 |
11 |
p. 303
|
artikel
|
| 347 |
Analysis of Validated Clonotypic Igh VDJ Sequences from a Large Cohort of MM Patients.
|
Taylor, Brian J.
|
|
|
106 |
11 |
p. 1543
|
artikel
|
| 348 |
Analysis of YY1 and XIAP Expression, Proteins That Regulate Resistance, in AIDS-NHL Tissue Arrays.
|
Huerta-Yepez, Sara
|
|
|
106 |
11 |
p. 1933
|
artikel
|
| 349 |
Analysis with the LightCycler System® Identifies a Highly Significant Correlation between ZAP-70 mRNA Expression and Immunoglobulin Variable Heavy Chain Gene Mutational Status in Chronic Lymphocytic Leukemia.
|
Dicker, Frank
|
|
|
106 |
11 |
p. 3259
|
artikel
|
| 350 |
Analytical Characterization of Infusion Volume Reduced Humate-P®/Haemate® P.
|
Metzner, Hubert J.
|
|
|
106 |
11 |
p. 4167
|
artikel
|
| 351 |
An Analysis of Angiotensin Converting Enzyme Gene Polymorphisms and Non-Infectious Pulmonary Dysfunction after Hematopoietic Stem Cell Transplantation.
|
Onizuka, Makoto
|
|
|
106 |
11 |
p. 1418
|
artikel
|
| 352 |
An Anti-Phosphatidylserine (PS) Antibody, Tarvacin™ That Targets Tumor Blood Vessels Does Not Affect Platelet Function In Vitro.
|
Dyszkiewicz-Korpanty, Anna M.
|
|
|
106 |
11 |
p. 3950
|
artikel
|
| 353 |
An Applicational Observation of Low-Dose Rituximab in Elderly Patients with Nodal Marginal Zone Lymphomas.
|
Roggero, Enrico
|
|
|
106 |
11 |
p. 4771
|
artikel
|
| 354 |
A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.
|
Shustik, C.
|
|
|
106 |
11 |
p. 2977
|
artikel
|
| 355 |
A National Survey of Treatment Practices for Elderly Cancer Patients in India.
|
Parikh, Purvish M.
|
|
|
106 |
11 |
p. 5568
|
artikel
|
| 356 |
A Nationwide Survey of Immunosuppressive Therapy for Idiopathic Acquired Pure Red Cell Aplasia in Japan and a Proposal for First-Line Treatment: Report of the PRCA Collaborative Study Group.
|
Hirokawa, Makoto
|
|
|
106 |
11 |
p. 3747
|
artikel
|
| 357 |
Anatomical Compartments Modulate the Response of Human Hematopoietic Cells to Mitogenic Signaling, In Vivo.
|
Wang, Linlin
|
|
|
106 |
11 |
p. 4321
|
artikel
|
| 358 |
A Natural Variant Sequence in the AHSP Gene May Impact Severity of Beta-Thalassemia.
|
dos Santos, Camila O.
|
|
|
106 |
11 |
p. 3629
|
artikel
|
| 359 |
An Audit of Inpatient Consultations to a Hematology Department over Two-Year Period.
|
Kim, Min Kyoung
|
|
|
106 |
11 |
p. 5571
|
artikel
|
| 360 |
8 and 11Gauge Bone Marrow Biopsy Needle Performance Characteristics.
|
Goldenberg, Alec
|
|
|
106 |
11 |
p. 5580
|
artikel
|
| 361 |
Androgen Modulates Thymopoiesis by Regulating Thymocyte Precursor Immigration.
|
Williams, Kirsten M.
|
|
|
106 |
11 |
p. 1271
|
artikel
|
| 362 |
An Early Block to Erythro-Megakaryocytic Development Conferred by Loss of Transcription Factor GATA-1.
|
Stachura, David L.
|
|
|
106 |
11 |
p. 1732
|
artikel
|
| 363 |
Anemia in Elderly Hospitalized Veterans: Prevalence, Causes, and Clinical Impact.
|
Rosing, Joanna L.
|
|
|
106 |
11 |
p. 3756
|
artikel
|
| 364 |
Anemia in the Elderly and the Risk of Injurious Falls.
|
Duh, Mei S.
|
|
|
106 |
11 |
p. 1333
|
artikel
|
| 365 |
An Empirical Analysis of the Probability of Finding a Well Matched Cord Blood Unit: Implications for a National Cord Blood Inventory.
|
Stevens, Cladd E.
|
|
|
106 |
11 |
p. 2047
|
artikel
|
| 366 |
An Entirely Novel Form of α Thalassemia in Patients from the South Pacific Linked to Chromosome 16.
|
Viprakasit, Vip
|
|
|
106 |
11 |
p. 2688
|
artikel
|
| 367 |
An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.
|
Lange, Andrzej
|
|
|
106 |
11 |
p. 4875
|
artikel
|
| 368 |
A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on Chronic Myeloid Leukaemia (CML) Ph+ Cells Resistant to Imatinib.
|
Martinelli, Giovanni
|
|
|
106 |
11 |
p. 2004
|
artikel
|
| 369 |
A New and Rapid Immunoassay for the Detection of 11-Dehydro-Thromboxane B2.
|
Geske, F. Jon
|
|
|
106 |
11 |
p. 2641
|
artikel
|
| 370 |
A New BACOPP Schedule Is Feasible and Effective in Elderly Hodgkin's Lymphoma Patients - Interim Results of a Multicenter Phase-II Trial of the German Hodgkin Study Group (GHSG).
|
Nogova, Lucia
|
|
|
106 |
11 |
p. 4735
|
artikel
|
| 371 |
A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.
|
Michel, Gérard
|
|
|
106 |
11 |
p. 1758
|
artikel
|
| 372 |
A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double-Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.
|
Powell, Jerry Sherman
|
|
|
106 |
11 |
p. 4076
|
artikel
|
| 373 |
A New Gene Which Regulates Platelet Dense Granules.
|
Gautam, Rashi
|
|
|
106 |
11 |
p. 2177
|
artikel
|
| 374 |
A New Human CD20 Antibody for Improved Killing of CD20-Transgenic T Cells for Allogeneic Stem Cell Transplantation.
|
van Meerten, Tom
|
|
|
106 |
11 |
p. 5538
|
artikel
|
| 375 |
A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.
|
Vassal, Gilles
|
|
|
106 |
11 |
p. 5200
|
artikel
|
| 376 |
A New Mechanism of Platelet Activation, Oxidation and Death Induced by ADAMTS-18.
|
Li, Zongdong
|
|
|
106 |
11 |
p. 652
|
artikel
|
| 377 |
A New Methodology To Screen Hemoglobinopathies Using Capillary Blood Samples.
|
Bento, Celeste
|
|
|
106 |
11 |
p. 5562
|
artikel
|
| 378 |
A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study.
|
Meloni, Giovanna
|
|
|
106 |
11 |
p. 1829
|
artikel
|
| 379 |
A New Model for Predicting Venesection Therapy Requirements in Hereditary Hemochromatosis Using Non-Invasive Liver Iron Concentration Measurement.
|
St. Pierre, Timothy G.
|
|
|
106 |
11 |
p. 3596
|
artikel
|
| 380 |
A New Perspective on the Natural History of Hereditary Hemochromatosis.
|
Waalen, Jill
|
|
|
106 |
11 |
p. 3595
|
artikel
|
| 381 |
A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).
|
Arat, Mutlu
|
|
|
106 |
11 |
p. 4517
|
artikel
|
| 382 |
A New Recurrent 9q34 Duplication in Pediatric T-Cell Acute Lymphoblastic Leukemia.
|
Van Vlierberghe, Pieter
|
|
|
106 |
11 |
p. 89
|
artikel
|
| 383 |
A New Role for FcγRIIA in the Potentiation of Human Platelet Activation Induced by Weak Stimulation.
|
Canobbio, Ilaria
|
|
|
106 |
11 |
p. 1648
|
artikel
|
| 384 |
A New Scoring System To Predict the Prognosis of Patients with Acute Myeloid Leukemia. -Study from the Japan Adult Leukemia Study Group.
|
Miyazaki, Yasushi
|
|
|
106 |
11 |
p. 2373
|
artikel
|
| 385 |
A New Validated Myelodysplastic Syndrome (MDS) Prognostic Model for Use When Cytogenetics Are Unavailable.
|
Silverman, Lewis R.
|
|
|
106 |
11 |
p. 2527
|
artikel
|
| 386 |
An Experimental Study on the Effects of Sensitized-Donor Lymphocytes Infusion after Non-Myeloablative Allo-Stem Cell Transplantation.
|
Chen, Bao-An
|
|
|
106 |
11 |
p. 5203
|
artikel
|
| 387 |
Angiogenesis and Osteoclastogenesis Are Mutually Stimulated in Myeloma: A Role for VEGF and Osteopontin.
|
Tanaka, Yoichi
|
|
|
106 |
11 |
p. 2500
|
artikel
|
| 388 |
Angiogenic Cytokines Are Increased in the Serum of Patients with Waldenstrom's Macroglobulinemia: Correlations with Clinical Data.
|
Anagnostopoulos, Athanasios
|
|
|
106 |
11 |
p. 2504
|
artikel
|
| 389 |
Angioimmunoblastic T-Cell Lymphoma: A Large Series Outcome Analysis.
|
Kyriakou, Charalampia
|
|
|
106 |
11 |
p. 2810
|
artikel
|
| 390 |
Angioimmunoblastic T- Cell Lymphoma by Flow Cytometric Analysis.
|
Agarwal, Ashima
|
|
|
106 |
11 |
p. 4707
|
artikel
|
| 391 |
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis.
|
Giuliani, Nicola
|
|
|
106 |
11 |
p. 2501
|
artikel
|
| 392 |
An Important Role for CD1d and NKT Cells in the Suppression of Hematopoiesis in Mice Induced by Infection with Cytomegalovirus.
|
Broxmeyer, Hal E.
|
|
|
106 |
11 |
p. 574
|
artikel
|
| 393 |
An Increased Frequency of Abnormalities Including Uniparental Disomy Is Detected by SNP Array Compared with Conventional Karyotype Analysis in Acute Myeloid Leukemia.
|
Raghavan, Manoj
|
|
|
106 |
11 |
p. 97
|
artikel
|
| 394 |
An Indispensable Role of GM-CSF in the Differentiation of Human Blood Monocytes toward Langerhans Cells.
|
Shibasaki, Tetsunori
|
|
|
106 |
11 |
p. 3868
|
artikel
|
| 395 |
An Inhibitor of p38 Mitogen-Activated Protein Kinase Abrogates Procoagulant and Proinflammatory Effects of Antiphospholipid Antibodies In Vivo.
|
Pierangeli, Silvia S.
|
|
|
106 |
11 |
p. 136
|
artikel
|
| 396 |
An Initial Analysis of an Allele-Specific Q-PCR Assay Which Detects Minimal Residual Disease in the Peripheral Blood of Follicular Lymphoma Patients.
|
Kautz, Naomi
|
|
|
106 |
11 |
p. 4704
|
artikel
|
| 397 |
An Integrated Approach to Analyzing Activation Profiles in Immune Cells by Combining Cytomic and Proteomic Techniques of Cell Analysis/Sorting and Protein Fractionation.
|
D'Costa, Sybil
|
|
|
106 |
11 |
p. 3934
|
artikel
|
| 398 |
An Integrated Epigenomic Analysis Approach To Determine the Molecular Basis of Acute Leukemias.
|
Figueroa, Maria E.
|
|
|
106 |
11 |
p. 3276
|
artikel
|
| 399 |
An In Vitro Model of Proliferating CLL Cells for Drug Sensitivity Analysis.
|
Ganeshaguru, K.
|
|
|
106 |
11 |
p. 2956
|
artikel
|
| 400 |
An In Vivo Model To Investigate the Identity of the Cell-of-Origin of Multiple Myeloma.
|
Asimakopoulos, Fotios A.
|
|
|
106 |
11 |
p. 1534
|
artikel
|
| 401 |
A Non-Human Primate Model To Study Anti-HIV Gene Therapy Strategies.
|
Trobridge, Grant D.
|
|
|
106 |
11 |
p. 3046
|
artikel
|
| 402 |
A Non-Internalizing Anti-CD40 Antibody, CHIR-12.12, Blocks CD40L-Induced Cytokine Production and Mediates Greater ADCC Than Rituximab in Primary CLL Cells.
|
Tong, Xia
|
|
|
106 |
11 |
p. 2964
|
artikel
|
| 403 |
An Oral Iron Chelator and Quality of Life.
|
De Abreu Lourenco, Richard
|
|
|
106 |
11 |
p. 5553
|
artikel
|
| 404 |
An Orally Bioavailable Inhibitor of FLT3 and Syk Kinases Prevents Tumor Growth in Subcutaneously Implanted Human Tumor Xenografts and Promotes Cell Death of FLT3 Mutant AML Cells.
|
Pine, Polly R.
|
|
|
106 |
11 |
p. 243
|
artikel
|
| 405 |
Another Look at Thrombin-GPIba Interaction in Solution Phaseα
|
Yegneswaran, Subramanian
|
|
|
106 |
11 |
p. 1646
|
artikel
|
| 406 |
An Outpatient Salvage Approach for Advanced Lymphoma Incorporating Stratification and Dose-Escalation.
|
Spencer, Andrew
|
|
|
106 |
11 |
p. 3336
|
artikel
|
| 407 |
A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.
|
Kang, Elizabeth M.
|
|
|
106 |
11 |
p. 5429
|
artikel
|
| 408 |
A Novel Animal Model for Detecting Damage to Human Platelet Transfusion Products: In Vivo Recovery and Survival in Severe Combined Immunodeficient Mice.
|
Piper, John T.
|
|
|
106 |
11 |
p. 1891
|
artikel
|
| 409 |
A Novel Anti CD23 Fully Human Monoclonal Antibody Potentially Useful for B-CLL Therapy.
|
Delcommenne, Marc
|
|
|
106 |
11 |
p. 5047
|
artikel
|
| 410 |
A Novel 5′ ATRX Point Mutation with Splicing Consequences in Chronic Myelomonocytic Leukemia with Immune Dysregulation and Acquired Alpha Thalassemia.
|
Nelson, Maria E.
|
|
|
106 |
11 |
p. 3652
|
artikel
|
| 411 |
A Novel Bcr-Abl Mediated Pro-Survival Pathway: Reduction of Releasable Calcium Levels in the Endoplasmic Reticulum Inhibits Calcium Dependent Apoptotic Signaling.
|
Vejda, Susanne
|
|
|
106 |
11 |
p. 2621
|
artikel
|
| 412 |
A Novel Congenital Bleeding Disorder Related to High Plasma Heparin-Like Anticoagulant Activity.
|
Wang, Zhaoyue
|
|
|
106 |
11 |
p. 4074
|
artikel
|
| 413 |
A Novel C-Type Lectin Receptor DCL-1 (CD302) Is a Potential Endocytic Receptor for Tumor Antigen Loading into Antigen Presenting Cells.
|
Kato, Masato
|
|
|
106 |
11 |
p. 2227
|
artikel
|
| 414 |
A Novel Culture System of Human ES Cells for High Efficient Hematopoietic and Endothelial Differentiation.
|
Wang, Zack Z.
|
|
|
106 |
11 |
p. 3616
|
artikel
|
| 415 |
A Novel 2′-Deoxy-2′-Fluoro (2′F-ANA) Ribose Modification Significantly Enhances the Duration, and Efficiency, of Nucleic Acid Mediated Gene Silencing.
|
Kalota, Anna
|
|
|
106 |
11 |
p. 3062
|
artikel
|
| 416 |
A Novel, Efficacious Therapeutic Approach to Patients with Acute Promyelocytic Leukemia (APL) Using Differentiating Agent and Metronomic Chemotherapy (CT).
|
Banavali, Shripad D.
|
|
|
106 |
11 |
p. 900
|
artikel
|
| 417 |
A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom's Macroglobulinemia.
|
Ho, Allen W.
|
|
|
106 |
11 |
p. 4701
|
artikel
|
| 418 |
A Novel Heterologous Expression System for Characterization of Individual NADH-Cytochrome b
5 Reductase Variants in Recessive Congenital Methemoglobinemia.
|
Percy, Melanie J.
|
|
|
106 |
11 |
p. 1676
|
artikel
|
| 419 |
A Novel Inherited Platelet Function Disorder Involving the Thromboxane A2 Pathway of Platelet Activation.
|
Rand, Margaret L.
|
|
|
106 |
11 |
p. 2175
|
artikel
|
| 420 |
A Novel In Vivo Animal Model for Human Multiple Myeloma Based on Bioluminescence Imaging of Tumor Cell Growth.
|
Martens, Anton C.
|
|
|
106 |
11 |
p. 3452
|
artikel
|
| 421 |
A Novel Mechanism of Action of Methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate (CDDO-Me): Direct Permeabilization of the Inner Mitochondrial Membrane To Inhibit Electron Transport and Induce Apoptosis.
|
Samudio, Ismael
|
|
|
106 |
11 |
p. 4462
|
artikel
|
| 422 |
A Novel Method for Efficient Production of Multipotential Hematopoietic Progenitors from Human Embryonic Stem Cells by Co-Culture with Murine Fetal Liver-Derived Stromal Cells.
|
Ma, Feng
|
|
|
106 |
11 |
p. 4214
|
artikel
|
| 423 |
A Novel Method for KIR-Ligand Typing by Pyrosequencing To Predict NK Cell Alloreactivity.
|
Yun, Gong
|
|
|
106 |
11 |
p. 1407
|
artikel
|
| 424 |
A Novel Method of Isolation of Mesenchymal Stem Cells from Human Umbilical Cord Tisssues.
|
Lu, Lulu
|
|
|
106 |
11 |
p. 4306
|
artikel
|
| 425 |
A Novel Multiparameter Flow Cytometric Cytotoxicity Assay Detects p53 Deletion as the Major Cause of In Vitro Resistance to Fludarabine in B-Cell Chronic Lymphocytic Leukemia.
|
Huang, James Z.
|
|
|
106 |
11 |
p. 4470
|
artikel
|
| 426 |
A Novel Mutation in the von Willebrand Factor Propeptide Causes Defective Regulated Storage in Platelets and Weibel-Palade Bodies.
|
Haberichter, Sandra L.
|
|
|
106 |
11 |
p. 1007
|
artikel
|
| 427 |
A Novel Non-Peptidyl Human C-Mpl Agonist, NIP-004, Stimulates Human Megakaryopoiesis and Thrombopoiesis.
|
Nakamura, Takanori
|
|
|
106 |
11 |
p. 3148
|
artikel
|
| 428 |
A Novel Splicing Factor RBM-9 Regulates Protein 4.1R Exon 16 Splicing.
|
Yang, Guang
|
|
|
106 |
11 |
p. 805
|
artikel
|
| 429 |
A Novel Suicide Gene Therapy Approach for Reduction of GvHD Using Lentiviral Delivery of a Modified Human Thymidylate Monophosphate Kinase.
|
Sato, Takeya
|
|
|
106 |
11 |
p. 5252
|
artikel
|
| 430 |
A Novel Switch Culture System for Proliferation and Differentiation of Monocytic Cells: ERK Activation Is Not Sufficient for Macrophage Differentiation by M-CSF.
|
Suzu, Shinya
|
|
|
106 |
11 |
p. 4257
|
artikel
|
| 431 |
A Novel Thrombin Fluorogenic Substrate of High Affinity, Catalytic Efficiency and Selectivity.
|
Baird, T. Regan
|
|
|
106 |
11 |
p. 1953
|
artikel
|
| 432 |
A Novel Thrombopoiesis-Stimulating Agent, AMG 531: Pharmacokinetics and Pharmacodynamics in FcRn Knock-Out and Wild Type Mice.
|
Sun, Yu-Nien
|
|
|
106 |
11 |
p. 3575
|
artikel
|
| 433 |
A Novel Umbilical Cord Blood Collection System.
|
Kuypers, Frans A.
|
|
|
106 |
11 |
p. 5285
|
artikel
|
| 434 |
An RNA Based Approach to vWD Type 1 Mutation Analysis.
|
Hadonou, Medard
|
|
|
106 |
11 |
p. 1784
|
artikel
|
| 435 |
Antagonist Anti-CD40 Antibody, CHIR-12.12, Induces ADCC, Inhibits Tumor Growth, and Prolongs Survival in a Human Multiple Myeloma Xenograft Model.
|
Long, Li
|
|
|
106 |
11 |
p. 3470
|
artikel
|
| 436 |
Antagonistic Effect of C/EBPα and Pax5 in Myeloid or Lymphoid Lineage Choice in Common Lymphoid Progenitors.
|
Fleischman, Angela G.
|
|
|
106 |
11 |
p. 2282
|
artikel
|
| 437 |
Antagonistic Roles of ERK1/2 and p38 MAP Kinases in Hemoglobin Synthesis.
|
Blank, Volker
|
|
|
106 |
11 |
p. 3636
|
artikel
|
| 438 |
Anti-Angiogenic In Vivo Effect of Lenalidomide (CC-5013) in Myelodysplastic Syndrome with del(5q) Chromosome Abnormality and Its Relation to the Course of Disease.
|
Buesche, Guntram
|
|
|
106 |
11 |
p. 372
|
artikel
|
| 439 |
Anti-Angiongenic Effects of mTOR-Inhibitors Is Regulated by AKT Activity in Multiple Myeloma Cells.
|
Frost, Patrick
|
|
|
106 |
11 |
p. 3406
|
artikel
|
| 440 |
Anti-Apoptotic Effect, Mediated by Elevated Intracellular Cyclic AMP Levels, in Neutrophils of Sickle Cell Disease Patients.
|
Conran, Nicola
|
|
|
106 |
11 |
p. 2343
|
artikel
|
| 441 |
Antibodies to CD40 Promote Dendritic Cell Recovery and Anti-Tumor Effects after Syngeneic Bone Marrow Transplant (BMT).
|
Welniak, Lisbeth A.
|
|
|
106 |
11 |
p. 1305
|
artikel
|
| 442 |
Antibodies to S-303 Treated RBC Prepared with the Original Treatment Process (OSRBC) for Pathogen Inactivation Do Not React with RBC Prepared with a Modified S-303 Treatment Process (MSRBC).
|
Conlan, Maureen G.
|
|
|
106 |
11 |
p. 430
|
artikel
|
| 443 |
Anti-CD20 and Anti-CD52 Monoclonal Antibodies Enhance Cytotoxicity of Bortezomib Against Chronic Lymphocytic Leukemia Cells.
|
Smolewski, Piotr
|
|
|
106 |
11 |
p. 2972
|
artikel
|
| 444 |
Anti-CD3/Anti-CD28 Bead-Activated T Cells Facilitate Engraftment of Murine Histoincompatible Allogeneic Transplants after Low-Dose Radiation.
|
Berenson, Ronald J.
|
|
|
106 |
11 |
p. 5221
|
artikel
|
| 445 |
Anti-CD20 Monoclonal Antibody (mAb) with Enhanced Affinity for CD16 Activates NK Cells at Lower Concentrations and More Effectively Than Rituximab ®.
|
Weiner, George J.
|
|
|
106 |
11 |
p. 348
|
artikel
|
| 446 |
Anti-CD20 Monoclonal Antibody (Rituximab) for Therapy of T-Cell/Histiocyte-Rich Large B-Cell Non-Hodgkin Lymphoma.
|
Park, EunSil
|
|
|
106 |
11 |
p. 4804
|
artikel
|
| 447 |
Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge.
|
Jilma, Bernd
|
|
|
106 |
11 |
p. 1880
|
artikel
|
| 448 |
Anticoagulant Heparan Sulfate Mediates Antithrombin Amelioration of Leukocyte-Endothelial Interactions in Sepsis.
|
Gross, Peter L.
|
|
|
106 |
11 |
p. 3684
|
artikel
|
| 449 |
Anticoagulant Therapy for the Treatment of Idiopathic Osteonecrosis.
|
Shehadat, Saaib Al
|
|
|
106 |
11 |
p. 919
|
artikel
|
| 450 |
Anticoagulation with Low Molecular Weight Heparin (LMWH) during Autologous Peripheral Blood Stem Cell Transplantation (PBSCT). Single Institution Experience.
|
Roy, Rajasree
|
|
|
106 |
11 |
p. 1885
|
artikel
|
| 451 |
Antifungal Prophylaxis with Oral and Intravenous Itraconazole in Pediatric Stem Cell Tansplantation: A Retrospective Comparison with Fluconazole and Amphotericin B-Preparations in 116 Children.
|
Grigull, Lorenz
|
|
|
106 |
11 |
p. 5356
|
artikel
|
| 452 |
Antifungal Therapy in Neutropenic Oncohemopatic Patients. A Single Centre Retrospective Analysis.
|
Bonini, Alessandro
|
|
|
106 |
11 |
p. 5334
|
artikel
|
| 453 |
Antifungal Treatment with Caspofungin: A Single Centre Experience.
|
Bonini, Alessandro
|
|
|
106 |
11 |
p. 5386
|
artikel
|
| 454 |
Antigen-Dependent Suppression of Graft Versus Host Disease by Foxp3-Induced Regulatory T Cells in Transplantation.
|
Albert, Michael H.
|
|
|
106 |
11 |
p. 1302
|
artikel
|
| 455 |
Antigen Levels of Thrombospondin-1 and ADAMTS13 Are Reduced in Parallel in TTP.
|
Liu, Fang
|
|
|
106 |
11 |
p. 1785
|
artikel
|
| 456 |
Antigen-Specific CD8+ Memory T Cells Survive, Function and Populate the Host Marrow Compartment Following Ablative TBI and Allogeneic BMT.
|
Shatry, Alwi M.
|
|
|
106 |
11 |
p. 1268
|
artikel
|
| 457 |
Antigen-Specific T Lymphocyte Function Following Unrelated Cord Blood Transplantation (UCBT).
|
Parkman, Robertson
|
|
|
106 |
11 |
p. 3032
|
artikel
|
| 458 |
Anti-Haemostatic Properties of Diverse Haematophagous Hirudinea from around the World Could Have New Therapeutic Potentials.
|
Wakeman, Lisa
|
|
|
106 |
11 |
p. 4140
|
artikel
|
| 459 |
Anti-Haemostatic Properties of Salivary Secretions of the Rhynchobdellid Leech Theromyzon tessulatum and the Arhynchobdellid Leech Haemopis sanguisuga: Potentially New Therapeutic Agents.
|
Wakeman, Lisa
|
|
|
106 |
11 |
p. 4139
|
artikel
|
| 460 |
Anti-HCV Agent, Ribavirin, Decreases Events of Bleeding in Hemophilia Patients, Possibly by Elevating the Clotting Activity of Factor VII.
|
Yamamoto, Koji
|
|
|
106 |
11 |
p. 3214
|
artikel
|
| 461 |
Anti-HTLV-I Tax-Protein-Specific CTL Is Not Necessarily Resposible for Graft-v.s.-ATL Effect in Allogeneic SCT for Patients with Adult T-Cell Leukemia/Lymphoma.
|
Fujiwara, Hiroshi
|
|
|
106 |
11 |
p. 5353
|
artikel
|
| 462 |
Anti-Interleukin 6 Receptor Monoclonal Antibody Therapy Reduced Serum Interleukin 4 and IgE Production in Castleman's Disease.
|
Nakahara, Hideko
|
|
|
106 |
11 |
p. 1510
|
artikel
|
| 463 |
Anti-Leukemia Immune Responses in CML Patients Treated with Imatinib Mesylate.
|
Chen, Christiane I.-U.
|
|
|
106 |
11 |
p. 1108
|
artikel
|
| 464 |
Antileukemic Activity of Shepherdin, a Novel Targeted Inhibitor of the Survivin-Hsp90 Complex.
|
Gyurkocza, Boglarka
|
|
|
106 |
11 |
p. 242
|
artikel
|
| 465 |
Anti-Leukemic Effect of Maintenance Chemotherapy Is Mediated by Induction of Differentiation.
|
Lin, Tara L.
|
|
|
106 |
11 |
p. 865
|
artikel
|
| 466 |
Anti-Myeloma Activity of the Maytansinoid Immunoconjugate of Internalizing Human Monoclonal Antibody Specific for HM1.24/BST2 (CD317).
|
Ozaki, Shuji
|
|
|
106 |
11 |
p. 3388
|
artikel
|
| 467 |
Anti-Myeloma Effects Induced by Myeloma Idiotype Pulsed Dendritic Cells In Vitro.
|
Zhang, Mei
|
|
|
106 |
11 |
p. 5131
|
artikel
|
| 468 |
Anti-Myeloma Effects of a Novel Synthetic Retinoid Am80 (Tamibarotene) through Inhibition of Angiogenesis.
|
Sanda, Takaomi
|
|
|
106 |
11 |
p. 5126
|
artikel
|
| 469 |
Anti-Myeloma Response to Bortezomib Is Associated with Increased Osteoblast Activity and Bone Formation in Primary Myelomatous SCID-rab Mice.
|
Yaccoby, Shmuel
|
|
|
106 |
11 |
p. 3450
|
artikel
|
| 470 |
Antineutrophil Antibodies Lead to Mistaken Identity in Severe Congenital Neutropenia.
|
Boxer, Laurence A.
|
|
|
106 |
11 |
p. 385
|
artikel
|
| 471 |
Antioxidant Effects of Neutrophil p29 Peroxiredoxin.
|
Ambruso, Daniel R.
|
|
|
106 |
11 |
p. 3087
|
artikel
|
| 472 |
Antiphospholipid Antibodies Impair the Clearance of Apoptotic Platelets.
|
Pierangeli, Silvia S.
|
|
|
106 |
11 |
p. 3948
|
artikel
|
| 473 |
Antiphospholipid Antibody Syndrome: Annexin V Competitive Flow Cytometric Assay for Determination of Anti-Platelet Phospholipid Autoantibodies.
|
Tomer, Aaron
|
|
|
106 |
11 |
p. 4126
|
artikel
|
| 474 |
Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Event after Ischemic Stroke.
|
Corinaldesi, Giorgio
|
|
|
106 |
11 |
p. 4141
|
artikel
|
| 475 |
Antiproliferative Effects of Tyrosine Kinase (STI 571) and Farnesyl Transferase Inhibitors (R115777 and SCH66336) on Acute Leukemia Human Tumor Cell Lines.
|
Russo, Domenico
|
|
|
106 |
11 |
p. 4416
|
artikel
|
| 476 |
Anti-Thrombotic Action of DZ-697b, a Novel Anti-Platelet Agent, on Photochemically Induced Thrombosis with Lower Bleeding Risk in Guinea Pigs.
|
Shibutani, Tomoko
|
|
|
106 |
11 |
p. 1870
|
artikel
|
| 477 |
Anti-Thymocyte Globulin (ATG) Induces Apoptosis in Myeloma Cells: A Basis for Myeloma Sero-Therapy?.
|
Ayuk, Francis A.
|
|
|
106 |
11 |
p. 5194
|
artikel
|
| 478 |
Antitumor Activity and Mechanism of Action of a Novel Stat3 Inhibitor, WP1066, Against Human B-Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.
|
Kong, Ling-Yuan
|
|
|
106 |
11 |
p. 1489
|
artikel
|
| 479 |
Anti-Tumor Activity of a Novel Bcr-Abl/Lyn Dual Inhibitor, NS-187, in Murine CNS Ph+ Leukemia Models.
|
Yokota, Asumi
|
|
|
106 |
11 |
p. 493
|
artikel
|
| 480 |
Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.
|
Saito, Anri
|
|
|
106 |
11 |
p. 2385
|
artikel
|
| 481 |
Anti-Tumor Effect of Direct Intratumor Injection of Recombinant Fowlpox Virus Encoding CD40 Ligand in B Cell Lymphoma Model.
|
Liu, Aichun
|
|
|
106 |
11 |
p. 1477
|
artikel
|
| 482 |
Antitumor Genotoxic Agents, Such as Fludarabine*, Doxorubincin or Cis-Platine, Induce Activation of STAT1 in a p53 Protein Dependent Manner.
|
Youlyouz-Marfak, Ibtissam
|
|
|
106 |
11 |
p. 4384
|
artikel
|
| 483 |
Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.
|
Lim, Wendy
|
|
|
106 |
11 |
p. 906
|
artikel
|
| 484 |
An Update of a Phase II Trial of CHOP Followed by Tositumomab/Iodine I-131 Tositumomab (Bexxar®) for Front-Line Treatment of Advanced Stage, Follicular Lymphoma: Southwest Oncology Group Protocol 9911.
|
Press, Oliver W.
|
|
|
106 |
11 |
p. 352
|
artikel
|
| 485 |
Anxiety, Self-Esteem and Social Functioning in Adolescents with Thalassemia Major.
|
Sachdeva, Anupam
|
|
|
106 |
11 |
p. 3843
|
artikel
|
| 486 |
A Phase 2 Clinical Trial of AP23573, an mTOR Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies.
|
Rizzieri, David A.
|
|
|
106 |
11 |
p. 2980
|
artikel
|
| 487 |
A Phase I Double-Blind, Ascending Dose Study of an Oral Synthetic Direct Thrombin Inhibitor, TGN167.
|
Combe, Sophie
|
|
|
106 |
11 |
p. 1863
|
artikel
|
| 488 |
A Phase I Humanized Anti-CD40 Monoclonal Antibody (SGN-40) in Patients with Multiple Myeloma.
|
Hussein, Mohamad A.
|
|
|
106 |
11 |
p. 2572
|
artikel
|
| 489 |
A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).
|
Takizawa, Jun
|
|
|
106 |
11 |
p. 4734
|
artikel
|
| 490 |
A Phase III Clinical Study of Treatment of Patients with Chronic Lymphoproliferative Disorders (CLPD) with Fludarabine, Cyclophosphamide, and Rituximab (FCR) Combination.
|
Galanopoulos, Athanasios G.
|
|
|
106 |
11 |
p. 4740
|
artikel
|
| 491 |
A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma (MM) Patients.
|
Mateos, M.V.
|
|
|
106 |
11 |
p. 786
|
artikel
|
| 492 |
A Phase I-II Pilot Study of Divalproex Sodium Alone and in Combination with All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia.
|
Gabrilove, Janice L.
|
|
|
106 |
11 |
p. 2799
|
artikel
|
| 493 |
A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma.
|
Popat, Rakesh
|
|
|
106 |
11 |
p. 2555
|
artikel
|
| 494 |
A Phase I/II Study of TACI-Ig To Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Multiple Myeloma or Active Previously-Treated Waldenström's Macroglobulinemia.
|
Rossi, Jean-Francois
|
|
|
106 |
11 |
p. 2566
|
artikel
|
| 495 |
A Phase I/II Trial Evaluating the Combination of Arsenic Trioxide, Bortezomib and Ascorbic Acid for Patients with Relapsed or Refractory Multiple Myeloma.
|
Berenson, James
|
|
|
106 |
11 |
p. 2565
|
artikel
|
| 496 |
A Phase I–II Trial of Bortezomib (Velcade) (Vc) and Oral Cyclophosphamide (CY) Plus Prednisone (P) for Relapsed/Refractory Multiple Myeloma (MM).
|
Reece, Donna E.
|
|
|
106 |
11 |
p. 2556
|
artikel
|
| 497 |
A Phase II Study of Dasatinib in Patients with Accelerated Phase Chronic Myeloid Leukemia (CML) Who Are Resistant or Intolerant to Imatinib: First Results of the CA180005 ‘START-A' Study.
|
Guilhot, Francois
|
|
|
106 |
11 |
p. 39
|
artikel
|
| 498 |
A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis or Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: The ‘START-L' CA180015 Study.
|
Ottmann, Oliver G.
|
|
|
106 |
11 |
p. 42
|
artikel
|
| 499 |
A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Crisis Who Are Resistant or Intolerant to Imatinib: First Results of the CA180006 ‘START-B' Study.
|
Talpaz, M.
|
|
|
106 |
11 |
p. 40
|
artikel
|
| 500 |
A Phase II Study of Enzastaurin, a Protein Kinase C-β (PKCβ) Inhibitor, in the Treatment of Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).
|
Robertson, Michael
|
|
|
106 |
11 |
p. 934
|
artikel
|
| 501 |
A Phase II Study of Myeloablative I-131-Anti CD-20 (Tositumomab) Radioimmunotherapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Adults ≥60 Years of Age with High-Risk Relapsed or Refractory B-Cell Lymphoma.
|
Gopal, Ajay K.
|
|
|
106 |
11 |
p. 487
|
artikel
|
| 502 |
A Phase II Study of PS-341 for Patients with High Risk, Newly Diagnosed Multiple Myeloma: A Trial of the Eastern Cooperative Oncology Group (E2A02).
|
Dispenzieri, Angela
|
|
|
106 |
11 |
p. 2546
|
artikel
|
| 503 |
A Phase II Study of Temozolomide Therapy for Poor Risk Patients Age ≥ 60 Years with Acute Myeloid Leukemia (AML) - Low Levels of MGMT May Predict for Response.
|
Brandwein, Joseph M.
|
|
|
106 |
11 |
p. 1860
|
artikel
|
| 504 |
A Phase II Study of the Combination of Topotecan, Ara-C, Cisplatin and Prednisolone (Toposhap) for Slavage of Primary Refractory and Relapsed Patients with Lymphoid Malignancies.
|
Giglio, Auro del
|
|
|
106 |
11 |
p. 4733
|
artikel
|
| 505 |
A Phase II Study of the Safety and Efficacy of a Novel Oral fXa Inhibitor (LY517717) for the Prevention of Venous Thromboembolism Following TKR or THR.
|
Agnelli, Giancarlo
|
|
|
106 |
11 |
p. 278
|
artikel
|
| 506 |
A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.
|
Zinzani, Pier Luigi
|
|
|
106 |
11 |
p. 4765
|
artikel
|
| 507 |
A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Follicular Lymphoma (FL) Patients.
|
Zinzani, Pier Luigi
|
|
|
106 |
11 |
p. 4763
|
artikel
|
| 508 |
A Phase I, Multi-Center, Dose Escalation Study of Atiprimod in Patients with Refractory or Relapsed Multiple Myeloma (MM).
|
Wang, Michael
|
|
|
106 |
11 |
p. 111
|
artikel
|
| 509 |
A Phase I Open-Label Trial To Determine the Pharmacokinetics of Glucarpidase in Subjects with Normal and Impaired Renal Function.
|
Phillips, Marc A.
|
|
|
106 |
11 |
p. 4450
|
artikel
|
| 510 |
A Phase I Pharmacokinetic Trial of Decitabine Administered as a 3-Hour Infusion to Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS).
|
Cashen, Amanda
|
|
|
106 |
11 |
p. 1854
|
artikel
|
| 511 |
A Phase I, Single and Fractionated, Ascending Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietic Mimetic Antibody Fusion Protein, CNTO528, in Healthy Male Subjects.
|
Franson, K.L.
|
|
|
106 |
11 |
p. 4283
|
artikel
|
| 512 |
A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.
|
Klisovic, Rebecca B.
|
|
|
106 |
11 |
p. 2790
|
artikel
|
| 513 |
A Phase I Study of Humanized Anti-CD40 Immunotherapy with SGN-40 in Non-Hodgkin's Lymphoma.
|
Advani, Ranjana H.
|
|
|
106 |
11 |
p. 1504
|
artikel
|
| 514 |
A Phase I Study of Immunization of Indolent Non Hodgkin's Lymphoma Patients with Autologous Monocyte-Derived Dendritic Cells Loaded with Heat Shocked and Killed Autologous Tumor Cells.
|
Di Nicola, Massimo
|
|
|
106 |
11 |
p. 2437
|
artikel
|
| 515 |
A Phase I Study of Temozolomide (Temodar®) in Pediatric Patients with Relapsed or Refractory Leukemia—A Children's Oncology Group Study.
|
Horton, Terzah M.
|
|
|
106 |
11 |
p. 4455
|
artikel
|
| 516 |
A Phase I Study of the Histone Deacetylase Inhibitor MGCD0103 (MG-0103) Given as a Three-Times Weekly Oral Dose in Patients with Leukemia or Myelodysplastic Syndromes (MDS).
|
Garcia-Manero, Guillermo
|
|
|
106 |
11 |
p. 4639
|
artikel
|
| 517 |
A Phase I Study of 90Y-Ibritumomab-Tiuxetan (90Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study.
|
Cairo, Mitchell S.
|
|
|
106 |
11 |
p. 2448
|
artikel
|
| 518 |
A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.
|
Allan, David
|
|
|
106 |
11 |
p. 2201
|
artikel
|
| 519 |
A Phase I Trial of CHIR-258, a Multitargeted RTK Inhibitor, in Acute Myeloid Leukemia (AML).
|
Morgan, Gareth J.
|
|
|
106 |
11 |
p. 2794
|
artikel
|
| 520 |
A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor GX15-070 Administered Intravenously (IV) Every 3 Weeks to Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL).
|
O'Brien, Susan
|
|
|
106 |
11 |
p. 446
|
artikel
|
| 521 |
A Phase 1 Pharmacokinetics (PK) Study of Hydroxyurea (HU) 1,000 mg Coated Breakable Tablets and 500 mg Capsules in Pediatric and Adult Patients with Sickle Cell Disease (SCD).
|
De Montalembert, Mariane
|
|
|
106 |
11 |
p. 3194
|
artikel
|
| 522 |
A Phase 3, Randomized, Placebo-Controlled Trial of Filgrastim in Patients (Pts) with Hematologic Malignancies (HM) Treated with a Myeloablative Conditioning Regimen and Allogenic Bone Marrow Transplantation (allo BMT).
|
Ernst, P.
|
|
|
106 |
11 |
p. 2033
|
artikel
|
| 523 |
A Phase 2, Single-Arm, Open-Label Trial To Evaluate the Effectiveness of Darbepoetin alfa for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndrome.
|
Gabrilove, Janice
|
|
|
106 |
11 |
p. 2541
|
artikel
|
| 524 |
A Phase 2 Study of Bortezomib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
|
de Vos, Sven
|
|
|
106 |
11 |
p. 4746
|
artikel
|
| 525 |
A Phase 2 Study of the Thrombospondin-Mimetic Peptide ABT-510 in Patients with Refractory Lymphoma.
|
Levine, Alexandra M.
|
|
|
106 |
11 |
p. 1493
|
artikel
|
| 526 |
A Phase 1 Trial of Lenalidomide (REVLIMID®) with Bortezomib (VELCADE®) in Relapsed and Refractory Multiple Myeloma.
|
Richardson, Paul
|
|
|
106 |
11 |
p. 365
|
artikel
|
| 527 |
A Phase 1 Trial of STA-5312, a Microtubule Inhibitor with a Novel Binding Site, in Hematologic and Solid Malignancies.
|
Burris, Howard
|
|
|
106 |
11 |
p. 2484
|
artikel
|
| 528 |
A Photodynamic Pathway to Apoptosis Induced by Hypericin in Human Myeloma ARH-77 Cell Line: Possible Relevance to Photodynamic Therapy.
|
Avcu, Ferit
|
|
|
106 |
11 |
p. 5076
|
artikel
|
| 529 |
Apigenin Induces Apoptosis in Primary Effusion Lymphoma.
|
Uddin, Shahab
|
|
|
106 |
11 |
p. 4807
|
artikel
|
| 530 |
A Pilot Application of SELDI-TOF Mass Spectrometry in Bone Marrow Failure Syndromes.
|
Kalmadi, Sujith Rao
|
|
|
106 |
11 |
p. 3421
|
artikel
|
| 531 |
A Pilot Study Comparing Megestrol Acetate Concentrated Suspension (MA-CS) to Megestrol Acetate Oral Suspension (MA-OS) on Weight Gain and Body Composition in Patients with HIV-Associated Unintended Weight Loss (UWL).
|
Cilla, Donald D.
|
|
|
106 |
11 |
p. 1433
|
artikel
|
| 532 |
A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.
|
Devine, Steven M.
|
|
|
106 |
11 |
p. 299
|
artikel
|
| 533 |
A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias.
|
Carpenter, Paul A.
|
|
|
106 |
11 |
p. 1095
|
artikel
|
| 534 |
A Pilot Study of Physical Activity Level and Mood among Long-Term Lymphoma Survivors.
|
Habermann, Thomas M.
|
|
|
106 |
11 |
p. 4692
|
artikel
|
| 535 |
A Pilot Study of Rabbit Antithymocyte Globulin - TECELAC Combined with Cyclosporine and Prednisolone as Immunosuppressive Therapy for Severe Aplastic Anemia.
|
Chandy, Mammen
|
|
|
106 |
11 |
p. 3749
|
artikel
|
| 536 |
A Pilot Study of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed and Refractory Classical Hodgkin Lymphoma (HL): Delivering Cross Fire Radiation by Targeting Reactive B Cells in the Microenvironment.
|
Younes, Anas
|
|
|
106 |
11 |
p. 4791
|
artikel
|
| 537 |
A Pilot Study To Evaluate the Safety, Efficacy and Effects on Liver Function of Granulocyte Colony-Stimulating Factor To Mobilize Hematopoietic Stem Cells in Patients with Liver Cirrhosis.
|
Isidori, Alessandro
|
|
|
106 |
11 |
p. 1698
|
artikel
|
| 538 |
A Pilot Study To Explore the Tolerability and Efficacy of Thalidomide Containing Regimens To Reduce Tumour Cell Load Prior to HSC in Multiple Myeloma and the Feasibility of Harvesting HSC Following Thalidomide Containing Regimens.
|
Horvath, Noemi
|
|
|
106 |
11 |
p. 5162
|
artikel
|
| 539 |
A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.
|
Janik, John E.
|
|
|
106 |
11 |
p. 3348
|
artikel
|
| 540 |
A Pilot Trial of Imatinib, Low-Dose Cytarabine (ara-C) and Idarubicin (Ida) in Patients (pts) with Chronic Myeloid Leukemia (CML) in Myeloid Blastic Phase (BP).
|
Quintas-Cardama, Alfonso
|
|
|
106 |
11 |
p. 4840
|
artikel
|
| 541 |
A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.
|
Baruchel, André
|
|
|
106 |
11 |
p. 1441
|
artikel
|
| 542 |
A Platelet Shedding Defect in Mice Lacking the Basic Helix-Loop-Helix Transcription Factor Scl.
|
McCormack, Matthew P.
|
|
|
106 |
11 |
p. 735
|
artikel
|
| 543 |
A Polymorphic Oncofetal Antigen Recognized by CD8+ CTL from Two Patients Experiencing Regression of Metastatic Renal Cell Carcinoma after Allogeneic HCT.
|
Warren, Edus H.
|
|
|
106 |
11 |
p. 3097
|
artikel
|
| 544 |
A Polymorphism in the C1qA Component of Complement Correlates with Prolonged Complete Remission Following Rituximab Therapy of Follicular Lymphoma.
|
Racila, Emilian
|
|
|
106 |
11 |
p. 778
|
artikel
|
| 545 |
Apoptosis Regulating Proteins bax and p53 in Mantle Cell Lymphoma.
|
Schrader, Carsten
|
|
|
106 |
11 |
p. 4710
|
artikel
|
| 546 |
Apoptotic Cross-Talk between Organelles Induced by Fenretinide in Hematopoietic Malignancy.
|
Wang, Kankan
|
|
|
106 |
11 |
p. 4430
|
artikel
|
| 547 |
Apoptotic Microparticles Derived from Endothelial Cells, Smooth Muscle Cells and Monocytes Induce Thrombin Generation Via Different Pathways.
|
Isobe, Hirotaka
|
|
|
106 |
11 |
p. 1944
|
artikel
|
| 548 |
A Population of Small CXCR4+ SSEA-1+ Oct-4+ Embryonic-Like Stem Cells Identified in Adult Bone Marrow.
|
Kucia, Magda
|
|
|
106 |
11 |
p. 3623
|
artikel
|
| 549 |
Appearance of Stress-Inducible Membrane Proteins ULBP on Blood Cells of Patients with PNH, Aplastic Anemia, and MDS: Possible Implication of ULBP in Immune-Mediated Marrow Injury.
|
Hanaoka, Nobuyoshi
|
|
|
106 |
11 |
p. 1041
|
artikel
|
| 550 |
Application of FAST
TM Fragment-Based Lead Discovery and Structure-Guided Design to Discovery of Small Molecule Inhibitors of BCR-ABL Tyrosine Kinase Active Against the T315I Imatinib-Resistant Mutant.
|
Burley, Stephen K.
|
|
|
106 |
11 |
p. 698
|
artikel
|
| 551 |
Application of the Luminex Platform for Multiplexed Genotyping of Non-Deletional Alpha Thalassemia Mutations.
|
Aslanian, Sharon
|
|
|
106 |
11 |
p. 3841
|
artikel
|
| 552 |
Applying of Fludarabine in One Patient with CLL/PL Prolymphocytic Transformation - One Case Report.
|
He, XueFeng
|
|
|
106 |
11 |
p. 5035
|
artikel
|
| 553 |
A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.
|
Fratantoni, Joseph C.
|
|
|
106 |
11 |
p. 450
|
artikel
|
| 554 |
A Preliminary Report of a Phase I Study of Zevalin® Using a Modified Treatment Regimen for Relapsed or Refractory CD20+ B-Cell Follicular or Transformed Non-Hodgkin's Lymphoma (NHL).
|
Forero-Torres, Andres
|
|
|
106 |
11 |
p. 4798
|
artikel
|
| 555 |
A Prognostic Model Using ZAP- 70, CD38 and Cytogenetics To Better Predict Need for Early Therapy and Response to Treatment in Chronic Lymphocytic Leukemia (CLL).
|
Acs, Peter
|
|
|
106 |
11 |
p. 2114
|
artikel
|
| 556 |
A Prospective Analysis of Adverse Events in a Phase 2 Trial of Imatinib in the Treatment of Polycythemia Vera.
|
Jones, C. Michael
|
|
|
106 |
11 |
p. 4951
|
artikel
|
| 557 |
A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.
|
Selby, Rita
|
|
|
106 |
11 |
p. 583
|
artikel
|
| 558 |
A Prospective Cost Analysis of Non-Myeloablative Hematopoietic Stem Cell Transplantation.
|
Skedgel, Chris
|
|
|
106 |
11 |
p. 2239
|
artikel
|
| 559 |
A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).
|
Alegre, A.
|
|
|
106 |
11 |
p. 3715
|
artikel
|
| 560 |
A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.
|
Lyman, Gary H.
|
|
|
106 |
11 |
p. 3328
|
artikel
|
| 561 |
A Prospective Study of Bortezomib in Combination with Melphalan and Prednisone for Patients with Previously Untreated Multiple Myeloma.
|
Gasparetto, Cristina
|
|
|
106 |
11 |
p. 5181
|
artikel
|
| 562 |
A Prospective Study of Combined m-BACOD Chemotherapy and Radiotherapy for Aggressive Nasal NK/T-Cell Lymphoma.
|
Lei, Kenny I.K.
|
|
|
106 |
11 |
p. 2680
|
artikel
|
| 563 |
A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.
|
Frangoul, Haydar
|
|
|
106 |
11 |
p. 1964
|
artikel
|
| 564 |
A Proteasome Specific Binding Assay for Quantitation of Constitutive and Immunoproteasome Active Sites.
|
Bennett, Mark K.
|
|
|
106 |
11 |
p. 2472
|
artikel
|
| 565 |
A Proteomic Approach to Discovery of Candidate Proteins Involved in the Transformation of Follicular Lymphoma.
|
Fan, Guang
|
|
|
106 |
11 |
p. 984
|
artikel
|
| 566 |
A Proteomic Approach to the Characterization of the Endothelial Dysfunction in Uremia.
|
Carbo, Carla
|
|
|
106 |
11 |
p. 3955
|
artikel
|
| 567 |
A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.
|
Bolwell, Brian
|
|
|
106 |
11 |
p. 1322
|
artikel
|
| 568 |
A Quick Method for Identifying the Molecular Targets of Potentially Diagnostic New Monoclonal Antibodies Using Protein Array Technology.
|
Barry, Richard
|
|
|
106 |
11 |
p. 2818
|
artikel
|
| 569 |
A Randomized Comparison of Induction Therapy for Untreated Acute Myeloid Leukemia (AML) in Patients < 60 Years Using P-Glycoprotein (Pgp) Modulation with Valspodar (PSC833): Preliminary Results of Cancer and Leukemia Group B Study 19808.
|
Kolitz, Jonathan E.
|
|
|
106 |
11 |
p. 407
|
artikel
|
| 570 |
A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade®, ICL670) Is Well Tolerated and Reduces Iron Burden.
|
Vichinsky, E.
|
|
|
106 |
11 |
p. 313
|
artikel
|
| 571 |
A Randomized Controlled Trial of Patient Controlled Analgesia Versus Continuous Infusion of Morphine during Vaso-Occlusive Crisis in Sickle Cell Disease.
|
van Beers, Eduard J.
|
|
|
106 |
11 |
p. 3782
|
artikel
|
| 572 |
A Randomized Crossover Study of High- and Standard-Dose Recombinant Factor VIIa for Treatment of Hemarthroses in Hemophiliacs with Inhibitors.
|
Santagostino, Elena
|
|
|
106 |
11 |
p. 323
|
artikel
|
| 573 |
A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.
|
Fong, Tom
|
|
|
106 |
11 |
p. 1800
|
artikel
|
| 574 |
A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition.
|
Levis, Mark
|
|
|
106 |
11 |
p. 403
|
artikel
|
| 575 |
A Randomized Phase III Trial of Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts).
|
Penack, Olaf
|
|
|
106 |
11 |
p. 82
|
artikel
|
| 576 |
A Randomized Phase II Study of Single-Agent Imatinib Versus Chemotherapy Therapy in Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Including Analysis of Resistance Patterns.
|
Pfeifer, Heike
|
|
|
106 |
11 |
p. 1824
|
artikel
|
| 577 |
A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.
|
Tanner, Mark A.
|
|
|
106 |
11 |
p. 3655
|
artikel
|
| 578 |
A Randomized Trial Comparing the Effectiveness of Peripheral Blood Stem Cell Mobilization with Chemotherapy and Early vs Delayed Initiation of Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Lymphoma and Multiple Myeloma.
|
Bence-Bruckler, Isabelle A.
|
|
|
106 |
11 |
p. 2929
|
artikel
|
| 579 |
A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.
|
Jung, Chul W.
|
|
|
106 |
11 |
p. 1769
|
artikel
|
| 580 |
A Randomized Trial of High-Dose (HD) Imatinib Mesylate (IM) with or without Peg-Interferon (PEG-IFN) and GM-CSF as Frontline Therapy for Patients with Chronic Myeloid Leukemia (CML) in Early Chronic Phase (CP).
|
Cortes, Jorge
|
|
|
106 |
11 |
p. 1084
|
artikel
|
| 581 |
A Randomized Trial of Valacyclovir Versus Valganciclovir To Prevent CMV Reactivation in Patients with CLL Receiving Alemtuzumab.
|
O'Brien, Susan
|
|
|
106 |
11 |
p. 2960
|
artikel
|
| 582 |
A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.
|
Lonial, Sagar
|
|
|
106 |
11 |
p. 1960
|
artikel
|
| 583 |
A Rapid Method for Comparing the Oncogenic Potential of Retroviral Vectors.
|
Hendrie, Paul C.
|
|
|
106 |
11 |
p. 1282
|
artikel
|
| 584 |
A Rapid Test for the Diagnosis of Thrombotic Thrombocytopenic Purpura Using SELDI-TOF-Mass Spectrometry.
|
Wu, Haifeng
|
|
|
106 |
11 |
p. 2660
|
artikel
|
| 585 |
A Rare Case of Primary Amyloidosis, Presenting with Severe Pulmonary Hypertension and Bilateral Pleural Effusion.
|
Agheli, Aref
|
|
|
106 |
11 |
p. 5100
|
artikel
|
| 586 |
A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.
|
Keller, Tymen
|
|
|
106 |
11 |
p. 2134
|
artikel
|
| 587 |
A Relatively Low Frequency of Bleeding in Patients with Severe Factor XI Deficiency Who Undergo Surgery Involving Tissues with Low Fibrinolytic Activity Supports on Demand Rather Than Prophylactic Use of Plasma.
|
Salomon, Ophira
|
|
|
106 |
11 |
p. 4036
|
artikel
|
| 588 |
Are Ovaries a Sanctuary for Lymphoma? Report of a Cure of Recurrent Lymphoma in Both Ovaries after Bilateral Oophorectomy.
|
Shojania, A. Majid
|
|
|
106 |
11 |
p. 4653
|
artikel
|
| 589 |
A Report of the Event-Free Survival (EFS) and Neurotoxicity for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) on Pediatric Oncology Group (POG) Protocol 9405.
|
Rodes, Stephen
|
|
|
106 |
11 |
p. 882
|
artikel
|
| 590 |
A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.
|
Bell, Beverly A.
|
|
|
106 |
11 |
p. 875
|
artikel
|
| 591 |
Are Statistically Non-Significant Findings Necessarily Negative? A Review of All Phase III Randomized Controlled Trials in Hematology Conducted by NCI Sponsored Cooperative Groups.
|
Kumar, Ambuj
|
|
|
106 |
11 |
p. 293
|
artikel
|
| 592 |
A Retrospective Comparison between Cyclophosphamide (Cy) Followed by G-CSF, and Ifosfamide, Etoposide and Epirubicin (IVE) Plus G-CSF Mobilisation Regimes in Haematological Malignancies.
|
Ortin, Miguel
|
|
|
106 |
11 |
p. 5484
|
artikel
|
| 593 |
A Retrospective Review of Outcomes of Patients with Chronic Myelomoncytic Leukemia Treated with 5-Azacitidine.
|
Dhruva, Anand
|
|
|
106 |
11 |
p. 4931
|
artikel
|
| 594 |
A Retrospective Study of Current Anticoagulant Use in Patients with Atrial Fibrillation: Results from a Managed Care Database.
|
Murray, Miranda
|
|
|
106 |
11 |
p. 2246
|
artikel
|
| 595 |
A Revisit of the Criteria To Define Remission in Patients with Idiopathic Thrombocytopenia Undergoing Splenectomy.
|
Chan, Howard H.
|
|
|
106 |
11 |
p. 3020
|
artikel
|
| 596 |
Are We Ready? A Case for Making Hematology Fellows Competent in Treating the Booming Culturally Diverse Minority Populations.
|
Iqbal, Uzma
|
|
|
106 |
11 |
p. 5586
|
artikel
|
| 597 |
Argatroban for Anticoagulation during Cardiopulmonary Bypass.
|
Martin, Monte E.
|
|
|
106 |
11 |
p. 4150
|
artikel
|
| 598 |
Arginine (R) at Position 595 in FLT3 Is Critical for Transforming Potential of FLT3-Length Mutations.
|
Vempati, Sridhar
|
|
|
106 |
11 |
p. 1598
|
artikel
|
| 599 |
Arginine Therapy Decreases Oxidative Stress and Attenuates Leukocyte Recruitment in Transgenic and Knockout Sickle Mice Resulting in Improved Microvascular Flow and Reduced Vaso-Occlusion.
|
Kaul, Dhananjay K.
|
|
|
106 |
11 |
p. 207
|
artikel
|
| 600 |
A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.
|
Lyman, Gary H.
|
|
|
106 |
11 |
p. 754
|
artikel
|
| 601 |
Arkansas Autotransplant (AT) Experience with > 2500 Myeloma (MM) Patients: Follow-Up Extending to >15 Years.
|
van Rhee, Frits
|
|
|
106 |
11 |
p. 1149
|
artikel
|
| 602 |
A Role for fbxo5 in Zebrafish Myelopoiesis.
|
Rhodes, Jennifer
|
|
|
106 |
11 |
p. 3608
|
artikel
|
| 603 |
A Role for Twist in Thymocyte Development.
|
Sugiyama, Daisuke
|
|
|
106 |
11 |
p. 4252
|
artikel
|
| 604 |
A Role of the Protein Tyrosine Kinase, Syk in Complement-Mediated Phagocytosis: A Mechanism on the Engulfment of Pathogen.
|
Tohyama, Yumi
|
|
|
106 |
11 |
p. 3076
|
artikel
|
| 605 |
Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.
|
Drandi, Daniela
|
|
|
106 |
11 |
p. 5088
|
artikel
|
| 606 |
Array-CGH and Gene Expression Profiling Based Molecular Characterization of Myeloid Leukemia Cell Lines.
|
Rucker, Frank G.
|
|
|
106 |
11 |
p. 4397
|
artikel
|
| 607 |
Array CGH Discovers Novel Genomic Signatures in De Novo Acute Myeloid Leukemia (AML): Results of Children's Oncology Group (COG) Study POG #9421.
|
Kuo, Dennis J.
|
|
|
106 |
11 |
p. 2771
|
artikel
|
| 608 |
Arsenic Trioxide (AS2O3) Therapy for Relapsed Acute Promyelocytic Leukemia (APL): Comparison with a Historic Control Combining All-Trans Retinoic Acid (ATRA) Plus Intensive Chemotherapy.
|
Thomas, Xavier
|
|
|
106 |
11 |
p. 895
|
artikel
|
| 609 |
Arsenic Trioxide (ATO) and MEK1 Inhibitor Activate Apoptotic p73 Pathway in Primary Acute Myelogenous Leukemia Blasts.
|
Lunghi, Paolo
|
|
|
106 |
11 |
p. 613
|
artikel
|
| 610 |
Arsenic Trioxide (ATO) Is Safe and Effective in Combination with Low-Dose Ara-C (LDAC) for the Treatment of IPSS-2 Myelodysplastic Syndrome (MDS) and Poor-Prognosis Acute Myeloid Leukemia (AML) in Elderly Patients.
|
Roboz, Gail J.
|
|
|
106 |
11 |
p. 2805
|
artikel
|
| 611 |
Arsenic Trioxide Enhances STI571-Induced Apoptosis of K562 Cells through Downregulating Bcl-XL and Bcr-Abl.
|
Zhang, Ri
|
|
|
106 |
11 |
p. 4449
|
artikel
|
| 612 |
Arsenic Trioxide Induces Regulated, Death Receptor- and Caspase-Independent Cell Death through the Mitochondrial Death Pathway.
|
Scholz, Christian
|
|
|
106 |
11 |
p. 4421
|
artikel
|
| 613 |
Arsenic Trioxide in Mantle Cell Lymphoma.
|
Kwong, Yok Lam
|
|
|
106 |
11 |
p. 4814
|
artikel
|
| 614 |
Arsenic Trioxide Targets the Interleukin-6 Cascade in Multiple Myeloma by Promoting Lysosomal Degradation of the Interleukin-6 Receptor Complex.
|
Cheung, Wai Chung
|
|
|
106 |
11 |
p. 5159
|
artikel
|
| 615 |
Arsenic Trioxide Targets the MDS1 and EVI1- Containing Oncoproteins for Degradation by Proteasome Dependent and Independent Mechanisms.
|
Shackelford, David
|
|
|
106 |
11 |
p. 1612
|
artikel
|
| 616 |
Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
|
Qazilbash, Muzaffar H.
|
|
|
106 |
11 |
p. 1159
|
artikel
|
| 617 |
Arterial Hypoxemia Syndrome in Sickle Cell Disease.
|
Adams-Graves, Patricia
|
|
|
106 |
11 |
p. 3801
|
artikel
|
| 618 |
Artificial Antigen Presenting Cell Can Be Used To Propagate Genetically Modified CD19-Specific T Cells through Chimeric Antigen Receptor.
|
Numbenjapon, Tontanai
|
|
|
106 |
11 |
p. 1295
|
artikel
|
| 619 |
Artificial Antigen-Presenting Cells Permit Selective In Vitro Generation of CMV-Specific T-Cells of Desired HLA Allelic Restriction for Adoptive Immunotherapy in Recipients of HLA Disparate Allografts.
|
Trivedi, Deepa
|
|
|
106 |
11 |
p. 1298
|
artikel
|
| 620 |
A Screening and Intervention Program Reducing Mortality and Serious Morbidity Associated with Neonatal Alloimmune Thrombocytopenia.
|
Kjeldsen-Kragh, Jens
|
|
|
106 |
11 |
p. 1232
|
artikel
|
| 621 |
A Selective Small Molecule Factor VIIa Inhibitor, CRA-027483, Suppresses Acute Inflammation in Mice.
|
Dalrymple, Stacie A.
|
|
|
106 |
11 |
p. 3089
|
artikel
|
| 622 |
A Sensitive Enzyme-Linked Assay of ADAMTS13 Antibodies for Diagnosis of TTP.
|
Raoufi, Mojgan
|
|
|
106 |
11 |
p. 553
|
artikel
|
| 623 |
A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.
|
Noizat-Pirenne, France
|
|
|
106 |
11 |
p. 954
|
artikel
|
| 624 |
A Shared Gene-Expression Signature in Innate-Like Lymphocytes.
|
Yamagata, Tetsuya
|
|
|
106 |
11 |
p. 3903
|
artikel
|
| 625 |
A Simple Two-Step Method for the Isolation of Human CD4+CD25+bright / FOXP3+ Regulatory T Cells Directly from Whole Blood.
|
Guilbault, Benoit
|
|
|
106 |
11 |
p. 2382
|
artikel
|
| 626 |
A Single Cell Analysis of Immunoglobulin Genes in Chronic Lymphocytic Leukemia (CLL): Evidence of Intraclonal Diversification Associated with Progressive Somatic Mutations and Progressive Antigen Drive in Immunoglobulin Heavy and Light Chains.
|
Levesque, Marc C.
|
|
|
106 |
11 |
p. 1186
|
artikel
|
| 627 |
A Single Center Experience with Allogeneic Sibling Umbilical-Cord-Blood Transplantation in Children with Malignant and Non-Malignant Disease.
|
Song, Yongping
|
|
|
106 |
11 |
p. 2042
|
artikel
|
| 628 |
A Single Nucleotide Polymorphism and Its Haplotype of ZNF42 Transcriptional Modulator Gene Predisposes Individuals to High-Risk Acute Myelogenous Leukemia (AML).
|
Lee, Il-Kwon
|
|
|
106 |
11 |
p. 4248
|
artikel
|
| 629 |
A Single Tube Antibody Panel for Differential Count by Flow Cytometry.
|
Bjornsson, Sven
|
|
|
106 |
11 |
p. 4938
|
artikel
|
| 630 |
A Small Number of PNH-Type Cells Predict Good Prognosis in Patients with Aplastic Anemia.
|
Sugimori, Chiharu
|
|
|
106 |
11 |
p. 1039
|
artikel
|
| 631 |
Aspirin Resistance - A Comparison of Platelet Functions and 11-Dehydro Thromboxane B2 and 8-epi Prostaglandin F2α Plasma Concentration.
|
Zawilska, Krystyna
|
|
|
106 |
11 |
p. 4005
|
artikel
|
| 632 |
Assembling the Players for Evaluation of Anti-Leukemic CTL Activity in NOD-SCID Mice.
|
Hsu, Andy K.W.
|
|
|
106 |
11 |
p. 4586
|
artikel
|
| 633 |
Assessing the Benefit/Risk Balance of Long-Term Anagrelide Hydrochloride (Xagrid®/Agrylin®) Treatment for Essential Thrombocythemia.
|
Petitt, Robert M.
|
|
|
106 |
11 |
p. 4957
|
artikel
|
| 634 |
Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([90Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.
|
Morschhauser, F.
|
|
|
106 |
11 |
p. 4795
|
artikel
|
| 635 |
Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models.
|
Schuettrumpf, Joerg
|
|
|
106 |
11 |
p. 1030
|
artikel
|
| 636 |
Assessment of Bleeding in Thrombocytopenic Patients (pts) with Immune Thrombocytopenic Purpura (ITP).
|
Page, Lemke K.
|
|
|
106 |
11 |
p. 1255
|
artikel
|
| 637 |
Assessment of Favorable (F) Versus Unfavorable (U) Early Stage Hodgkin's Disease (HD); the Stanford V + Radiotherapy (RT) Experience.
|
Advani, Ranjana
|
|
|
106 |
11 |
p. 1932
|
artikel
|
| 638 |
Assessment of Genetic Aberrations in Plasma Cells Using a Sequential Morphology (Phenotype)/FISH (Genotype) Approach Significantly Improves the Detection of Residual Disease in Post Treatment Multiple Myeloma.
|
Slovak, Marilyn L.
|
|
|
106 |
11 |
p. 1549
|
artikel
|
| 639 |
Assessment of Menorrhagia in Females Followed for Bleeding Disorders at the Hemophilia Center of Western New York-Correlation between Clinical Presentation and Laboratory Parameters.
|
Bush, Eric
|
|
|
106 |
11 |
p. 4054
|
artikel
|
| 640 |
Assessment of Minimal Residual Disease (MRD) by Qualitative RT-PCR (Q-PCR) vs Real-Time Quantitative RT-PCR (RQ-PCR) in a Phase II Study of Acute Promyelocytic Leukemia (APL).
|
Gallagher, Robert E.
|
|
|
106 |
11 |
p. 3262
|
artikel
|
| 641 |
Assessment of PML-RARa Real-Time Quantitative PCR for Definition of Molecular Relapse in APL Patients (Results of the APL Study Group).
|
Cassinat, Bruno
|
|
|
106 |
11 |
p. 672
|
artikel
|
| 642 |
Assessment of Serum Free Light Chain Assay for Screening for Plasma Cell Disorders.
|
Smith, David E.
|
|
|
106 |
11 |
p. 2563
|
artikel
|
| 643 |
Assessment of Symptoms and Symptom Burden before and after Engraftment during Allogeneic Blood or Marrow Transplant (BMT).
|
Williams, Loretta A.
|
|
|
106 |
11 |
p. 1323
|
artikel
|
| 644 |
Assessment of the Aryl Hydrocarbon Receptor Gene as a Therapeutic Target in Childhood T-Lineage Acute Lymphoblastic Leukemia.
|
Meier, Marrit
|
|
|
106 |
11 |
p. 536
|
artikel
|
| 645 |
Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.
|
Kos, Cynthia A.
|
|
|
106 |
11 |
p. 4078
|
artikel
|
| 646 |
Association of a Novel Regulatory Polymorphism (-938C>A) in the BCL2 Gene with Disease Progression in Chronic Lymphocytic Leukemia.
|
Nueckel, Holger
|
|
|
106 |
11 |
p. 2105
|
artikel
|
| 647 |
Association of HLA-E Polymorphism with the Incidence of Severe Bacterial Infections in Sickle Cell Anemia.
|
Tamouza, Ryad
|
|
|
106 |
11 |
p. 2335
|
artikel
|
| 648 |
Association of Mild Anemia and Executive Cognitive Function Impairment in High Functioning Community-Dwelling Older Women.
|
Chaves, Paulo H.M.
|
|
|
106 |
11 |
p. 3552
|
artikel
|
| 649 |
Association of Polymorphisms of the Transforming Growth Factor-β/Bone Morphogenetic Protein (TGF-β/BMP) Pathway with Sickle Cell Bacteremia.
|
Adewoye, Adeboye H.
|
|
|
106 |
11 |
p. 3170
|
artikel
|
| 650 |
Associations of Birthweight and Maternal Fertility Problems with Childhood Cancers.
|
Dorak, M. Tevfik
|
|
|
106 |
11 |
p. 4546
|
artikel
|
| 651 |
A Stem Cell Population Capable of Producing Both Lympho- and Hematopoietic Cells Can Be Used To Detect Increased Sensitivity and Residual Stem Cell Damage after Initial Drug Administration.
|
Rich, Ivan N.
|
|
|
106 |
11 |
p. 4199
|
artikel
|
| 652 |
A Stem-Loop in the 3′-UTR Mediates Iron-Dependent Regulation of Alpha Hemoglobin Stabilizing Protein mRNA Stability.
|
dos Santos, Camila O.
|
|
|
106 |
11 |
p. 3628
|
artikel
|
| 653 |
Asthma Is Associated with Mortality in Children with Sickle Cell Anemia.
|
Boyd, Jessica H.
|
|
|
106 |
11 |
p. 317
|
artikel
|
| 654 |
A Stromal Cell Derived Factor 1 (SDF-1) Agonist Stimulates Neutrophil Mobilization in Normal Humans after Subcutaneous Injection.
|
Wong, Donald
|
|
|
106 |
11 |
p. 4262
|
artikel
|
| 655 |
A Structure-Function Analysis Revealed Histidine in the Transmembrane Domain of Human Thrombopoietin Receptor Is Essential for a Novel Non-Peptidyl Thromobopoietin Mimetics, NIP-004, To Induce Signaling for Cellular Proliferation.
|
Yamane, Akiko
|
|
|
106 |
11 |
p. 3149
|
artikel
|
| 656 |
A Study on the Etiology of 912 Anemia Patients in General Hospital.
|
Zhao, Xiaoying
|
|
|
106 |
11 |
p. 3743
|
artikel
|
| 657 |
A Successful Syngeneic Bone Marrow Transplant after an Ortotopic Liver Transplantation for Fulminant Hepatitis - Case Report.
|
Silla, Lucia
|
|
|
106 |
11 |
p. 5442
|
artikel
|
| 658 |
A Supervised Group Exercise Program for Patients with Multiple Myeloma.
|
Chen, Christine I.
|
|
|
106 |
11 |
p. 5171
|
artikel
|
| 659 |
A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.
|
Bai, Lijun
|
|
|
106 |
11 |
p. 5222
|
artikel
|
| 660 |
Asymptomatic Factor VII Padua in African Americans.
|
Tidd, Theresa M.
|
|
|
106 |
11 |
p. 4069
|
artikel
|
| 661 |
AT 101, an Inhibitor of Bcl-2 Family Members Is Cytotoxic to a Heterogeneous Group of CLL Samples and Synergistic with Rituximab.
|
James, Danelle F.
|
|
|
106 |
11 |
p. 2979
|
artikel
|
| 662 |
AT-101, a Small Molecule Inhibitor of Bcl-2 Family Proteins, Has Significant In Vitro Activity in Multiple Myeloma.
|
Kumar, Shaji
|
|
|
106 |
11 |
p. 1581
|
artikel
|
| 663 |
A t(8;21) Fusion Protein Disrupts the Spindle Checkpoint and Promotes Aneuploidy.
|
Boyapati, Anita
|
|
|
106 |
11 |
p. 1345
|
artikel
|
| 664 |
A Thrombin Inhibitor, but Not a Factor Xa Inhibitor, DU-176b, Aggravates Tissue Factor-Induced Hypercoagulation in Rats.
|
Morishima, Yoshiyuki
|
|
|
106 |
11 |
p. 1878
|
artikel
|
| 665 |
Atiprimod Blocks STAT3 and STAT5 Phosphorylation, Inhibits Proliferation, and Induces Apoptosis in Acute Myeloid Leukemia (AML) but Not Normal Cells.
|
Faderl, Stefan
|
|
|
106 |
11 |
p. 2462
|
artikel
|
| 666 |
ATM and ATR Are Not Required for DNA Damage-Dependent Accumulation of Chk1 at the Centrosome.
|
Loeffler, Harald
|
|
|
106 |
11 |
p. 4288
|
artikel
|
| 667 |
ATP Binding Domain Mutants of BCR-ABL in Patients with Chronic Myeloid Leukemia Treated with Imatinib.
|
Liu, Xiaoli
|
|
|
106 |
11 |
p. 4859
|
artikel
|
| 668 |
A Trangenic Mouse Model of Plasma Cell Malignancy Shows Cytogenetic and Gene Expression Profiles Similar to Human Multiple Myeloma.
|
Boylan, Kristin
|
|
|
106 |
11 |
p. 619
|
artikel
|
| 669 |
A Transgenic Mouse Model of Homozygous HbE Disease.
|
Chen, Qiuying
|
|
|
106 |
11 |
p. 3192
|
artikel
|
| 670 |
ATR-Chk1 Axis Is Activated, but the Function of Chk1 Is Disrupted in BCR/ABL Leukemia Cells Responding to DNA Damage.
|
Nieborowska, Margaret
|
|
|
106 |
11 |
p. 2883
|
artikel
|
| 671 |
Attenuated Dose of Idarubicin for the Elderly De Novo Acute Myeloid Leukemia with Normal Karyotype.
|
Cheong, June-Won
|
|
|
106 |
11 |
p. 4608
|
artikel
|
| 672 |
Attenuation of Surface CXCR4 Down-Regulation in Human Cord Blood HSC during Ex Vivo Expansion Using the HUBEC Co-Culture System.
|
Takebe, Naoko
|
|
|
106 |
11 |
p. 1068
|
artikel
|
| 673 |
A Two Step Nonmyeloablative Allogeneic Transplantation Protocol Using In Vitro T-Cell Depleted Mobilized Stem Cells Followed by Donor Lymphocyte Infusions in Patients with Advanced CLL.
|
Barge, Renee M.Y.
|
|
|
106 |
11 |
p. 5396
|
artikel
|
| 674 |
Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).
|
Nicolini, Franck E.
|
|
|
106 |
11 |
p. 3285
|
artikel
|
| 675 |
Atypical Hemoglobin H Disease Due to Compound Heterozygosity for -α3.7 and --SEA Deletions and Heterozygosity for the β-Chain Variant Hemoglobin Raleigh (β1 VAL→ALA).
|
Kutlar, Ferdane
|
|
|
106 |
11 |
p. 3849
|
artikel
|
| 676 |
Atypical Presentations of EBV Reactivation and EBV-Associated PTLD Post-HSCT: Implication for Routine EBV Surveillance after Allogeneic HSCT?.
|
Dobbelstein, Christiane E.
|
|
|
106 |
11 |
p. 5364
|
artikel
|
| 677 |
Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia (ALL): The MDACC Experience with Intensified L-Asparaginase and Vincristine in Adult ALL Salvage.
|
Faderl, Stefan
|
|
|
106 |
11 |
p. 1840
|
artikel
|
| 678 |
Augmented Preparative Regimens Using Total Body Irradiation or BCNU Prior to Autologous Stem Cell Transplant (AuSCT) Are Well-Tolerated and Yield Substantial Rates of Progression-Free Survival in Patients with Poor Risk Hodgkin Lymphoma (HL) or Diffuse Large B-Cell Lymphoma (DLBCL).
|
Ritchie, David S.
|
|
|
106 |
11 |
p. 5499
|
artikel
|
| 679 |
Autoantibodies Against the Fibrinolytic Receptor, Annexin 2, in Antiphospholipid Syndrome.
|
Cesarman, Gabriela
|
|
|
106 |
11 |
p. 134
|
artikel
|
| 680 |
Autoantibody Formation in Sickle Cell Disease Patients Receiving Multiple Blood Transfusions.
|
Sakhalkar, Vishwas S.
|
|
|
106 |
11 |
p. 3186
|
artikel
|
| 681 |
Autocrine Signaling by Osteopontin Regulates Actin Remodeling in Human Primary Erythroid Progenitors.
|
Wickrema, Amittha
|
|
|
106 |
11 |
p. 1667
|
artikel
|
| 682 |
Autografting Followed Closely by Nonmyeloablative Allografting as Consolidation Immunotherapy Reduces Disease Progression Compared to Tandem Autografting in Multiple Myeloma.
|
Carella, A.M.
|
|
|
106 |
11 |
p. 1126
|
artikel
|
| 683 |
Autoimmune Hemolytic Anemia (AIHA) in Children: A French Observational Study of 171 Patients for the French Society of Pediatric Hematology and Immunology (SHIP).
|
Aladjidi, Nathalie
|
|
|
106 |
11 |
p. 1684
|
artikel
|
| 684 |
Autoimmunity and Hypercoagulability in Anderson Fabry Patients from Argentina.
|
Aggio, Mario C.
|
|
|
106 |
11 |
p. 4115
|
artikel
|
| 685 |
Autoimmunity Caused by Cell Type-Specific Deficiency in Apoptosis.
|
Chen, Min
|
|
|
106 |
11 |
p. 3913
|
artikel
|
| 686 |
Autologous Bone Marrow Stem Cells (ABMC) for Cardiormyoplasty in 15 Patients with Acute and Chronic Myocardial Disease (ACMD) in Colombia.
|
Cuéllar-Ambrosi, Francisco
|
|
|
106 |
11 |
p. 4225
|
artikel
|
| 687 |
Autologous Bone Marrow Transplant after Failed Peripheral Blood Stem Cell Mobilization Does Not Adversely Affect Engraftment or Transplant Related Toxicity.
|
Rioux-Masse, B.
|
|
|
106 |
11 |
p. 2736
|
artikel
|
| 688 |
Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease, the Summary of Phase I Trial.
|
Oyama, Yu
|
|
|
106 |
11 |
p. 2919
|
artikel
|
| 689 |
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: A Report of the European Blood and Marrow Transplantation Group (EBMT).
|
Saccardi, Riccardo
|
|
|
106 |
11 |
p. 155
|
artikel
|
| 690 |
Autologous Non-Myeloablative Hematopoietic Stem Cell Transplantation for Diffuse Scleroderma.
|
Oyama, Yu
|
|
|
106 |
11 |
p. 2920
|
artikel
|
| 691 |
Autologous Peripheral Stem Cell Transplantation(ASCT) for Refractory or Recurrent Hodgkin Lymphoma.
|
Koike, Mitsuru
|
|
|
106 |
11 |
p. 5497
|
artikel
|
| 692 |
Autologous Stem Cell (AUTO) vs Non-Myeloablative Allogeneic Transplantation (NMT) after High-Dose Rituximab (HD-R) -Containing Conditioning Regimens for Relapsed Chemosensitve Follicular Lymphoma (FL).
|
Khouri, Issa F.
|
|
|
106 |
11 |
p. 48
|
artikel
|
| 693 |
Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin's Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.
|
Bolwell, Brian
|
|
|
106 |
11 |
p. 2083
|
artikel
|
| 694 |
Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.
|
Sanz, Guillermo F.
|
|
|
106 |
11 |
p. 793
|
artikel
|
| 695 |
Autologous Stem Cell Transplantation and Rituximab for Mantle Cell Lymphoma.
|
Capote, Francisco Javier
|
|
|
106 |
11 |
p. 2092
|
artikel
|
| 696 |
Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients with AL (Primary) Amyloidosis: Results of the French Multicentric Randomized Trial (MAG and IFM Intergroup).
|
Jaccard, A.
|
|
|
106 |
11 |
p. 421
|
artikel
|
| 697 |
Autologous Stem Cell Transplantation (ASCT) Versus Standard Treatments for CLL Patients: First Interim Analysis of a Prospective Randomized Study from the French Cooperative Study Group on CLL.
|
Sutton, Laurent
|
|
|
106 |
11 |
p. 5471
|
artikel
|
| 698 |
Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.
|
Reimer, Peter
|
|
|
106 |
11 |
p. 2074
|
artikel
|
| 699 |
Autologous Stem Cell Transplantation (AuSCT) with Total Lymphoid Irradiation (TLI) and High-Dose Chemotherapy (CT) Results in High Survival Rates for “Poor-Prognosis” Relapsed/Refractory (R/R) Hodgkin's Disease (HD): Multivariate Analysis of Outcome Shows Marked Benefit for TLI in a Prospective Phase I/II Trial.
|
Evens, Andrew M.
|
|
|
106 |
11 |
p. 2080
|
artikel
|
| 700 |
Autologous Stem Cell Transplantation for Multiple Myeloma in Patients over 70 Years: A Matched Comparison with Patients under 65 Years.
|
Kumar, Shaji
|
|
|
106 |
11 |
p. 1173
|
artikel
|
| 701 |
Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.
|
Holowiecki, Jerzy
|
|
|
106 |
11 |
p. 5492
|
artikel
|
| 702 |
Automated Detection of Neutrophil Dysplasia for the Screening of Myelodysplasia and Myelodysplastic Syndromes.
|
Wiesent, Thilo
|
|
|
106 |
11 |
p. 4892
|
artikel
|
| 703 |
Automated Erythropoietin Testing on Beckman Coulter's Family of Access® Immunoassay Systems.
|
Retka, Susan
|
|
|
106 |
11 |
p. 3761
|
artikel
|
| 704 |
Automated Pre-Classification of Anemia Based on the Results of a Routine Automated Hematology System.
|
Kratz, Alexander
|
|
|
106 |
11 |
p. 2253
|
artikel
|
| 705 |
Automated Quantitative Assessment of Bone Marrow in Normal Samples: Correlation with the Reference Method.
|
Zini, Gina
|
|
|
106 |
11 |
p. 4192
|
artikel
|
| 706 |
Automated Retroviral Insertion Site Sequence Analysis and Mapping Tool Followed by Database Analysis.
|
Laufs, Stephanie
|
|
|
106 |
11 |
p. 5528
|
artikel
|
| 707 |
Automated Screening for Genomic Imbalances in Multiple Myeloma Using Microarray-Based Comparative Genomic Hybridization (mCGH).
|
Wendl, Christiane
|
|
|
106 |
11 |
p. 499
|
artikel
|
| 708 |
Autophagic Cell Death in Leukemia Cells Regulated by Ceramide and Sphingosine-1-Phosphate through Mammalian Target of Rapamycin.
|
Harakawa, Nari
|
|
|
106 |
11 |
p. 4408
|
artikel
|
| 709 |
Autopsies Post Hematopoietic Stem Cell Transplant: A Reassessment of Their Role in Patient Management.
|
Hofmeister, Craig C.
|
|
|
106 |
11 |
p. 1332
|
artikel
|
| 710 |
A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.
|
Kochenderfer, James
|
|
|
106 |
11 |
p. 61
|
artikel
|
| 711 |
A Variant of Congenital Neutropenia Is Caused by a 3′-UTR Mutation in the Gene Encoding the Endosomal Adaptor Protein p14 (MAPBPIP).
|
Bohn, Georg
|
|
|
106 |
11 |
p. 92
|
artikel
|
| 712 |
Avascular Necrosis of Femoral Head in Childhood Acute Lymphoblastic Leukemia.
|
Tang, JingYan
|
|
|
106 |
11 |
p. 4544
|
artikel
|
| 713 |
A Very Short Mutational Hot-Spot in the IGH 5′Sμ Region Suggests That the Acquisition of a Class Switch Recombination Defect Is an Important Step Toward Lymphomagenesis.
|
Ruminy, Philippe
|
|
|
106 |
11 |
p. 284
|
artikel
|
| 714 |
Avian Sarcoma Leukosis Virus (ASLV) Derived Retroviral Vectors Efficiently Transduce CD34+ Cells and Have a Distinct Integration Profile in the Rhesus Macaque Transplantation Model.
|
Hu, Jingqiong
|
|
|
106 |
11 |
p. 1290
|
artikel
|
| 715 |
A Weekly Dose of Pegylated Interpheron alpha-2b (Pegintron®) as Maintenance Treatment after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Multiple Myeloma (MM): Preliminary Experience.
|
Alegre, A.
|
|
|
106 |
11 |
p. 5174
|
artikel
|
| 716 |
A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes.
|
Malcovati, Luca
|
|
|
106 |
11 |
p. 788
|
artikel
|
| 717 |
A 3-Year Follow-Up of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As2O3) as Front Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia (APL).
|
Hu, Jiong
|
|
|
106 |
11 |
p. 886
|
artikel
|
| 718 |
Azacitidine Prolongs Survival and Time to AML Transformation in High-Risk Myelodysplastic Syndrome (MDS) Patients ≥ 65 Years of Age.
|
Silverman, Lewis R.
|
|
|
106 |
11 |
p. 2524
|
artikel
|
| 719 |
Azacitidine (Vidaza®) Treatment Response Assessed Using Three Alternative Dosing Schedules in Patients with Myelodysplastic Syndromes (MDS).
|
Lyons, Roger
|
|
|
106 |
11 |
p. 2517
|
artikel
|
| 720 |
5-Azacytidine Potentiates the Anti-Proliferative Activity of Anti-CD33 Monoclonal Antibodies (mAb) in Acute Myeloid Leukemia in Part through Induction of Syk and SHP-1 Expression.
|
Balaian, Larissa
|
|
|
106 |
11 |
p. 2459
|
artikel
|
| 721 |
Azacytidine Suppressors Autocrine IL-6 Secretion and Demonstrates In Vitro and In Vivo Activity Against Multiple Myeloma.
|
Khong, Tiffany
|
|
|
106 |
11 |
p. 1566
|
artikel
|
| 722 |
Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion.
|
Brito-Babapulle, Vasantha
|
|
|
106 |
11 |
p. 2110
|
artikel
|
| 723 |
Bacterial Endotoxin LPS but Not LTA Can Enhance Osteogenic Differentiation of Human Mesenchymal Stem Cells.
|
Chan, Godfrey ChiFung
|
|
|
106 |
11 |
p. 4230
|
artikel
|
| 724 |
Bad Phosphorylation Is Reduced in Response to Inhibition of Constitutively Activated FLT3.
|
Kim, Kyu-Tae
|
|
|
106 |
11 |
p. 1367
|
artikel
|
| 725 |
BAFF and APRIL Protect CLL B Cells from Apoptosis through Activation of NF-κB Canonical Pathway.
|
Endo, Tomoyuki
|
|
|
106 |
11 |
p. 179
|
artikel
|
| 726 |
B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity.
|
Aguiar, Ricardo C.T.
|
|
|
106 |
11 |
p. 2400
|
artikel
|
| 727 |
Baicalein Inhibits IL-6-Mediated Multiple Signaling Cascades through Jak Family Kinase in Human Myeloma Cells.
|
Ma, Zi
|
|
|
106 |
11 |
p. 3390
|
artikel
|
| 728 |
Baseline N-Telopeptide Levels Correlate with Risk of Skeletal Morbidity in Patients with Multiple Myeloma during Zoledronic Acid Therapy.
|
Lipton, Allan
|
|
|
106 |
11 |
p. 3456
|
artikel
|
| 729 |
Baseline Nucleophosmin Status in Mutated(M) Versus Unmutated (U) Immunoglobulin B-CLL Is a Nuclear Reflection of Different Signal Transduction Physiology.
|
Boelens, Jerina
|
|
|
106 |
11 |
p. 5005
|
artikel
|
| 730 |
Baseline Serum Albumin and Proteinuria Predict Renal Response after Autologous Stem Cell Transplantation in AL Amyloidosis.
|
Leung, Nelson
|
|
|
106 |
11 |
p. 1166
|
artikel
|
| 731 |
Basiliximab in the Treatment of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.
|
Ma, Xiao
|
|
|
106 |
11 |
p. 5362
|
artikel
|
| 732 |
B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter's Syndrome.
|
Skoulidis, Ferdinandos
|
|
|
106 |
11 |
p. 4999
|
artikel
|
| 733 |
B Cell Post Transplant Lymphoproliferative Disorder Complicating Solid Organ Transplantation (B-PTLD): A Single Centre Review Reporting 1) Results with Chemo-Immunotherapy (CHOP/R) and 2) the Predictive Ability of FDG-PET Scanning To Correlate with Long Term Overall Survival.
|
Tulpule, Sameer
|
|
|
106 |
11 |
p. 1500
|
artikel
|
| 734 |
B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles.
|
Giudice, Ilaria Del
|
|
|
106 |
11 |
p. 4372
|
artikel
|
| 735 |
B-Cell Receptor Signaling Enhances Migration of B-Cell Chronic Lymphocytic Leukemia Cells in Response to the Chemokine Stromal Cell-Derived Factor-1 (SDF-1/CXCL12).
|
Burger, Jan A.
|
|
|
106 |
11 |
p. 1187
|
artikel
|
| 736 |
B-Cell Scaffold Protein with Ankyrin Repeats (BANK1) Is Differentially Expressed in ZAP-70 Negative Compared to ZAP-70 Positive Chronic Lymphocytic Leukemia Cells.
|
Dicker, Frank
|
|
|
106 |
11 |
p. 2938
|
artikel
|
| 737 |
Bcl2 Associated Induction of the Suppressor of Cytokine Signaling-3 (SOCS3) Gene Involves Activation of the p44/42 MAPK Pathway.
|
Kim, Julie
|
|
|
106 |
11 |
p. 2286
|
artikel
|
| 738 |
BCL6 Attenuates DNA Damage Sensing in Normal and Malignant B-Cells by Directly Repressing ATR.
|
Ranuncolo, Stella M.
|
|
|
106 |
11 |
p. 157
|
artikel
|
| 739 |
BCL11AXL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.
|
Pulford, Karen
|
|
|
106 |
11 |
p. 4392
|
artikel
|
| 740 |
BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.
|
Ezzat, Hatoon
|
|
|
106 |
11 |
p. 4674
|
artikel
|
| 741 |
Bcl2 Expression Predicts Better Overall Survival in 90 Patients with Mantle Cell Lymphoma.
|
Schrader, Carsten
|
|
|
106 |
11 |
p. 4677
|
artikel
|
| 742 |
Bcl2 Flexible Loop Domain Positively and Negatively Regulates Survival Function through Direct Interaction with p53.
|
Deng, Xingming
|
|
|
106 |
11 |
p. 2623
|
artikel
|
| 743 |
BCL6 Is Regulated by p53 through a Response Element Frequently Disrupted in B-Cell Non-Hodgkin's Lymphoma.
|
Margalit, Ofer
|
|
|
106 |
11 |
p. 158
|
artikel
|
| 744 |
BCL6, p53 and Molecular Targeted Therapy in B-Cell Lymphomas.
|
Cerchietti, Leandro C.A.
|
|
|
106 |
11 |
p. 1484
|
artikel
|
| 745 |
Bcl-2 siRNA Induces Apoptosis and Enhances the Sensitivity to Arsenic Trioxide in NB4 Cells.
|
He, Dongmei
|
|
|
106 |
11 |
p. 4441
|
artikel
|
| 746 |
Bcl-x Is Indispensable for the Development of Natural Killer Cells.
|
Harb, Jason G.
|
|
|
106 |
11 |
p. 340
|
artikel
|
| 747 |
BCR-ABL Decreases the Expression of CCN3 Leading to Increased Clonogenic Potential and Cell Growth.
|
McCallum, Lynn M.R.
|
|
|
106 |
11 |
p. 1216
|
artikel
|
| 748 |
BCR-ABL Fusion Gene and BCR-ABL Transcript - Correlation with Response to Therapy in Chronic Myeloid Leukaemia.
|
Geraldes, C.
|
|
|
106 |
11 |
p. 4868
|
artikel
|
| 749 |
BCR/ABL Induces Expression of Histidine Decarboxylase and Synthesis of Histamine in CML Cells.
|
Aichberger, Karl J.
|
|
|
106 |
11 |
p. 4835
|
artikel
|
| 750 |
BCR-ABL Is Not an Immunodominant Antigen in CML.
|
Grünebach, Frank
|
|
|
106 |
11 |
p. 2881
|
artikel
|
| 751 |
BCR/ABL Kinase Disrupts Formation of Mismatch Repair Complex To Induce Genomic Instability.
|
Stoklosa, Tomasz
|
|
|
106 |
11 |
p. 2864
|
artikel
|
| 752 |
BCR-ABL Kinase Dynamics and Drug Resistance.
|
Azam, Mohammad
|
|
|
106 |
11 |
p. 1996
|
artikel
|
| 753 |
Bcr-Abl-Mediated Suppression of Normal Hematopoiesis in Chronic Myeloid Leukemia: Involvement of a Modified Form of NGAL.
|
Lin, Hui
|
|
|
106 |
11 |
p. 2869
|
artikel
|
| 754 |
BCR/ABL Modifies the Kinetics and Fidelity of DNA Double-Strand Breaks Repair in Leukemia Cells.
|
Slupianek, Artur
|
|
|
106 |
11 |
p. 1982
|
artikel
|
| 755 |
BCR/ABL Oncogene Controls MICA Translation.
|
Boissel, Nicolas
|
|
|
106 |
11 |
p. 4389
|
artikel
|
| 756 |
BCR/ABL Post-Translationally Enhances hnRNP E2 Expression and Translation-Inhibitory Function through the Activation of ERK1/2 Mitogen-Activated Protein Kinases.
|
Chang, Ji-Suk
|
|
|
106 |
11 |
p. 4376
|
artikel
|
| 757 |
BCR/ABL Regulates the Expression and Interacts with Werner Syndrome Helicase/Exonuclease To Modulate Its Biochemical Properties.
|
Slupianek, Artur
|
|
|
106 |
11 |
p. 2873
|
artikel
|
| 758 |
Bcr-Abl Resistance Screening Predicts a Limited Spectrum of Point Mutations To Be Associated with Clinical Resistance to the Abl Kinase Inhibitor AMN107.
|
von Bubnoff, Nikolas
|
|
|
106 |
11 |
p. 1983
|
artikel
|
| 759 |
BCR/ABL Tyrosine 177 Complexes with Grb2, Gab2 and Shp2, and Plays a Critical Role in Akt Activation and Altered p27 Signaling in BCR/ABL Transformed Human CD34+ Cells.
|
Chu, Su
|
|
|
106 |
11 |
p. 1988
|
artikel
|
| 760 |
BCR Gene Breakpoint and Type of BCR/ABL-Transcript in Children with Chronic Myeloid Leukemia.
|
Suttorp, Meinolf
|
|
|
106 |
11 |
p. 4863
|
artikel
|
| 761 |
B Domain of Coagulation Factor VIII Regulates Exposure of Its Heparin-Binding Site.
|
Makogonenko, Evgeny M.
|
|
|
106 |
11 |
p. 1014
|
artikel
|
| 762 |
BEAC or BEAM Chemotherapy Followed by Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma Patients: Comparative Analysis on Efficacy and Toxicity.
|
Koo, Ja Eun
|
|
|
106 |
11 |
p. 5291
|
artikel
|
| 763 |
BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma and Hodgkin's Disease: A Single Center Comparative Study of 219 Patients.
|
Bashey, Asad
|
|
|
106 |
11 |
p. 2079
|
artikel
|
| 764 |
Bedside Leukoreduction of Cellular Blood Components in Preventing Cytomegalovirus Transmission in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients.
|
Narvios, Aida B.
|
|
|
106 |
11 |
p. 4165
|
artikel
|
| 765 |
Beliefs, Attitudes and Utilization of Complementary and Alternative Medicine (CAM) among Long-Term Lymphoma Survivors: A Pilot Study.
|
Habermann, Thomas M.
|
|
|
106 |
11 |
p. 4700
|
artikel
|
| 766 |
Bendamustine HCl (TREANDATM) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).
|
Robinson, Katherine Sue
|
|
|
106 |
11 |
p. 923
|
artikel
|
| 767 |
Bendamustine HCl (TREANDATM) Treatment Results in High Rates of Objective Response in Patients with Rituximab-Refractory and Alkylator-Refractory Indolent B-Cell Non-Hodgkin's Lymphoma (NHL): Results from a Phase II Multicenter Single-Agent Study (SDX-105-01).
|
Friedberg, Jonathan W.
|
|
|
106 |
11 |
p. 229
|
artikel
|
| 768 |
Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.
|
Poenisch, Wolfram
|
|
|
106 |
11 |
p. 5154
|
artikel
|
| 769 |
Beneficial Effects of Cytogenetic and Molecular Response on Long-Term Outcome in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib (IM): Update from the IRIS Study.
|
Simonsson, Bengt
|
|
|
106 |
11 |
p. 166
|
artikel
|
| 770 |
Beneficial Prophylactic Antimicrobial Use Against Infectious Complications during Autologous Stem Cell Transplantation: A Result of Randomized Phase II Study in Multiple Myeloma and Non-Hodgkin's Lymphoma Patients.
|
Kim, Shin
|
|
|
106 |
11 |
p. 5477
|
artikel
|
| 771 |
Benefit of Early Switch to Liposomal Amphotericin B in Patients with Amphotericin B Deoxycholate-Induced Nephrotoxicity Versus Late Switch.
|
Isnard, Françoise
|
|
|
106 |
11 |
p. 5381
|
artikel
|
| 772 |
Benefit of the Adjunction of Rituximab in Salvage Regimen before Autologous Stem-Cell Transplantation (ASCT) in Follicular Lymphoma at Relapse. A Single Institution Study.
|
Belhadj, Karim
|
|
|
106 |
11 |
p. 2075
|
artikel
|
| 773 |
Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.
|
Hsieh, Matthew
|
|
|
106 |
11 |
p. 3069
|
artikel
|
| 774 |
Berkeley Sickle Mice Demonstrate CD8- and NK1.1-Dependent Increased Rejection of Allogeneic Hematopoietic Stem Cell Transplants.
|
Kean, Leslie
|
|
|
106 |
11 |
p. 2332
|
artikel
|
| 775 |
Beta-Catenin and N-Cadherin in Myeloma: Implications for Adhesion and Migration.
|
Zhan, Fenghuang
|
|
|
106 |
11 |
p. 2497
|
artikel
|
| 776 |
Beta 3 Integrin Phosphorylation and VEGF Signaling.
|
Mahabaleshwar, Ganapati H.
|
|
|
106 |
11 |
p. 532
|
artikel
|
| 777 |
Beta-2 Microglobulin and Soluble Interleukin-2 Receptor Serum Levels Correlates with Human Immunodeficiency Virus Associated Non-Hodgkins Lymphoma-Diffuse Large B-Cell Lymphoma (HIV-NHL-DLBCL).
|
McPherson, Eugene
|
|
|
106 |
11 |
p. 4675
|
artikel
|
| 778 |
Better Molecular Response (MR) to Imatinib (IM) in Early Chronic Phase (CP) Versus Late CP Chronic Myeloid Leukemia (CML) Patients (pts) in Complete Cytogenetic Response (CCR): A Comparison at 24 Months of 2 Clinical Trials of the GIMEMA Working Party on CML on Behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML).
|
Poerio, Angela
|
|
|
106 |
11 |
p. 1096
|
artikel
|
| 779 |
Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.
|
Molina, Ana M.
|
|
|
106 |
11 |
p. 3344
|
artikel
|
| 780 |
Bi-Allelic Deletion of 13q14 Is Associated with Inferior Progression Free Survival Compared to Mono-Allelic 13q14 Deletion in B-Cell Chronic Lymphocytic Leukaemia.
|
O'Connor, Sheila J.
|
|
|
106 |
11 |
p. 2936
|
artikel
|
| 781 |
BIC and miR-155 Are Highly Expressed in Hodgkin, Primary Mediastinal and Diffuse Large B Cell Lymphomas.
|
Kluiver, Joost
|
|
|
106 |
11 |
p. 970
|
artikel
|
| 782 |
Bim Is the Critical, and Bad and Bmf Are the Ancillary BH3-Only Proteins for Imatinib Mesylate-Induced Apoptosis of Bcr/Abl-Positive Leukemias.
|
Kuroda, Junya
|
|
|
106 |
11 |
p. 2876
|
artikel
|
| 783 |
Bim Promoter Is Highly Methylated in Malignant Lymphoid Cell Lines, Leading to Downregulation of Bim Expression and Protection from Apoptosis.
|
Piazza, Rocco G.
|
|
|
106 |
11 |
p. 2625
|
artikel
|
| 784 |
Binding Properties of a Human Anti-Ib ScFv Antibody (HIb-1) to Native, Recombinant, and Transgenicially Expressed Human Platelet GP Ibα Antigen.
|
Kim, Antony Y.
|
|
|
106 |
11 |
p. 4162
|
artikel
|
| 785 |
Binding Site Specificity, Mechanics, and Kinetics of Bimolecular Interactions Underlying Fibrin Polymerization.
|
Litvinov, Rustem I.
|
|
|
106 |
11 |
p. 1955
|
artikel
|
| 786 |
Biochemical and Cellular Characterization of the Novel Proteasome Inhibitor PR-171.
|
Demo, Susan D.
|
|
|
106 |
11 |
p. 1588
|
artikel
|
| 787 |
Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions. Hematologic Implications.
|
Fareed, Jawed
|
|
|
106 |
11 |
p. 1876
|
artikel
|
| 788 |
Biodistribution of DiI-Labeled Bone Marrow-Derived Mononuclear Cells Following Intracoronary Injection in a Porcine Model of Chronic Myocardial Ischemia.
|
Bhakta, Shyam
|
|
|
106 |
11 |
p. 3974
|
artikel
|
| 789 |
Biological Differences in Peripheral T-Cell Lymphomas Identified by DNA Microarrays.
|
Martinez-Delgado, Beatriz
|
|
|
106 |
11 |
p. 3012
|
artikel
|
| 790 |
Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment.
|
Jamieson, Catriona
|
|
|
106 |
11 |
p. 696
|
artikel
|
| 791 |
Biosynthesis and Apical Secretion of ADAMTS13 Metalloprotease in Vascular Endothelial Cells and in Madin-Darby Canine Kidney Cells.
|
Shang, Dezhi
|
|
|
106 |
11 |
p. 2652
|
artikel
|
| 792 |
BiovaxID™ Vaccine Therapy of Follicular Lymphoma in First Remission: Long-Term Follow-Up of a Phase II Trial and Status of a Controlled, Randomized Phase III Trial.
|
Santos, Carlos
|
|
|
106 |
11 |
p. 2441
|
artikel
|
| 793 |
Biphasic Waveform of the Activated Partial Thromboplastin Time (A2 Flag) Is Associated with Adverse Events in the Coronary Care Unit.
|
Bane, Christopher
|
|
|
106 |
11 |
p. 4037
|
artikel
|
| 794 |
BiRD (Biaxin®/Revlimid®/Dexamethasone) Combination Therapy (Rx) Results in High Complete Remissions (CR) and Overall Responses in Myeloma (MM) with Poor Prognostic Features.
|
Niesvizky, Ruben
|
|
|
106 |
11 |
p. 642
|
artikel
|
| 795 |
Birth Order and Outcome in HLA-Identical Sibling Donor Hematopoietic Stem Cell Transplants. Impact of a Sequential Fetomaternal - Maternofetal Cell Transfer?.
|
Bucher, Christoph M.
|
|
|
106 |
11 |
p. 2034
|
artikel
|
| 796 |
Bisphosphonate Related Osteonecrosis (BRON) of the Jaw: Single Institutional Update.
|
Mehrotra, Bhoomi
|
|
|
106 |
11 |
p. 291
|
artikel
|
| 797 |
Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.
|
Tosi, Patrizia
|
|
|
106 |
11 |
p. 3461
|
artikel
|
| 798 |
Bivalirudin in Patients with HIT or Clinically Suspected HIT.
|
Ramirez, Luz M.
|
|
|
106 |
11 |
p. 918
|
artikel
|
| 799 |
Blastic Mantle Cell Leukemia Maitaining Remission for 3 Years after the Treatment with Rituximab.
|
Tsuji, Masanori
|
|
|
106 |
11 |
p. 4774
|
artikel
|
| 800 |
BLIMP-1 Is a Target of Cellular Stress and Downstream of the Unfolded Protein Response.
|
Doody, Gina
|
|
|
106 |
11 |
p. 2207
|
artikel
|
| 801 |
Blockade of Adaptive Defensive Changes in Cholesterol Uptake and Synthesis in AML by the Addition of Pravastatin to Idarubicin + High Dose Ara-C: A Phase I Study.
|
Kornblau, Steven M.
|
|
|
106 |
11 |
p. 405
|
artikel
|
| 802 |
Blocking Complement-Mediated Hemolysis Using RNA Aptamers That Bind Complement Component C8.
|
Nishimura, Jun-ichi
|
|
|
106 |
11 |
p. 186
|
artikel
|
| 803 |
Blocking Pleiotrophin Activity Inhibits Multiple Myeloma (MM) Cell Growth In Vitro and in a Severe Combined Immunodeficient (SCID)-hu Murine Model of Human MM.
|
Campbell, Richard A.
|
|
|
106 |
11 |
p. 114
|
artikel
|
| 804 |
Blood Lipid Abnormalities in Sickle Cell Disease Are Pancellular and Clinically Important.
|
Okpala, Iheanyi
|
|
|
106 |
11 |
p. 2339
|
artikel
|
| 805 |
Blood Transfusion, Anesthesia, Surgery and Risk of Non-Hodgkin Lymphoma.
|
Cerhan, James R.
|
|
|
106 |
11 |
p. 4697
|
artikel
|
| 806 |
Bmi-1 Expression Is Useful To Design Therapy and To Predict Prognosis in Patients with Acute Myeloid Leukemia.
|
Chowdhury, Moniruddin
|
|
|
106 |
11 |
p. 3296
|
artikel
|
| 807 |
BMI-1 Overexpression in 32Dcl3 Cells Suppresses Granulocytic Differentiation and Ameliorates Their Growth under IL-3 Diminished Conditions.
|
Hishida, Asahi
|
|
|
106 |
11 |
p. 4211
|
artikel
|
| 808 |
BMP4 Favors Hematopoietic Differentiation from Murine Embryonic Stem Cells and Acts by Activation of the cdx-hox Pathway.
|
Lengerke, Claudia
|
|
|
106 |
11 |
p. 3613
|
artikel
|
| 809 |
BMP4 Induces Changes in Jagged 1 Expression in Bone Marrow Stroma: Association with Induction of Notch Regulated Genes in CD34+Cells.
|
Fagerlie, Sara R.
|
|
|
106 |
11 |
p. 1388
|
artikel
|
| 810 |
BMP4/Madh5 Dependent Signaling Is Required for the Expansion of a Population of Stress Erythroid Progenitors in the Fetal Liver.
|
Paulson, Robert F.
|
|
|
106 |
11 |
p. 4195
|
artikel
|
| 811 |
BMS-214662 Targets Quiescent Chronic Myeloid Leukaemia Stem Cells and Enhances the Activity of Both Imatinib and Dasatinib (BMS-354825).
|
Copland, Mhairi
|
|
|
106 |
11 |
p. 693
|
artikel
|
| 812 |
Body Size Measures and the Risk of Venous Thrombosis: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
|
Cushman, Mary
|
|
|
106 |
11 |
p. 1626
|
artikel
|
| 813 |
Bone Marrow BCL2/IgH+ Cells at Diagnosis and Not FCGRIIIA Polymorphism Predict Response in Follicular Non-Hodgkin's Lymphoma Patients Treated with Sequential CHOP and Rituximab.
|
Carlotti, Emanuela
|
|
|
106 |
11 |
p. 985
|
artikel
|
| 814 |
Bone Marrow Connexin-43 Expression Is Critical for Hematopoietic Regeneration after Chemotherapy.
|
Lee, Andrew W.
|
|
|
106 |
11 |
p. 469
|
artikel
|
| 815 |
Bone Marrow-Derived Aldehyde Dehdrogenase Expressing Cells Possess Endothelial Progenitor Function in Addition to Hematopoietic Repopulating Ability and Aid in Blood Flow Recovery after Acute Ischemic Injury.
|
Capoccia, Benjamin J.
|
|
|
106 |
11 |
p. 2663
|
artikel
|
| 816 |
Bone Marrow-Derived, BCR/ABL+ and Flk1+CD31−CD34− Stem Cells from CML Patients That Are Insensitive to STI571 In Vitro.
|
Song, Yongping
|
|
|
106 |
11 |
p. 4853
|
artikel
|
| 817 |
Bone Marrow Derived, De Novo Generated CD4+ T Cells Are Previously Unsuspected Participants in CD8+ T Cell-Mediated Graft-Versus-Host Disease.
|
Zhang, Yi
|
|
|
106 |
11 |
p. 581
|
artikel
|
| 818 |
Bone Marrow Effects of High Dose Folic Acid Therapy in Chronic Idiopathic Thrombocytopenic Purpura.
|
Schulz, Elizabeth
|
|
|
106 |
11 |
p. 4016
|
artikel
|
| 819 |
Bone Marrow Erythroid Maturation and Cytokine Production in Refractory Anemia Patients with Positive Mitogen-Stimulated-Direct Antiglobulin Test.
|
Zaninoni, Anna
|
|
|
106 |
11 |
p. 4898
|
artikel
|
| 820 |
Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results.
|
Gugliotta, Luigi
|
|
|
106 |
11 |
p. 4962
|
artikel
|
| 821 |
Bone Marrow Fibrosis in Chronic Idiopathic Myelofibrosis Is Associated with Megakaryocyte Expression of Osteoprotegerin.
|
Centkowski, Piotr
|
|
|
106 |
11 |
p. 4955
|
artikel
|
| 822 |
Bone Marrow Fibrosis Is a Not Predictor of Overall Survival in Patients with Myeloma.
|
Roberts, P.
|
|
|
106 |
11 |
p. 5091
|
artikel
|
| 823 |
Bone Marrow Hypocellularity, Decreased Platelet Counts and Colony Forming Units Serve as Prognostics Parameters for Early Complications after Autologous Peripheral Blood Stem Cell Transplantation.
|
Mueller, Antonia M.S.
|
|
|
106 |
11 |
p. 5514
|
artikel
|
| 824 |
Bone Marrow Mast Cells Are Significantly Increased in Patients with Waldenstrom's Macroglobulinemia, and Their Number Following Therapeutic Intervention Is Dependent on Extent of Response.
|
Santos, Daniel Ditzel
|
|
|
106 |
11 |
p. 980
|
artikel
|
| 825 |
Bone Marrow Microcirculation Parameter Amplitude A of Contrast-Enhanced Dynamic MRI Is a Prognostic Factor for Progressive Multiple Myeloma for Patients with Low Beta2-Microglobulin.
|
Hillengass, Jens
|
|
|
106 |
11 |
p. 5062
|
artikel
|
| 826 |
Bone Marrow Patterns of Expression of p53, Caspase-3, Ki-67, P21waf and WT-1 Proteins May Provide a Tool To Differentiate Inherited from Acquired Cytopenias: A Study of 199 Patients.
|
Elghetany, M. Tarek
|
|
|
106 |
11 |
p. 1035
|
artikel
|
| 827 |
Bone Marrow Procedure-Related Pain and Anxiety Improved with Propofol Protocol.
|
Palac, Diane
|
|
|
106 |
11 |
p. 1325
|
artikel
|
| 828 |
Bone Marrow Stromal Cells Modulate Sensitivity of CXCR4-Deficient CML Cells to Pharmacological Inhibitors of PI3K/AKT Signaling.
|
Jin, Linhua
|
|
|
106 |
11 |
p. 4888
|
artikel
|
| 829 |
Boosts with Highly Purified Stem Cells Can Improve Hematopoietic Regeneration after Allogeneic Transplantation from Alternative Donors.
|
Lang, Peter
|
|
|
106 |
11 |
p. 2917
|
artikel
|
| 830 |
Bortezomib Alters Peripheral Blood Lymphocyte Subsets in Patients with Multiple Myeloma.
|
Uy, Geoffrey L.
|
|
|
106 |
11 |
p. 2387
|
artikel
|
| 831 |
Bortezomib - A Potential Therapeutic Approach in B Chronic Lymphocytic Leukaemia.
|
Sarmento-Ribeiro, A.
|
|
|
106 |
11 |
p. 5007
|
artikel
|
| 832 |
Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.
|
Richardson, Paul
|
|
|
106 |
11 |
p. 2547
|
artikel
|
| 833 |
Bortezomib Does Not Impair Cytokine Induced Mobilization of Stem Cells Prior to Autologous Transplantation in Multiple Myeloma.
|
Uy, Geoffrey L.
|
|
|
106 |
11 |
p. 2926
|
artikel
|
| 834 |
Bortezomib in Combination with High-Dose Dexamethasone and Continuous Low-Dose Oral Cyclophosphamide for Relapsed Multiple Myeloma.
|
Kropff, Martin
|
|
|
106 |
11 |
p. 2549
|
artikel
|
| 835 |
Bortezomib Induces Rapid Upregulation of Topoisomerase IIα and Demonstrates Schedule-Dependent Synergistic Cytotoxicity with Anthracyclines and Etoposide in Acute Myeloid Leukemia and Myeloma Cell Lines.
|
Carroll, Michael P.
|
|
|
106 |
11 |
p. 2478
|
artikel
|
| 836 |
Bortezomib Induces Selective Depletion of Activated T Lymphocytes and Modifies the Cytokine's Production Pattern.
|
Blanco, Belen
|
|
|
106 |
11 |
p. 615
|
artikel
|
| 837 |
Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.
|
Kyrtsonis, Marie-Christine
|
|
|
106 |
11 |
p. 5193
|
artikel
|
| 838 |
Bortezomib Plus Rituximab in Patients with Indolent Non-Hodgkin's Lymphoma (NHL): A Phase 2 Study.
|
de Vos, Sven
|
|
|
106 |
11 |
p. 17
|
artikel
|
| 839 |
Bortezomib (PS-341) Sensitizes Multiple Myeloma Cell Lines to Etoposide-Induced Apoptosis.
|
Zavrski, Ivana
|
|
|
106 |
11 |
p. 5166
|
artikel
|
| 840 |
Bortezomib Therapy Alone and in Combination with Dexamethasone for Patients with Previously Untreated Multiple Myeloma.
|
Jagannath, Sundar
|
|
|
106 |
11 |
p. 783
|
artikel
|
| 841 |
Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).
|
Ducastelle, Sophie
|
|
|
106 |
11 |
p. 5399
|
artikel
|
| 842 |
Bortezomib (Velcade™) and the Bcl-2 Inhibitor HA14-1 Synergistically Stimulate Apoptosis in EBV-Transformed Lymphocytes: A Potential Approach to Treatment of EBV-Associated Lymphoproliferative Disorders.
|
Srimatkandada, Pavani
|
|
|
106 |
11 |
p. 2408
|
artikel
|
| 843 |
Bortezomib (Velcade) When Given Pretransplant and Once Weekly as Consolidation Therapy Following High Dose Chemotherapy (HDCT) Leads to High Rates of Reactivation of Varicella Zoster Virus (VZV).
|
Peles, Shachar
|
|
|
106 |
11 |
p. 3237
|
artikel
|
| 844 |
Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.
|
Watanabe, Norihiro
|
|
|
106 |
11 |
p. 2383
|
artikel
|
| 845 |
Both G0/G1 Cell Cycle Arrest and Continuous Activation of MAPK Induce Autophagic Cell Death in bcr-abl-Positive Leukemic Cells.
|
Mishima, Yuko
|
|
|
106 |
11 |
p. 4301
|
artikel
|
| 846 |
BP1 Expression in a Myeloma Cell Line: Modulation by Arsenic Trioxide and Ascorbic Acid.
|
Do, Khanh
|
|
|
106 |
11 |
p. 5113
|
artikel
|
| 847 |
Breast Cancer Resistance Protein (BCRP) Expression Affects Event-Free Survival in Adult Acute Lymphoblastic Leukemia Patients Uniformly Treated According to the GIMEMA LAL 2000 Protocol.
|
Gregorj, Chiara
|
|
|
106 |
11 |
p. 854
|
artikel
|
| 848 |
Burkitt's Lymphoma in Korea: Clinical Manifestations and Efficacy of Modified CALGB 9251 Regimen (BNHL).
|
Lee, Danbi
|
|
|
106 |
11 |
p. 4661
|
artikel
|
| 849 |
Ca 15-3 a Marker for the Megaloblastic Anaemia?.
|
Mettivier, Vincenzo
|
|
|
106 |
11 |
p. 3733
|
artikel
|
| 850 |
Calcitonin A Genotype Is Associated with Risk of Acute Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation for Children with Acute Myeloid Leukemia in First Remission.
|
Goyal, Rakesh K.
|
|
|
106 |
11 |
p. 1813
|
artikel
|
| 851 |
Calibration of Myocardial T2* Values in Post-Mortem Hearts.
|
Pennell, Dudley J.
|
|
|
106 |
11 |
p. 3837
|
artikel
|
| 852 |
CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.
|
van Grotel, Martine
|
|
|
106 |
11 |
p. 3279
|
artikel
|
| 853 |
Campath-IH Combined with Fludarabine/Cyclophophamide/Rituximab (FCR) as Conditioning for Unrelated Non-Myeloablative Hematopoietic Transplantation (NMT) for Non-Hodgkin's Lymphoma (NHL): Low Mortality Rate and Lower Than Expected Incidence of Cytomegalovirus (CMV) Reactivation.
|
Khouri, Issa F.
|
|
|
106 |
11 |
p. 2902
|
artikel
|
| 854 |
Canadian Variation in Blood Product Demand Is Influenced by Provincial Rates of Coronary Artery Bypass Graft Surgery.
|
Pendergrast, Jacob M.
|
|
|
106 |
11 |
p. 5578
|
artikel
|
| 855 |
Cancer as the Initial Presentation in Patients with Fanconi's Anemia.
|
Alter, Blanche P.
|
|
|
106 |
11 |
p. 3745
|
artikel
|
| 856 |
Cancer Incidence in Sickle Cell Disease. Howard University, 1996–2004.
|
Dawkins, Fitzroy
|
|
|
106 |
11 |
p. 3788
|
artikel
|
| 857 |
Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.
|
Chng, Wee-Joo
|
|
|
106 |
11 |
p. 3381
|
artikel
|
| 858 |
Can Elimination of Total Body Irradiation (TBI) in Conditioning Regimens for Autologous Stem Cell Transplantation (SCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma Decrease the Risk of Secondary AML/MDS(sAML/MDS)? A Retrospective Case-Control Study at the University of Nebraska Medical Center.
|
Maness, Lori J.
|
|
|
106 |
11 |
p. 682
|
artikel
|
| 859 |
Can Health Care Plans Afford Hemophilia Costs? Yes.
|
Aledort, Louis M.
|
|
|
106 |
11 |
p. 5551
|
artikel
|
| 860 |
Canonical Notch Signaling Is Dispensable for the Maintenance of Adult Hematopoietic Stem Cells.
|
Maillard, Ivan
|
|
|
106 |
11 |
p. 267
|
artikel
|
| 861 |
Capturing the Financial Impact of Heparin-Induced Thrombocytopenia.
|
Smythe, Maureen A.
|
|
|
106 |
11 |
p. 3127
|
artikel
|
| 862 |
γ-Carboxylation Is Not Required for gas6-Axl Binding but Is Necessary for gas6-Dependent Endothelial Cell Survival.
|
Blostein, Mark D.
|
|
|
106 |
11 |
p. 3702
|
artikel
|
| 863 |
Cardiac and Pulmonary Function Late Effects after Bone Marrow Transplantation in Childhood: Prospective Study on Behalf of EBMT LEWP Group.
|
Uderzo, Cornelio
|
|
|
106 |
11 |
p. 1113
|
artikel
|
| 864 |
Cardiac Followed by Autologous Stem Cell Transplantation for Systemic AL Amyloidosis.
|
Gillmore, J.D.
|
|
|
106 |
11 |
p. 1158
|
artikel
|
| 865 |
Cardiac Myofibroblasts of Hematopoietic Origin Are Mobilized by G-CSF and Contribute to Cardiac Repair after Myocardial Infarction.
|
Kawada, Hiroshi
|
|
|
106 |
11 |
p. 1699
|
artikel
|
| 866 |
Cardiac Toxicities after Treatment of Primary Hodgkin's Lymphoma (HL). Analysis of the LENT-SOMA Questionnaire Registered in the Database of the German Hodgkin Study Group (GHSG).
|
Behringer, Karolin
|
|
|
106 |
11 |
p. 5566
|
artikel
|
| 867 |
Cardioprotection by Deferiprone[L1] Inspite of Rising Serum Ferritin in Beta Thalassemia Major Patients.
|
Pathare, Anil
|
|
|
106 |
11 |
p. 3816
|
artikel
|
| 868 |
Carotid and Vertebral Artery Dissection Syndromes.
|
Grand, Beatriz
|
|
|
106 |
11 |
p. 4145
|
artikel
|
| 869 |
Casein Kinase II Inhibition in MEG-01 Cell Line Results in Apoptosis, Megakaryocytopoiesis and Functional Platelets Release.
|
Ciocea, Alieta
|
|
|
106 |
11 |
p. 4328
|
artikel
|
| 870 |
Case Report of Priapism in a Patient with Thalassemia Minor.
|
Mankan, Nagender
|
|
|
106 |
11 |
p. 3820
|
artikel
|
| 871 |
Case Report of Temozolamide Associated Steroid-Refractory ITP and Successful Treatment with Rituximab.
|
Reddy, Sandeep
|
|
|
106 |
11 |
p. 4015
|
artikel
|
| 872 |
Cas-L/Hef1 Is Required for Marginal Zone B Cell Maintenance and Lymphocyte Trafficking.
|
Seo, Sachiko
|
|
|
106 |
11 |
p. 3920
|
artikel
|
| 873 |
Caspase 3 Expression in Mantle Cell Lymphoma: An Immunohistochemical Study of 84 Patients.
|
Schrader, Carsten
|
|
|
106 |
11 |
p. 4676
|
artikel
|
| 874 |
Caspase-3 Has Apoptotic and Non-Apoptotic Functions in Regulating the Fate of Hematopoietic Stem Cells.
|
Janzen, Viktor
|
|
|
106 |
11 |
p. 1717
|
artikel
|
| 875 |
Cataracts and Other Neurosensory and Neuromotor Late Effects in Childhood HSCT Survivors.
|
Gurney, James G.
|
|
|
106 |
11 |
p. 1110
|
artikel
|
| 876 |
Cbl-Deficient Mice Display Erythropoietin Hypersensitivity and Enhanced Phosphorylation of Protein Kinase B/Akt.
|
Richmond, Terri D.
|
|
|
106 |
11 |
p. 3137
|
artikel
|
| 877 |
CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children's Oncology Group.
|
Hilden, Joanne M.
|
|
|
106 |
11 |
p. 7
|
artikel
|
| 878 |
CD1a Is a Dimorphic Antigen-Presenting Protein That May Be Mismatched without Increasing the Risk of Graft Versus Host Disease.
|
Lanning, Eleanor M.
|
|
|
106 |
11 |
p. 1811
|
artikel
|
| 879 |
CD41+ and Vascular Endothelial (VE)-Cadherin+ Cells: Two Developmental Origins of Hematopoietic Cell Lineages That Show Different Hematogenic Potentials.
|
Hashimoto, Kazuaki
|
|
|
106 |
11 |
p. 3612
|
artikel
|
| 880 |
CD30 as Target for Radioimmunotherapy (RIT) of Lymphoma.
|
Staak, Jan O.
|
|
|
106 |
11 |
p. 1501
|
artikel
|
| 881 |
CD5+B Lymphocytes in the Bone Marrow of Immunic Hemocytopenia Patients and Its Clinical Significancy.
|
Shao, Zonghong
|
|
|
106 |
11 |
p. 3905
|
artikel
|
| 882 |
CD8+ but Not CD4+ T Cells Require Cognate Interactions with Target Tissues To Mediate GVHD across Only Minor H Antigens but CD4+ and CD8+ T Cells Both Require Direct Leukemic Contact for GVL.
|
Shlomchik, Warren D.
|
|
|
106 |
11 |
p. 580
|
artikel
|
| 883 |
CD154:CD40 Co-Stimulatory Blockade: A Novel Approach To Prevent Sensitization to Donor Alloantigens.
|
Xu, Hong
|
|
|
106 |
11 |
p. 1273
|
artikel
|
| 884 |
CD4+CD25+ T Cells Can Inhibit CD8 T Cell Mediated GVHD: Requirement for In Vivo Recognition of Allogeneic Host MHC Class II Antigens.
|
Levy, Robert B.
|
|
|
106 |
11 |
p. 1307
|
artikel
|
| 885 |
CD4+CD28+ T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.
|
Weng, Jianyu
|
|
|
106 |
11 |
p. 3922
|
artikel
|
| 886 |
CD34+ Cells Mobilized with the New CXCR4 Antagonist AMD3100 + G-CSF Show Increased Anti-Apoptotic, Cell Cycle, DNA Repair and Cell Motility-Associated Gene Expression When Compared to G-CSF Mobilization Alone.
|
Seeger, Timon
|
|
|
106 |
11 |
p. 4264
|
artikel
|
| 887 |
CD8+ Central Memory T Cells Mediate Graft-Versus-Host Disease Although Retain Graft-Versus-Leukemia Effect.
|
Zheng, Hong
|
|
|
106 |
11 |
p. 1312
|
artikel
|
| 888 |
CD28-Costimulation Provided through a CD19-Specific Chimeric Immunoreceptor Enhances In Vivo Persistence and Anti-Tumor Efficacy of Adoptively Transferred T Cells.
|
Kowolik, Claudia M.
|
|
|
106 |
11 |
p. 1278
|
artikel
|
| 889 |
CD3 Depleted Hematopoietic Peripheral Blood Stem Cell Grafts in Children with Refractory Hematologic Malignancies Undergoing Transplantation from Mismatched Related Donors.
|
Hale, Gregory A.
|
|
|
106 |
11 |
p. 5458
|
artikel
|
| 890 |
CDDO Increases Translation of CCAAT Enhancer Binding Protein alpha To Induce Granulocytic Differentiation.
|
Koschmieder, Steffen
|
|
|
106 |
11 |
p. 2458
|
artikel
|
| 891 |
CD4+ Effector Memory and Naive T Cells Mediate Graft-Versus-Leukemia Via Direct Recognition of MHCII on Leukemic Cells.
|
Zheng, Hong
|
|
|
106 |
11 |
p. 579
|
artikel
|
| 892 |
CD62E-Positive Endothelial Microparticle-Neutrophil Conjugates, a Novel Marker of Prothrombotic and Inflammatory Disorders.
|
Chirinos, Julio A.
|
|
|
106 |
11 |
p. 3958
|
artikel
|
| 893 |
CD38 Expression in B-Cell Chronic Lymphocytic Leukemia: Association with Clinical Presentation and Laboratory Features in 64 Newly Diagnosed Patients.
|
Matias, Kleber
|
|
|
106 |
11 |
p. 4492
|
artikel
|
| 894 |
CD38 Expression in Chronic Lymphocytic Leukemia (CLL) Patients Is Associated with Family History of Hematological Neoplasms.
|
Domingo-Domenech, E.
|
|
|
106 |
11 |
p. 5002
|
artikel
|
| 895 |
CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).
|
Saber, Wael
|
|
|
106 |
11 |
p. 3292
|
artikel
|
| 896 |
CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.
|
Mori, Akio
|
|
|
106 |
11 |
p. 5142
|
artikel
|
| 897 |
CD66 Expression on Malignant and Normal Plasma Cells: A Potential Target for Therapy.
|
Richardson, Deborah
|
|
|
106 |
11 |
p. 5073
|
artikel
|
| 898 |
CD28 Fails to Costimulate Tumor-Specific Activation of Epstein Barr-Virus-Specific Memory Effector T Cells.
|
Altvater, Bianca
|
|
|
106 |
11 |
p. 1294
|
artikel
|
| 899 |
CD24High / FLJ/P1Low Expression Correlates with Bad Prognosis and Shorter Survival in Adult ALL.
|
Coignet, Lionel J.
|
|
|
106 |
11 |
p. 1451
|
artikel
|
| 900 |
CD 138 Immunostaining of Bone Marrow Trephine Specimens Is the Most Sensitive Method for Quantifying Marrow Involvement in Patients with Plasma Cell Dyscrasias.
|
Ng, Ashley P.
|
|
|
106 |
11 |
p. 5071
|
artikel
|
| 901 |
CD26 Inhibition Enhances Allogeneic Donor Cell Homing and Engraftment after In Utero Bone Marrow Transplantation.
|
Peranteau, William H.
|
|
|
106 |
11 |
p. 1275
|
artikel
|
| 902 |
CD97 Is Differentially Expressed on Murine Hematopoietic Stem Cells and Progenitor Cells.
|
van Pel, Melissa
|
|
|
106 |
11 |
p. 2281
|
artikel
|
| 903 |
CD69 Is Required for Activated NK Cell-Mediated Killing of Resistant Targets.
|
Marden, Chloe M.
|
|
|
106 |
11 |
p. 3322
|
artikel
|
| 904 |
CD62L and CD31 Matching Are Independent Risk Factors for Survival after Bone Marrow Transplantation.
|
Yu, Wong
|
|
|
106 |
11 |
p. 1423
|
artikel
|
| 905 |
CD44 Ligation Induces Apoptosis Via Caspase- and Serine Protease-Dependent Pathways in Acute Promyelocytic Leukemia Cells.
|
Maquarre, Eliane
|
|
|
106 |
11 |
p. 4432
|
artikel
|
| 906 |
CD30+ Lymphoproliferative Disorder/Lymphomatoid Papulosis - A Regression Caused by Mistletoe Therapy.
|
Seifert, Georg
|
|
|
106 |
11 |
p. 4779
|
artikel
|
| 907 |
CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.
|
Thanopoulou, Eleni
|
|
|
106 |
11 |
p. 3425
|
artikel
|
| 908 |
CD27-Mediated Apoptosis Is Dependent on Siva-Induced Caspase Activation in Human Multiple Myeloma.
|
Tai, Yu-Tzu
|
|
|
106 |
11 |
p. 3398
|
artikel
|
| 909 |
CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival.
|
Lee, Kelvin P.
|
|
|
106 |
11 |
p. 355
|
artikel
|
| 910 |
CD56+ Monomorphic Enteropathy-Type T-Cell Lymphoma Is a Genetically Distinct Entity Characterized by 8q Gains and Lack of 1q and 5q Gains.
|
deLeeuw, Ronald J.
|
|
|
106 |
11 |
p. 2840
|
artikel
|
| 911 |
CD19-Negative Diffuse Large B-Cell Lymphoma Shows High Serum LDH Level and Poor Prognosis.
|
Kimura, Miho
|
|
|
106 |
11 |
p. 1924
|
artikel
|
| 912 |
CD39/NTPDase1 Variants Identified in Human Neutrophils Regulate Antithrombotic Activity.
|
Olson, Kim E.
|
|
|
106 |
11 |
p. 3088
|
artikel
|
| 913 |
CD4+ Perforin+ T Cells in B-CLL: MHC Class II Restriction and Anti-Cytomegalovirus Reactivity.
|
Walton, James
|
|
|
106 |
11 |
p. 4979
|
artikel
|
| 914 |
CD34 Positive Cells Mobilized with Chemotherapy Plus Recombinant Human Growth Hormone (rhGH) and Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) Allows Sustained Engraftment in Previously Non-Mobilizer Patients.
|
Almici, Camillo
|
|
|
106 |
11 |
p. 5259
|
artikel
|
| 915 |
CD10− Pre-B Acute Lymphoblastic Leukemia (ALL): A Distinct High-Risk Subgroup of Adult ALL.
|
Gleissner, Beate
|
|
|
106 |
11 |
p. 1443
|
artikel
|
| 916 |
CD34+ Selected T-Cell Depleted Peripheral Blood Stem Cell Transplantation from HLA-Haplocompatible Donors for the Treatment of Severe Combined Immunodeficiency Disease.
|
Hung, Giun-Yi
|
|
|
106 |
11 |
p. 2914
|
artikel
|
| 917 |
CD34+ Selection before Autologous Peripheral Blood Stem Cell Transplantation: Comparison of the Nexell Isolex 300i® and Miltenyi Biotec CliniMACS® Systems.
|
Mantha, Simon
|
|
|
106 |
11 |
p. 1070
|
artikel
|
| 918 |
CD3+ T-Cell Content of Short Term Ex Vivo Expanded UCB on a MSC Platform Predicts Human Engraftment in a NOD/SCID Model.
|
Kozik, M.
|
|
|
106 |
11 |
p. 2303
|
artikel
|
| 919 |
CD8+ T Cell Responses to the Polycomb Protein EZH2 in Patients with Haemopoietic Malignancies.
|
Kalk, Emma
|
|
|
106 |
11 |
p. 3914
|
artikel
|
| 920 |
CD8+/TCR− Graft Facilitating Cells Enhance HSC Engraftment and Survival Via TNF-α Mediated Prevention of Apoptosis.
|
Ildstad, Suzanne T.
|
|
|
106 |
11 |
p. 1352
|
artikel
|
| 921 |
CD4 T-Helper Responses to the ALK Protein in Patients with ALK-Positive ALCL.
|
Ait-Tahar, Kamel K.
|
|
|
106 |
11 |
p. 3352
|
artikel
|
| 922 |
CEBOPP/VIML Followed by Radiotherapy for Intermediate- and Advanced-Stage Hodgkin's Disease: A Long-Term Analysis.
|
Nowrousian, M.R.
|
|
|
106 |
11 |
p. 2675
|
artikel
|
| 923 |
C/EBPα and C/EBPα Myeloid Oncoproteins Induce Bcl-2 Via Interaction of Their Basic Regions with NF-κB p50.
|
Paz-Priel, Ido
|
|
|
106 |
11 |
p. 2992
|
artikel
|
| 924 |
C/EBP Is Deregulated by PML-RAR in Acute Promyelocytic Leukemia.
|
Guibal, Florence
|
|
|
106 |
11 |
p. 3015
|
artikel
|
| 925 |
C/EBPε Knockout (KO) EML and PBiIM Cell Lines Replicate the In Vivo Phenotype of the C/EBPε KO Mouse.
|
Halene, Stephanie
|
|
|
106 |
11 |
p. 2725
|
artikel
|
| 926 |
C/EBPα Zippers with AP-1 but Not Maf Proteins, and C/EBPα:AP-1 Heterodimers Preferentially Bind a Hybrid cis Element.
|
Cai, Dong Hong
|
|
|
106 |
11 |
p. 2717
|
artikel
|
| 927 |
Cell Adhesion and Migration Regulated by EphB6 Expressed on Human Hematopoietic Progenitors.
|
Matsui, Toshimitsu
|
|
|
106 |
11 |
p. 1386
|
artikel
|
| 928 |
Cell-Autonomous Upregulation of Dendritic Cell Immunocompetence Is Antigen-Dependent.
|
Decker, William K.
|
|
|
106 |
11 |
p. 2230
|
artikel
|
| 929 |
Cell Based Assays Completed with the Mantle Cell Lymphoma Cell Lines Z138 and NCEB-1 Indicate That Combinations of Bortezomid and Flavopiridol Interact To Achieve Synergistic Activity.
|
Kapanen, Anita
|
|
|
106 |
11 |
p. 2410
|
artikel
|
| 930 |
Cell Cycle Regulation and Cell Fate Decisions in Hematopoietic Stem Cells.
|
Passegue, Emmanuelle
|
|
|
106 |
11 |
p. 1349
|
artikel
|
| 931 |
Cell Penetrating Mechanism of Bax Inhibiting Peptides.
|
Gomez, Jose A.
|
|
|
106 |
11 |
p. 4298
|
artikel
|
| 932 |
Cellular and Molecular Events Underlying the Interaction of Hematopoietic Stem and Progenitor Cells with Mesenchymal Stem Cells.
|
Bauer, Nicola
|
|
|
106 |
11 |
p. 2309
|
artikel
|
| 933 |
Cellular Composition of Allogeneic and Autologous PBPC Grafts and Patient Engraftment.
|
Barbosa, Isabel L.
|
|
|
106 |
11 |
p. 5277
|
artikel
|
| 934 |
Cellular Expression of Tissue Factor, CD40 Ligand and P-Selectin in Normal Healthy Subjects during Hyperglycemia and Hyperinsulinemia.
|
Vaidyula, Vijender R.
|
|
|
106 |
11 |
p. 2628
|
artikel
|
| 935 |
Cellular Iron Metabolism Studies Demonstate Safety of Magnetic Tracking of Mesenchymal Stem Cells.
|
Pawelczyk, Edyta
|
|
|
106 |
11 |
p. 4320
|
artikel
|
| 936 |
Central Line-Associated Venous Late Effects in Children without Any Prior History of Thrombosis - A Cross-Sectional Study of Children Previously Treated for Malignant or Hematological Diseases.
|
Ruud, Ellen
|
|
|
106 |
11 |
p. 4118
|
artikel
|
| 937 |
Central Nervous System (CNS) Relapse in Adult Patients with Acute Lymphoblastic Leukemia (ALL): Frequency and Prognosis in 467 Patients without Cranial Irradiation for CNS Prophylaxis.
|
Sancho, Juan-Manuel
|
|
|
106 |
11 |
p. 1841
|
artikel
|
| 938 |
Central Venous Access Device-Related Infections in Hemophilia.
|
Journeycake, Janna M.
|
|
|
106 |
11 |
p. 3216
|
artikel
|
| 939 |
Cerebral Blood Flow Velocities Measured by Transcranial Doppler Ultrasonography in Children with Sickle Cell Disease in Africa.
|
Makani, Julie
|
|
|
106 |
11 |
p. 3779
|
artikel
|
| 940 |
Cerebral Sinovenous Thrombosis Post Head Injury - 10 Year Experience in Children.
|
Komwilaisak, Patcharee
|
|
|
106 |
11 |
p. 4132
|
artikel
|
| 941 |
Cerebral Thromboses during Treatment of Childhood Acute Lymphoblastic Leukaemia.
|
Pautard, Brigitte
|
|
|
106 |
11 |
p. 876
|
artikel
|
| 942 |
Ceruloplasmin Is Essential for the Mobilization of Tissue Iron Stores.
|
Rivera, Seth
|
|
|
106 |
11 |
p. 3581
|
artikel
|
| 943 |
c-FLIP Level Determines the Sensitivity of Mantle Cell Lymphoma Cells to TRAIL-Induced Apoptosis Following Inhibition of NFkB Signalling or Proteasome Activity.
|
Roue, Gael
|
|
|
106 |
11 |
p. 4820
|
artikel
|
| 944 |
Change in SP Distribution with Age Reflects Intrinsic Age-Based Changes in Stem Cell Biology: Implications for the Mechanism of Aging.
|
Pearce, Daniel J.
|
|
|
106 |
11 |
p. 4209
|
artikel
|
| 945 |
Change over Time of Transcranial Doppler Cerebral Blood Flow Velocity and the Relationship with Turbulence on Magnetic Resonance Angiography in Patients with Sickle Cell Anemia.
|
Kotecha, Krishna
|
|
|
106 |
11 |
p. 3799
|
artikel
|
| 946 |
Changes in Bone Metabolism Induced by Short-Term Treatment with G-CSF for the Mobilization of Allogeneic Hematopoietic Progenitor Cells.
|
Kroschinsky, Frank P.
|
|
|
106 |
11 |
p. 1772
|
artikel
|
| 947 |
Changes in Mcl-1 and Bim Expression with Bortezomib and Melphalan Therapy for Multiple Myeloma.
|
Popat, Rakesh
|
|
|
106 |
11 |
p. 2481
|
artikel
|
| 948 |
Characterisation of 6 Factor XI Missense Mutations.
|
Mitchell, Michael J.
|
|
|
106 |
11 |
p. 1787
|
artikel
|
| 949 |
Characterisation of SCL DNA-Binding Functions In Vivo in Haematopoiesis.
|
Kassouf, Mira
|
|
|
106 |
11 |
p. 1733
|
artikel
|
| 950 |
Characterisation of the Novel, High Purity, Double Virus Inactivated Von Willebrand Factor and Factor VIII Concentrate Wilate®.
|
Stadler, Monika
|
|
|
106 |
11 |
p. 4067
|
artikel
|
| 951 |
Characteristics and Outcome of B-Cell Chronic Lymphocytic Leukemia in HCV-Positive Patients.
|
Molica, Stefano
|
|
|
106 |
11 |
p. 4986
|
artikel
|
| 952 |
Characteristics and Outcome of Therapy-Related MDS Developing after Primary Cancer in Children.
|
Ammann, R.
|
|
|
106 |
11 |
p. 2514
|
artikel
|
| 953 |
Characteristics and Survival of 29 Patients with Sezary Syndrome.
|
Sampogna, Francesca
|
|
|
106 |
11 |
p. 5587
|
artikel
|
| 954 |
Characteristics of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) in European Children.
|
Wagner, Hans-Joachim S.
|
|
|
106 |
11 |
p. 3883
|
artikel
|
| 955 |
Characterization and Optimization of Synthetic, VLDL Receptor Targeting, Antiangiogenic Peptides with TFPIc23-Like Activity.
|
Hembrough, Todd
|
|
|
106 |
11 |
p. 531
|
artikel
|
| 956 |
Characterization of a Megakaryocyte-Specific Enhancer of the Key Hemopoietic Transcription Factor GATA1.
|
Guyot, Boris
|
|
|
106 |
11 |
p. 834
|
artikel
|
| 957 |
Characterization of an Immunodeficient Mucopolysaccharidosis Type I (MPS-I) Mouse Model Suitable for Preclinical Testing of Human Stem Cell and Gene Therapy.
|
Quito-Rivera, Mayra F.
|
|
|
106 |
11 |
p. 1265
|
artikel
|
| 958 |
Characterization of Anti-Human GPVI Autoantibodies Mediating Persistent Target Immnunodepletion over a 15-Year Period.
|
Takayama, Hiroshi
|
|
|
106 |
11 |
p. 2168
|
artikel
|
| 959 |
Characterization of Cancer Stem-Like Cells in a Novel STI571-Resistant Chronic Myeloid Leukemia Cell Line.
|
Song, Yongping
|
|
|
106 |
11 |
p. 4852
|
artikel
|
| 960 |
Characterization of CD6-Negative Suppressor Cells Facilitating HLA-Haploidentical Stem Cell Transplantation.
|
Bigalke, Iris
|
|
|
106 |
11 |
p. 2909
|
artikel
|
| 961 |
Characterization of Circulating Primitive Erythroid Cells during Embryogenesis Using a Human ε-Globin-GFP Transgenic Mouse Model.
|
Fraser, Stuart T.
|
|
|
106 |
11 |
p. 3611
|
artikel
|
| 962 |
Characterization of Distinct Molecular Signatures in Myeloproliferative Diseases with the JAK2V617F Mutation and Wild Type JAK2.
|
Ebert, Benjamin L.
|
|
|
106 |
11 |
p. 119
|
artikel
|
| 963 |
Characterization of ‘Early' vs ‘Late' Endothelial Progenitor Cells (EPCs) Which Are Derived from Human Umbilical Cord Blood (HCB) during Ex Vivo Expansion.
|
Yoo, Eun-Sun
|
|
|
106 |
11 |
p. 1706
|
artikel
|
| 964 |
Characterization of Gene Expression Associated with Cyclophosphamide Resistance in Chronic Myeloid Leukemia (CML).
|
Bao, Fei
|
|
|
106 |
11 |
p. 1532
|
artikel
|
| 965 |
Characterization of Hematopoietic Stem/Progenitor Property of Cells in the Culture of the Mouse Aorta-Gonad-Mesonephros Region.
|
Nobuhisa, Ikuo
|
|
|
106 |
11 |
p. 3620
|
artikel
|
| 966 |
Characterization of IMiDs (Immunomodulating Agents) Induced “Flare Reaction” in Patients with Chronic Lymphocytic Leukemia (CLL) and Correlation with Changes in Serum Cytokine Levels.
|
DiMiceli, Laurie
|
|
|
106 |
11 |
p. 5049
|
artikel
|
| 967 |
Characterization of MSC Potential To Treat GVHD Using Molecular Markers Linked to MSC-Mediated Immunosuppression In Vitro.
|
Carter, Diane
|
|
|
106 |
11 |
p. 4322
|
artikel
|
| 968 |
Characterization of New Aberrations in 25 Splenic Marginal Zone B-Cell Lymphomas (SMZBCL) Using Spectral Karyotyping Technique (SKY).
|
Baro, C.
|
|
|
106 |
11 |
p. 4658
|
artikel
|
| 969 |
Characterization of Oncogene Dysregulation in Multiple Myeloma by Combined FISH and RT-PCR Analyses.
|
Qian, Shenxian
|
|
|
106 |
11 |
p. 5056
|
artikel
|
| 970 |
Characterization of p53 Abnormalities in CLL Patients in Relation to IGVH Mutation Status and Previous Treatment.
|
Trbusek, M.
|
|
|
106 |
11 |
p. 2947
|
artikel
|
| 971 |
Characterization of Patients with Multiple Myeloma and t(4;14) Detected by Fluorescence In Situ Hybridization.
|
Collado, Rosa
|
|
|
106 |
11 |
p. 5092
|
artikel
|
| 972 |
Characterization of Pica in Adults with Sickle Cell Disease.
|
Redding-Lallinger, Rupa
|
|
|
106 |
11 |
p. 3785
|
artikel
|
| 973 |
Characterization of Platelet TFPI.
|
Maroney, Susan A.
|
|
|
106 |
11 |
p. 1937
|
artikel
|
| 974 |
Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.
|
Watanabe, Ken-ichiro
|
|
|
106 |
11 |
p. 386
|
artikel
|
| 975 |
Characterization of the CATS Protein Which Interacts with the Leukemogenic Fusion Protein CALM/AF10 Using Mono-Clonal Antibodies and Fluroescent Protein Tags.
|
Archangelo, Leticia Fröhlich
|
|
|
106 |
11 |
p. 2856
|
artikel
|
| 976 |
Characterization of the Immune Response to Canine Factor IX Following AAV-Mediated Intravascular Gene Delivery to Skeletal Muscle in Hemophilia B Dogs.
|
Hui, Daniel J.
|
|
|
106 |
11 |
p. 1297
|
artikel
|
| 977 |
Characterization of the Proteomic and Genomic Profiles of Chronic Lymphocytic Leukemia Patients with Distinct Clinical Prognosis According to the Mutational Status of the IgVH and BCL6 and Expression Level of CD38 and ZAP70.
|
Marin, Miguel
|
|
|
106 |
11 |
p. 3272
|
artikel
|
| 978 |
Characterization of Vaccine Site and Cellular Infiltrate in Subjects with Chronic Myeloid Leukemia (CML) Receiving K562/GM-CSF Vaccination in Combination with Imatinib Mesylate with or without Topical Imiquimod.
|
Chia, Christina Y.
|
|
|
106 |
11 |
p. 2399
|
artikel
|
| 979 |
Characterizing Thymoglobulin® Reactivity with Human Myeloma and Plasma Cells.
|
Wang, Kathy S.
|
|
|
106 |
11 |
p. 3912
|
artikel
|
| 980 |
Charcterization of a Newly Established Megakaryo/Erythroid Leukemia Cell Line, JAS-R.
|
Yamada, Hisashi
|
|
|
106 |
11 |
p. 4327
|
artikel
|
| 981 |
Chemo-Immunotherapy with Hyper-CVAD Plus Ritixumab for Adult Burkitt's and Burkitt's Type Lymphoma (BL) or Acute Lymphoblastic Leukemia (B-ALL).
|
Thomas, Deborah A.
|
|
|
106 |
11 |
p. 149
|
artikel
|
| 982 |
Chemokines and Cytokines Required for Migration of Mesechymal Stem Cells into Marrow or Injured Tissues.
|
Tondreau, Tatiana
|
|
|
106 |
11 |
p. 4268
|
artikel
|
| 983 |
Chemosensitization of CDDP-Resistant Multiple Myeloma Cell Lines Following Treatment with Anti-TfR IgG3-Av.
|
Suzuki, Eriko
|
|
|
106 |
11 |
p. 5119
|
artikel
|
| 984 |
Chemosensitization of Drug and Rituximab-Resistant Daudi B-NHL Clones to Drug-Induced Apoptosis by the Proteasome Inhibitor NPI-0052.
|
Suzuki, Eriko
|
|
|
106 |
11 |
p. 1521
|
artikel
|
| 985 |
Chemosensitization of Drug-Resistant Ramos B-NHL to Drug-Induced Apoptosis: YY1 Expression Is Decreased in Response to Cytoskeletal-Interacting Drugs.
|
Neshat, Mehran
|
|
|
106 |
11 |
p. 4806
|
artikel
|
| 986 |
Childhood Secondary ALL after ALL Treatment.
|
Zuna, Jan
|
|
|
106 |
11 |
p. 852
|
artikel
|
| 987 |
Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.
|
Rizzari, Carmelo
|
|
|
106 |
11 |
p. 9
|
artikel
|
| 988 |
Chimeric Anti CD-20 Monoclonal Antibody-Rituximab in Refractory Childhood Idiopathic Thrombocytopenic Purpura: An Indian Experience.
|
Sharma, Ajay
|
|
|
106 |
11 |
p. 4010
|
artikel
|
| 989 |
Chimeric Anti-CD20 Monoclonal Antibody (Rituximab;Mabthera) in Remission Induction and Maintenance Treatment of Relapsed /Resistant Follicular Non-Hodgkin's Lymphoma: Final Analysis of a Phase III Randomized Intergroup Clinical Trial.
|
Van Oers, Marinus H.J.
|
|
|
106 |
11 |
p. 353
|
artikel
|
| 990 |
CHIR-12.12, an Antagonist Anti-CD40 Antibody, Exhibits Greater ADCC Than Rituximab Against a Variety of Malignant B Cells: Evaluation of FcγRIIIa Polymorphism and ADCC Response.
|
Luqman, Mohammad
|
|
|
106 |
11 |
p. 1472
|
artikel
|
| 991 |
CHIR-258 Efficacy in a Newly Developed Preclinical Bone Marrow Model of t(4;14) Multiple Myeloma.
|
Xin, Xiaohua
|
|
|
106 |
11 |
p. 3449
|
artikel
|
| 992 |
Chloroquine Inhibits Autophagy, Enhances p53-Dependent Apoptosis, and Delays Tumor Recurrence in a Mouse Model of B Cell Lymphoma.
|
Amaravadi, Ravi K.
|
|
|
106 |
11 |
p. 2421
|
artikel
|
| 993 |
CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).
|
Gallamini, Andrea
|
|
|
106 |
11 |
p. 3345
|
artikel
|
| 994 |
CHOP Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Hemolytic Anemia (AIHA) or Richter's Transformation (RT): First Interim Analysis of a Phase II Trial of the German CLL Study Group (GCLLSG).
|
Eichhorst, Barbara F.
|
|
|
106 |
11 |
p. 2126
|
artikel
|
| 995 |
Chromatin Conformation and a Distal Regulatory Element Activate the Human Erythroid Ankyrin-1 Promoter.
|
Owen, Ashley N.
|
|
|
106 |
11 |
p. 803
|
artikel
|
| 996 |
Chromosomal Abnormalities in Philadelphia Chromosome (Ph)-Negative Metaphases Appearing during Imatinib Mesylate (IM) Therapy in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase.
|
Jabbour, Elias
|
|
|
106 |
11 |
p. 1090
|
artikel
|
| 997 |
Chromosomal Deletions and Amplifications in Multiple Myeloma Detected by 500K Single Nucleotide Polymorphism Array Analysis.
|
Tai, Yu-Tzu
|
|
|
106 |
11 |
p. 1551
|
artikel
|
| 998 |
Chromosomal Instability Induced by Overexpression of Telomere Repeats Binding Factor 1.
|
Lan, Jianping
|
|
|
106 |
11 |
p. 4398
|
artikel
|
| 999 |
Chromosome 9 and 22 Breakpoints Cluster Regions Definition of Deleted Sequences on der(9) in Chronic Myeloid Leukemia.
|
Albano, Francesco
|
|
|
106 |
11 |
p. 4842
|
artikel
|
| 1000 |
Chromosome 21 Encoded RUNX1 and ETS-2 Overexpression in Regenerating Hematopoiesis in Children with Down Syndrome - Implications for Leukemiogenesis?.
|
Reinhardt, Dirk
|
|
|
106 |
11 |
p. 4373
|
artikel
|
Tijdschrift beschrijving